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ABSTRACT 
The heat shock protein haem oxygenase-1 (HO-1) and the enzyme inducible nitric oxide 
synthase  (iNOS)  are  both  induced  during  conditions  of  oxidative  stress  and  by  pro-
inflammatory mediators. Both HO-1 and iNOS may therefore be induced by a range of 
disease states that result in tissue inflammation. Both have been demonstrated to have 
potentially beneficial anti-inflammatory effects. Both HO-1 and iNOS and their respective 
gaseous products carbon monoxide and nitric oxide have being the subject of investigation 
as potential therapeutic targets for human respiratory disease, most notably asthma.  The 
pathogenesis  of  inflammatory  diseases  of  the  equine  lower  respiratory  tract  has  many 
similarities with human asthma and both HO-1 and iNOS have been demonstrated in fixed 
equine pulmonary tissue. 
The aim of the study was to investigate the expression of HO-1 and iNOS in the equine 
respiratory tract. The primary objective was to investigate whether HO-1 and iNOS were 
expressed  within  leukocytes  from  equine  BALF  and  to  semi-quantify  expression  in 
different cell types. If it proved possible to characterise and quantify expression, additional 
aims were to investigate associations between HO-1 expression, iNOS expression, clinical 
signs of respiratory disease and markers of oxidative stress in exhaled breath condensate. 
We were successful in demonstrating the expression of both HO-1 and iNOS in leukocytes 
from equine BALF. Expression was most intense in macrophages and neutrophils which 
was consistent with previous studies performed in other species. We did not identify an 
association between the degree of HO-1 or iNOS staining in leukocytes from BALF and 
the  severity  of  clinical  respiratory  disease.  We  also  failed  to  identify  an  association 
between expression of HO-1 and iNOS in leukocytes from BALF and markers of oxidative 
stress in exhaled breath condensate. Further investigations ought to be performed into the 
expression and activity of both HO-1 and iNOS in the equine respiratory tract.   3 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1   Epidemiology and Aetiopathogenesis of Recurrent Airway 
Obstruction 
1.1.1 Definition 
 
An  association  between  stabling  and  equine  respiratory  disease  is  well  documented  in 
historical texts and has likely afflicted equids for as long as they have been domesticated 
within  confined  airspaces.  In  333  BC,  Aristotle  described  a  characteristic  “heave”  or 
expiratory  effort  associated  with  the  condition  (Smith  1919).  In  the  last  century  the 
association between dusty or mouldy hay and occurrence of the condition was reported 
(Gillespie and Tyler 1969; Gerber 1973). Of the lower airway inflammatory conditions that 
affect  horses,  recurrent  airway  obstruction  (RAO)  is  probably  the  best  understood.  A 
number of terms have been used to describe the clinical manifestations of the condition 
including  heartache,  heaves,  broken  wind,  chronic  obstructive  pulmonary  disease  and 
recurrent airway obstruction (McPherson and Thomson 1983; Beech 1991). Other terms 
based on aetiopathogenesis have included allergic airway disease, hay sickness, chronic 
bronchiolitis,  small  airway  disease  and  emphysema  (McPherson  and  Thomson  1983; 
Beech  1991;  Mair  and  Derksen  2000;  Ainsworth  and  Hackett  2004).  An  international 
workshop on chronic airway disease held in Michigan in 2000 resulted in the publication 
of a consensus statement:  
 
“The term „heaves‟ or recurrent airway obstruction should be used for the mature horse 
with  airway  obstruction  that  is  reversed  by  a  change  in  environment  or  the  use  of 
bronchodilators” (Robinson 2001).  
 
The term „equine COPD‟ was derived from the human literature and used to describe the 
syndrome of airway obstruction, mucus accumulation and neutrophilic inflammation in the 
mature horse (Sasse 1971). However, human COPD is a progressive irreversible condition 2 
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generally associated with smoking and is different from „heaves‟. The Michigan workshop 
concluded: 
 
“New information in human and equine medicine has revealed major differences between 
human COPD and equine „heaves‟ so that, at present, it is no longer appropriate to use the 
term COPD in equine medicine” (Robinson 2001). 
 
Recurrent Airway Obstruction (RAO) is associated with housing, most commonly during 
the winter months. A clinically indistinguishable condition with similar clinicopathological 
features that occurs between spring and early autumn in horses at pasture has been termed 
summer pasture-associated obstructive pulmonary disease or SPAOPD (Beadle 1983). The 
acronym SPARAO might be considered to be more appropriate given the similarities with 
RAO  and  the  absence  of  any  clinicopathological  association  with  human  obstructive 
pulmonary  disease.  Recurrent  airway  obstruction  and  SPARAO  are  not  mutually 
exclusive.  Approximately  10%  of  horses  with  RAO  also  suffer  from  SPARAO  and 
approximately 50% of horses with SPARAO demonstrate hypersensitivity to hay and straw 
(Mair 1996). 
 
1.1.2 Epidemiology 
 
Respiratory disease is the second most common cause of lost training days and retirement 
in  racehorses  after  orthopaedic  disease  (Morris  and  Seeherman  1991;  Rush  and  Mair 
2004). The true prevalence of RAO is unknown; however estimates have varied from 2% 
to 80% depending upon inclusion criteria (McPherson et al. 1978; Larson and Busch 1985; 
Winder and von Fellenberg 1987; Bracher et al. 1991; Morris and Seeherman 1991). In the 
United Kingdom, RAO is recognised as a common cause of chronic coughing (McPherson 
and Thomson 1983) yet the true prevalence is unknown. From 270 horses presenting to a 
University  Clinic  in  Scotland,  148  (54.8%)  were  diagnosed  with  RAO  (Dixon  et  al. 
1995a), however this prevalence information was derived from a population of referred 
horses and is unlikely to represent the true prevalence of disease. In another study of 106 
cases  with  chronic  pulmonary  disease  referred  to  a  University  in  the  South  West  of 
England, 91 were diagnosed with RAO (Mair 1987). In Switzerland, which has a climate 
that is broadly comparable to the United Kingdom, a prevalence of 54% was determined 
based upon the results  of clinical examination, endoscopy, tracheal wash cytology and 
arterial blood gases (Bracher et al. 1991). Unfortunately these studies were performed prior 3 
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to  publication  of  a  consensus  statement  on  what  constituted  RAO  and  attempts  at 
differentiation between RAO and inflammatory airway disease (IAD) (Robinson 2001).  
The  disease  is  reportedly  more  common  in  the  northern  hemisphere  where  horses  are 
stabled through winter and fed hay cured during humid weather in the summer (Robinson 
et  al.  1996).  The  condition  is  rare  in  the  warmer,  drier  regions  of  the  United  States 
(Robinson et al. 1996) and has not been reported in Australia. In an abattoir survey of 166 
horses in the northern United States of America (USA), 12% of horses had inflammatory 
lesions of the bronchi (Larson and Busch 1985). 
 
Several  studies  with  inconsistent  inclusion  criteria  have  reported  gender  or  breed 
predilections (McPherson et al. 1979b; Dixon et al. 1995b; Seahorn et al. 1996; Aviza et 
al. 2001; Couetil and Ward 2003;) often with conflicting findings. Although one large 
retrospective  study  of  1,444  horses  identified  thoroughbreds  to  be  at  greater  risk  than 
ponies (Couetil and Ward 2003), there is no convincing evidence of an association between 
breed or gender and RAO. There does appear to be an association with age; most horses 
are 7 years of age or older at time of diagnosis (Couetil and Ward 2003; Couetil and 
Hinchcliff 2004; Lavoie 2007) and the mean age in one study was 12 years (Aviza et al. 
2001). 
 
A heritable basis for RAO has long been suspected. Only a proportion of horses kept under 
identical conditions will develop RAO and a high prevalence of the disease within families 
of  horses  has  been  reported  (Gerber  1989).  Marti  et  al.  (1991)  identified  a  genetic 
predisposition to chronic respiratory disease in populations of German Warmblood and 
Lippizaner horses with an increased prevalence in horses with one parent affected by the 
disease and a further increase in prevalence if both parents were affected. Management 
conditions appeared to influence development of the disease in genetically predisposed 
individuals demonstrating that both genotype and environment influence development of 
the disease. This work was supported by evidence for genetic influences on the production 
of allergen specific IgE thought to be via an association with genes encoding for major 
histocompatability complexes (MHC) (Eder et al. 2001). 
 
By contrast to RAO, SPARAO most commonly occurs from late spring to early autumn in 
horses  that  are  at  pasture.  No  genetic  or  breed  predisposition  for  SPARAO  has  been 
identified (Seahorn and Beadle 1993; Mair 1996) and the reported mean age of horses with 
the condition is 10 – 14 years  (Seahorn and Beadle 1993; Rush and Mair 2004). The 
genetic basis of SPARAO has not been investigated. 4 
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1.1.3 Aetiology 
 
The association between RAO and poor quality hay has been recognised for over 100 years 
(Cagney et al. 1904) and the connection between the disease and poor air quality was later 
established (McPherson et al. 1979b). Conventional equine housing systems expose horses 
to  high  levels  of  airborne  particulates  that  arise  from  feed  and  bedding  (Clarke  1987; 
Webster et al. 1987; Woods et al. 1993; Vandenput et al. 1997; McGorum et al. 1998). 
Stable dust may  contain a myriad of  agents  including around 70 species  of fungi  and 
actinomycetes, numerous species of forage mites, endotoxins and inorganic components 
(Halls and Gudmundsson 1985; Clarke and Madelin 1987; Woods et al. 1993; Pirie et al. 
2002,  2003a).  The  relative  importance  of  individual  agents  in  the  pathogenesis  of  the 
disease  is  yet  to  be  elucidated  and  has  been  the  subject  of  considerable  scientific 
investigation (Robinson 2001). 
 
1.1.3.1 Moulds 
Aspergillus  fumigatus,  Faenia  rectivirgula  (formerly  Micropolyspora  faeni)  and 
Thermoactinomyces vulgaris are particularly abundant in poor quality hay (Woods et al. 
1993)  and  have  been  suspected  to  be  aetiological  agents  of  RAO.  Inhalation  of  A. 
fumigatus  or  F.  rectivirgula  has  been  identified  to  cause  a  neutrophilic  pulmonary 
inflammatory  response  and  impaired  pulmonary  function  in  horses  with  RAO  but  not 
control horses (McPherson et al. 1979a; Derksen et al. 1988; McGorum et al. 1993d).  
Horses  with  RAO  have  significantly  higher  levels  of  IgE  to  mould  allergens  in 
bronchoalveolar lavage fluid (BALF) (Halliwell et al. 1993; Schmallenbach et al. 1998; 
Eder et al. 2000) and serum (Eder et al. 2000) compared to control animals. Horses with 
RAO show a greater disease response to hay and straw exposure than to experimental 
mould extracts (McGorum et al. 1993c) suggesting that other factors present in hay/straw 
are also important in triggering disease. Moulds contain a number of components that may 
contribute to disease in humans and animals including glucans, proteases and mycotoxins 
(Williams 1997). In horses, hay dust suspensions with a higher concentration of β-glucan 
are more likely to induce airway inflammation (Pirie et al. 2002) and in humans, β-glucan 
potentiates the inflammatory response to other agents, particularly endotoxin  (Williams 
1997). By contrast, horses with SPARAO do not have increased circulating concentrations 
of mould or pollen specific IgG or IgE (Seahorn et al. 1997). 
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1.1.3.2 Endotoxin 
Experimentally, endotoxin exposure induces a dose-dependent airway neutrophilia in both 
horses with RAO and horses with no evidence of airway disease (Pirie et al. 2001). In 
addition, airway dysfunction occurs in horses with RAO after exposure to endotoxin (Pirie 
et  al.  2001).  Endotoxin  has  the  capacity  to  prime  neutrophils  and  inhibit  neutrophil 
apoptosis (Pirie et al. 2001). Endotoxin has also been demonstrated to have a synergistic 
effect  with  organic  dust  particles  (particularly  mould  spores)  in  inducing  neutrophilic 
airway inflammation (Pirie et al. 2003b). However, reported concentrations of endotoxin 
in stables in Sydney, Australia (where RAO has not been reported) were similar to those 
reported previously in the UK (Malikides 2004).  
 
1.1.3.3 Mites 
Forage mites have been implicated in  the aetiopathogenesis of occupational asthma in 
humans  (Cuthbert  et  al.  1979)  and  are  present  in  high  concentrations  in  the  stable 
environment  (Halls  and  Gudmundsson  1985;  Clarke  and  Madelin  1987;  Woods  et  al. 
1993). Although their importance has been investigated, meaningful conclusions regarding 
their importance in the aetiopathogenesis of RAO have not been reached (Robinson 2001).  
 
1.1.3.4 Non-specific hyperreactivity 
Horses with RAO develop a generalised airway hyperreactivity (Derksen et al. 1985b) and 
are sensitive to non-specific inflammation by environmental factors such as noxious gases 
(ammonia, hydrogen sulphide and ammonia),  inorganic dusts and cold or dry air (Lavoie 
2007). 
 
1.1.3.5 Bacterial and viral infections 
Circumstantial evidence has led to the suggestion that bacterial or viral infections may 
predispose to the development of RAO (Gerber 1973; Lavoie 1997; Mair and Derksen 
2000) however this remains to be substantiated. 
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1.1.4 Pathogenesis 
 
The  series  of  events  between  exposure  of  horses  to  aetiological  agents  and  the 
development of clinical signs is yet to be elucidated fully; from what is currently known it 
would appear to be highly complex. 
 
 
1.1.4.1 Inflammation 
1.1.4.1.1 Hypersensitivity reactions 
It  is  well  established  that  IgE-mediated  reactions  play  an  important  role  in  asthma  in 
humans (Guo et al. 1994; Coyle et al. 1996). The finding that horses with RAO have 
significantly  higher  concentrations  of  IgE  directed  against  mould  allergens  in 
bronchoalveolar lavage fluid (BALF) (Halliwell et al. 1993; Schmallenbach et al. 1998; 
Eder et al. 2000) and serum (Eder et al. 2000) than unaffected horses is consistent with a 
Type  I  hypersensitivity  response.  Alternatively,  such  findings  could  merely  represent 
sensitisation of horses following exposure. Conversely, in one study, tracheal wash fluid 
from horses with SPARAO contained lower concentrations of IgE than that collected from 
control  horses  (Seahorn  et  al.  1997).  Typically,  clinical  signs  of  RAO  are  not  seen 
immediately  following  exposure  of  susceptible  animals  to  allergen,  suggesting  an  IgE 
mediated mast cell response (a classical Type I hypersensitivity reaction) is not central to 
the disease process. However, involvement of IgE and mast cells in the aetiology of RAO 
cannot be dismissed. 
 
Increased concentrations of serum precipitating antibodies to F. rectivurgula in one study 
was consistent with a Type III hypersensitivity response in horses with RAO (Halliwell et 
al.  1979),  however  in  another  study  increases  in  precipitating  antibodies  were  not 
identified consistently (Lawson et al. 1979). Furthermore, pathological changes in RAO 
are not characteristic of a type III hypersensitivity response (Lawson et al. 1979). 
 
1.1.4.1.2 Mast cells 
The role of mast cells in the pathogenesis of RAO remains controversial. In response to 
allergen  challenge,  the  concentration  of  histamine  in  pulmonary  epithelial  lining  fluid 
(PELF) has been shown to increase coincident with a decrease in the number of mast cells 
in BALF (Derksen et al. 1988; McGorum et al. 1993c). These findings are consistent with 
the degranulation of mast cells in response to allergen (Derksen et al. 1988; McGorum et 7 
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al. 1993c). In vitro, pulmonary mast cells from horses with RAO degranulate faster in 
response to challenge with fungal antigens than do those from control horses, consistent 
with sensitisation of mast cells in horses with RAO (Hare 1999). Mast cells from both 
healthy and RAO-affected horses have been shown to degranulate in response to challenge 
with hay dust suspension in vitro (Dacre et al. 2005), however numbers of mast cells have 
been demonstrated to increase to a similar degree after antigen exposure in both RAO and 
control  horses  (Marlin  et  al.  2005).  A  recent  study  demonstrated  that  the  number  of 
chymase-positive mast cells was increased in the bronchial and bronchiolar walls of horses 
with RAO with a relationship being identified between numbers of chymase positive mast 
cells and both pulmonary fibrosis and infiltration of lymphocytes and neutrophils (van der 
Haegen et al. 2005). 
 
1.1.4.1.3 TH1 vs TH2 lymphocyte responses 
Lower  airway  inflammation,  reversible  airway  obstruction  and  bronchial  hyper-
responsiveness are characteristic of both human asthma and RAO. A T helper type 2 (TH2) 
response is involved in the aetiopathogenesis of human asthma and it has been postulated 
that similar mechanisms would also be prominent in RAO (Lavoie 2007). Evidence of IgE-
mediated degranulation of mast cells and the discovery that histamine levels in BALF are 
increased 5 hours after natural challenge (McGorum et al. 1993b) were consistent with 
TH2  response  in  horses  with  RAO.  Furthermore,  increased  mRNA  expression  for 
interleukin-4  (IL-4)  and  interleukin-5  (IL-5)  and  decreased  expression  for  interferon 
gamma (IFNγ) in BALF have been identified (Lavoie et al. 2001; Cordeau et al. 2004; 
Horohov  et  al.  2005)  providing  further  evidence  of  a  TH2  response.  Interleukin-4 
stimulates proliferation of the TH2 cell phenotype and induces B lymphocytes to produce 
IgE  consistent  with  previous  findings  of  increased  IgE  in  BALF  and  serum  following 
induction of disease (Eder et al. 2000; Halliwell et al. 1993; Schmallenbach et al. 1998). 
Conversely,  other  authors  did  not  demonstrate  characteristic  TH-2  cytokine  profiles  in 
horses with RAO (Beadle et al. 2002; Giguere et al. 2002; Ainsworth et al. 2003; Kleiber 
et  al.  2005)  and  failed  to  demonstrate  a  correlation  between  antigen-specific  IgE  and 
expression  of  disease  (Dixon  et  al.  1996;  Eder  et  al.  2000)  casting  doubt  that  the 
mechanism of disease is a typical TH2 response. Furthermore, IgG responses in horses 
with RAO identified in some studies would be more consistent with a T helper type 1 
(TH1) response than a TH2 response (Halliwell et al. 1993; Ainsworth et al. 2002). The 
reason for discrepancies between studies is unclear; however they may include differences 
in challenge, differing methodologies, interaction of other non-allergic pro-inflammatory 8 
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aetiological agents or differences in time points of the disease process at which samples 
were collected. 
 
1.1.4.1.4 Neutrophils 
A TH-2 response and the release of increased levels of IL-5 would be expected to result in 
eosinophilia as occurs in human asthma; however this is an uncommon cytological finding 
in the airways of horses with RAO and SPARAO in which neutrophils are the predominant 
inflammatory  cell.  Blood  and  airway  neutrophils  are  activated  in  horses  with  RAO 
(Tremblay et al. 1993; Marr et al. 1997; Pellegrini et al. 1998; Brazil et al. 2005) and 
accumulate in the airways of diseased animals within 6 hours of exposure to mouldy hay 
(Fairbairn et al. 1993b; Pirie et al. 2001; Brazil et al. 2005). Apoptosis of neutrophils is 
delayed in  horses  with  RAO contributing to  the neutrophilia in  the peripheral  airways 
(Brazil 2000; Turlej et al. 2001). The triggers for neutrophil migration to the airway are 
poorly  understood,  however  upregulation  of  mRNA  expression  of  the  neutrophil 
chemoattractants  IL-8, macrophage inflammatory protein 2 (MIP-2), IL-1β and TNF-α 
have been shown to be up-regulated in RAO (Franchini et al. 1998; Franchini et al. 2000; 
Giguere et al. 2002; Laan et al. 2005). In one study, expression of IL-8 mRNA remained 
increased  even  when  horses  were  in  remission  (Giguere  et  al.  2002).  Interleukin-17 
(secreted  by  activated  T-cells)  promotes  maturation,  chemotaxis  and  activation  of 
neutrophils; increased mRNA expression of this cytokine was found in horses with RAO 
following  exposure  to  mouldy  hay  (Debrue  et  al.  2004).  Recent  evidence  suggests  an 
important  role  for  airway-derived  IL-8  in  neutrophil  chemotaxis  with  IL-17  not  being 
upregulated until later in the course of disease (Ainsworth et al. 2006). In man some TH-2 
cytokines  such  as  IL-4  are  able  to  modulate  neutrophil  kinetics  hastening  neutrophil 
maturation and delaying apoptosis (Bober et al. 1995; Girard et al. 1997).  
 
Neutrophils produce pro-inflammatory cytokines and chemokines including TNF-α, IL-1β, 
IL-6,  IL-8  and  MIP-2  (Joubert  et  al.  2001;  Giguere  et  al.  2002).  Increases  in  mRNA 
expression of IL-1β, TNF-α and IL-8 are consistent with increased nuclear factor kappa 
beta (NF-κβ) activity in RAO (Bureau et al. 2000a; Bureau et al. 2000b; Sandersen et al. 
2001).  
 
Nuclear factor-κβ is activated by, and regulates expression of, a number of inflammatory 
cytokines  (including  IL-1β,  TNF-α  and  IL-8)  and  is  associated  with  resistance  of 
inflammatory cells to apoptosis resulting in autoregulatory positive feedback loops that 
potentiate the inflammatory process (Barnes 1997). Nuclear factor-κβ is also activated by 9 
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endotoxin  (Barnes  1997).  Nuclear  factor-κβ  complexes  identified  in  RAO  were  p65 
homodimers  rather  than  the  more  typical  p65-p50  heterodimers;  a  finding  that  might 
explain the bias toward a neutrophilic rather than an eosinophilic inflammatory response 
(Sandersen et al. 2001) considering that p65 homodimers induce IL-8 production (a potent 
neutrophilic chemoattractant) whereas p65-p50 heterodimers induce eotaxin production (a 
potent  eosinophilic  chemoattractant).  Bronchial  NF-κβ  activity  strongly  correlates  to 
airway neutrophilia and its activity remains increased until granulocyte death (Bureau et al. 
2000a).  
 
Activated neutrophils may potentially contribute to the pathogenesis of RAO by a number 
of pathophysiological mechanisms. Neutrophils may release up to 50 histotoxins including 
reactive oxygen species, proteases (elastase, collagenase, metalloproteinase-9) which may 
contribute to tissue damage and release of pro-inflammatory mediators (LTB4, platelet-
activating  factor,  thromboxane  A2,  LTA4,  lactoferrin,  myeloperoxidase,  lysozyme  and 
nitric oxide) (Lavoie 2007). Pathologic increases in collagenolytic activity associated with 
increased  expression  and  synthesis  of  matrix  metalloproteinase-8  (MMP-8)  and  matrix 
metalloproteinase-13 (MMP-13) have been identified in horses with RAO (Koivunen et al. 
1997a). Excessive synthesis of these enzymes may result in destruction of the extracellular 
matrix and basement membrane, facilitating recruitment of inflammatory cells to sites of 
inflammation (Riley et al. 1988). Gelatinolytic and elastinolytic MMPs including MMP-2 
and  MMP-9  are  also  upregulated  in  horses  with  RAO  and  may  be  involved  in  the 
pathogenesis of this disease (Koivunen et al. 1997b; Raulo and Maisi 1998; Raulo et al. 
2000; Raulo et al. 2001; Nevalainen et al. 2002; Simonen-Jokinen et al. 2005a; Simonen-
Jokinen et al. 2005b).  
 
Increases in the production of neutrophil elastase 2A have also been identified in horses 
with RAO (Brazil 2000). Myeloperoxidase activity is increased in the BALF of horses 
with RAO during disease exacerbation and remission and may prove to be a marker of 
neutrophil activation (Art et al. 2006). 
 
1.1.4.1.5 Oxidative and Nitrosative injury 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) may enter the lung by 
inhalation or, more commonly, are generated by endogenous enzymatic or other chemical 
reactions. Reactive oxygen species is a collective term for multiple free oxygen radicals 
such as the super oxide anion and hydroxyl radicals and derivatives of oxygen that do not 
contain unpaired electrons such as hydrogen peroxide, hypochlorous acid, peroxynitrite 10 
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and ozone. The products of reaction between NO and super oxide, such as peroxynitrite, 
NO2Cl and NO2* are more reactive than their precursors. Simultaneous release of the two 
molecules is common during inflammatory processes and enhances cytotoxicity. 
 
Production of free radicals is an inevitable consequence of normal metabolic processes in 
all cells. The major function of ROS and RNS is the killing of invading micro-organisms. 
These  molecules  may  be  generated  in  granulocytes  by  peroxidases  which  catalyse  the 
reaction of hydrogen peroxide with halides leading to the formation of hypohalides such as 
hypochlorous  acid  (Andreadis  et  al.  2003).  In  addition,  all  activated  phagocytes 
(macrophages,  monocytes,  neutrophils  and  eosinophils)  generate  superoxide  anions  in 
response to activation of the membrane bound NADPH-oxidase complex by particulate 
matter,  micro-organisms  and  other  mediators  (Henricks  et  al.  1986;  Babior  2000). 
However, exposure of tissues to increased levels of ROS and RNS results in damage to 
DNA,  lipids,  proteins  and  carbohydrates,  neutrophil  migration  and  sequestration,  and 
escalation  of  the  inflammatory  process.  Considerable  research  has  focused  on  the 
regulation  of  redox  sensitive  transcription  factors  during  periods  of  oxidative  stress. 
Nuclear factor-κβ and activation protein-1 (AP-1) are fundamental in the inflammatory 
response and are activated by both ROS and RNS (Barnes 1997). Furthermore, synergistic 
activity has been demonstrated between ROS/RNS and inflammatory mediators such as 
TNF-α (Bowler and Crapo 2002).  
 
Oxidative or nitrosative stress is an imbalance between numbers and activity of oxidants 
and anti-oxidants. Pulmonary epithelial lining fluid and lung tissues contain enzymes and 
chemicals  to  protect  against nitrosative and oxidative injury. The most important  anti-
oxidant enzyme systems are the copper-zinc super oxide dismutases which rapidly convert 
the super oxide anion to hydrogen peroxide, catalase which converts hydrogen peroxide 
into  water  and  oxygen  and  the  glutathione  redox  system  (GSH-peroxidase  and  GSH-
reductase) that inactivates NO, hydrogen peroxide and other hydroperoxides (Cantin et al. 
1990; Repine et al. 1997; Pietarinen-Runtti et al. 2000). Other molecules that scavenge 
free radicals in the airways include vitamin E (α-tocopherol), vitamin C (ascorbic acid), 
uric  acid,  β-carotene,  flavonoids,  taurine,  lactoferrin,  albumin  and  bilirubin.  There  are 
marked differences between the anti-oxidant defenses in the upper and lower respiratory 
tract.  Bronchoalveolar  lavage  fluid  contains  ceruloplasmin  and  transferrin  and  large 
amounts of ascorbic acid and glutathione [95% of which is in a reduced state (Cantin et al. 
1987)] (Horvath et  al.  2005). However, little data  exists  on the normal  range of  anti-
oxidant  defences  in  epithelial  lining  fluid  and  marked  differences  may  occur  between 11 
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normal individuals. Asthmatics have been shown to have reduced levels of ascorbic acid 
and tocopherol within ELF; however how this reduction relates to antioxidant defences is 
unknown (Bowler and Crapo 2002).  
 
Whilst there is a huge quantity of circumstantial evidence implicating oxidative stress in 
the pathogenesis of inflammatory lung diseases, the  hypothesis is unproven due to the 
absence of any potent anti-oxidants that could be used to demonstrate the importance of the 
oxidant/anti-oxidant balance (Horvath et al. 2005).  
 
Considering  the  above  caveat,  there  is  considerable  circumstantial  evidence  of  the 
importance  of  ROS  and  RNS  in  the  pathogenesis  of  pulmonary  disease  in  man,  in 
particular  acute  respiratory  distress  syndrome  (ARDS),  interstitial  lung  disease,  cystic 
fibrosis, COPD and asthma (Huie and Padmaja 1993; Repine et al. 1997; Vallyathan and 
Shi 1997; Goldstein and Czapski 2000; Folkerts et al. 2001; Bowler and Crapo 2002). 
Horses with RAO have been shown to have evidence of pulmonary oxidative stress on the 
basis of oxidation of glutathione in the pulmonary epithelial lining fluid (PELF) (Art et al. 
1999) and a decrease in reduced ascorbic acid in PELF and plasma (Deaton et al. 2004a; 
Deaton et al. 2006). However, in another study, when horses with RAO were challenged 
with  organic  dust  there  was  no  evidence  of  severe  pulmonary  oxidative  stress  despite 
ascorbic acid consumption (Deaton et al. 2005a).  
 
1.1.4.1.6 Macrophages 
Whilst  most  research  has  centred  on  the  role  of  the  acquired  immune  system  in  the 
pathogenesis of RAO, there is  evidence of the  involvement of macrophages  and other 
antigen-presenting cells in the disease. It has been suggested that BAL macrophages from 
RAO-affected  horses  are  in  an  increased  state  of  activation  (Tremblay  et  al.  1993) 
compared  to  control  horses  and  exhibit  an  increased  expression  of  the  neutrophil 
chemoattractants TNF-α, IL-1β, and IL-8 (Laan et al. 2005; Laan et al. 2006). 
 
1.1.4.1.7 Non-inflammatory cells  
The  importance  and  role  of  epithelial  cells  in  the  pathogenesis  of  RAO  is  poorly 
understood. The location of airway epithelial cells affords these cells an important role in 
determining  responses  to  the  environment  and  they  are  able  to  signal  to,  and  receive 
signals  from,  the  innate  and  adaptive  limbs  of  the  immune  system  (Ainsworth  2005). 
Bronchial  epithelial  cells  of  horses  with  heaves  have  been  demonstrated  to  express 12 
  12 
increased  quantities  of  NF-κβ  that  correlate  to  decreased  airway  function  and  BALF 
neutrophilia (Bureau et al. 2000a; Bureau et al. 2000b). Bronchial epithelial cells of horses 
with SPARAO demonstrate increased immunoreactivity to inducible nitric oxide synthase 
(iNOS) (Costa et al. 2001) which may down-regulate the TH1 response in favour of a TH2 
response.   
 
 
1.1.4.2 Bronchoconstriction 
 
The importance of bronchospam in the pathogenesis of RAO is demonstrated by the rapid 
improvement  in  clinical  signs  and  pulmonary  function  following  administration  of 
bronchodilators (Murphy et al. 1980; Pearson and Riebold 1989; Erichsen et al. 1994). The 
precise cause of the bronchospasm is unknown and is likely multifactorial. Anticholinergic 
and β2-adrenergic agonists have similar bronchodilatory effects suggesting that muscarinic 
receptors are important in mediating bronchospasm (Robinson 2001).  
 
Multiple inflammatory mediators including endothelin-1, serotonin/5-HT, histamine and 
leukotriene  D4  (LTD4)  have  the  potential  to  induce  bronchoconstriction  via  specific 
receptors (Derksen et al. 1985a; Klein and Deegen 1986; Benamou et al. 1998; Marr et al. 
1998b; Doucet et al. 1990; Guthrie et al. 1992; Olszewski et al. 1997; Olszewski et al. 
1999a; Olszewski et al. 1999b) however their relative importance is unknown.  Histamine, 
5-HT  and  LTD4  increase  the  response  of  smooth  muscle  to  acetylcholine  (Ach)  and 
histamine and 5-HT also increase the release of Ach from these nerves. Antagonism of 
histamine or leukotrienes  fails  to  induce a significant  clinical  response  suggesting that 
these mediators are not central to the induction of bronchoconstriction (Lavoie et al. 2002; 
Marr et al. 1998a; Olszewski et al. 1999a). Reduced inhibition of bronchoconstriction by 
inhibitory nonadrenergic noncholinergic nerves may also have a role (Yu et al. 1994). 
 
 
1.1.4.3 Mucus accumulation 
 
Mucus  is  a  complex  biofilm  composed  of  water,  electrolytes,  enzymes,  epithelial  and 
inflammatory cells and mucins (high molecular weight O-linked glycoproteins) secreted by 
goblet cells in the surface epithelium and subepithelial glands (Robinson 2001). Mucus 
accumulation may be a consequence of increased secretion (Kaup et al. 1990), alterations 13 
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in the ciliary apparatus or increased mucus viscosity (Robinson 2001). The presence of 
large quantities of mucus is a consistent finding in the airways of horses with RAO (Dixon 
et al. 1995a; Robinson et al. 1996). Mucus produced in diseased animals is of higher 
viscosity and slower to clear than in control animals (Gerber et al. 2000) and may remain 
present even during periods of remission (Jefcoat et al. 2001). Accumulation of mucus in 
the lower airways is associated with airway neutrophilia and coughing (Robinson et al. 
2003). Increased tracheal secretions are produced in horses with RAO within 5 hours of 
challenge (Pirie et al. 2001). Quantitative and qualitative changes in the carbohydrate side-
chains occur in the mucins of horses with RAO (Jefcoat et al. 2001) which may be the 
result  of  expression  of  different  mucin  genes.  One  mucin  in  particular,  eqMUC5AC 
appears to be upregulated in horses with RAO (Gerber et al. 2003b). Accumulation of 
mucus may result in plugging of the distal airways and ventilation-perfusion mis-matching 
as well as predisposing affected animals to secondary bacterial infection (Lavoie 2007). 
 
 
1.1.4.4 Airway remodelling 
 
RAO has generally been considered to be a reversible disease; however evidence exists of 
progressive loss of pulmonary function as the disease progresses. A relationship between 
pulmonary function and bronchiolar remodelling post mortem has been identified (Kaup et 
al.  1990).  Pulmonary  smooth  muscle  mass  may  increase  3-fold  in  horses  with  RAO 
resulting  in  narrowing  of  the  peripheral  airways.    In  human  asthma,  smooth  muscle 
hypertrophy  is  the  most  important  contributor  to  increased  airway  resistance  and  it  is 
proposed that the process may be of similar importance in horses with RAO (Lavoie 2005). 
Peribronchiolar  fibrosis  and  epithelial  hyperplasia  also  occur  in  response  to  chronic 
inflammation of the airways and will contribute to a narrowing of the airways (Kaup et al. 
1990).  
 
1.1.5. Pathology 
The results of macroscopic examination of the lungs of horses affected by RAO indicate 
that pathology may be variable in distribution and severity (Gerber 1973; Beech 1991). 
The  lungs  may  appear  normal  or  there  may  be  evidence  of  hyperinflation  and  pallor 
(Gerber  1973;  Beech  1991).  With  severe  disease,  hyperinflation  may  be  evident  as 
emphysema, however this finding must be interpreted with caution as it may be identified 14 
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in older horses in the absence of respiratory disease (Thurlbeck and Lowell 1964). An 
increased quantity of exudate is commonly present within the airways. 
 
Histological  abnormalities  of RAO are most notable within the distal  airways.  Mucus, 
neutrophils and other cellular debris are present within the airways often coalescing to 
form pools of exudate and mucin plugs (Thurlbeck and Lowell 1964; Kaup et al. 1990). 
The  distal  airways  show  evidence  of  smooth  muscle  hypertrophy,  lymphocytic  and 
plasmacytic  infiltration,  epithelial  metaplasia,  desquamation,  goblet  cell 
hyperplasia/metaplasia  and  fibrosis  (Thurlbeck  and  Lowell  1964;  Winder  and  von 
Fellenberg 1987; Kaup et al. 1990). Eosinophilia is not a consistent finding in contrast to 
the findings of examination of the distal airways from patients with asthma (Barnes 1987). 
Bronchiectasis may result in separation of the cartilaginous plates of the dilated bronchi, 
disruption of chondrocyte arrangement and a reduction in the number of elastic fibres in 
the lamina propria (Lavoie et al. 2004). It has been reported that fibrosis and emphysema 
are not prominent findings in horses with SPARAO (Costa et al. 2000b), however this is 
possibly due to the smaller case numbers that have been examined.  
 
1.2 Epidemiology and Aetiopathogenesis of Inflammatory Airway 
Disease 
 
1.2.1 Definition 
The term “inflammatory airway disease” (IAD) was proposed in 2000 to distinguish a less 
severe form of respiratory tract inflammation from recurrent airway obstruction (Robinson 
2001).  In  2002,  a  workshop  entitled  “Inflammatory  Airway  Disease:  defining  the 
syndrome” was held to clarify what was known of the clinical presentation, epidemiology, 
diagnosis,  functional  consequences  and  pathology  of  the  syndrome  (Robinson  2003). 
Further  research  into  the  syndrome  followed  and  in  2007  the  American  College  of 
Veterinary Internal Medicine published a consensus statement in order to further clarify the 
distinctions between IAD and RAO (Couëtil et al. 2007). The authors of the consensus 
statement proposed the following minimum criteria to define the IAD phenotype in horses 
of any age:  
  Poor  performance,  exercise  intolerance,  or  coughing,  with  or  without  excess 
tracheal mucus. 15 
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  Nonseptic  inflammation  detected  by  cytologic  examination  of  bronchoalveolar 
lavage fluid (BALF) or pulmonary dysfunction based on evidence of lower airway 
obstruction, airway hyper-responsiveness, or impaired blood gas exchange at rest 
or during exercise. 
 
Further, the authors proposed the following exclusion criteria: 
 
  Evidence  of  systemic  signs  of  infection  (fever,  haematologic  abnormalities 
compatible with infection). 
  Increased respiratory effort at rest (i.e., heaves) (Couëtil et al. 2007) 
The  authors  of  the  consensus  statement  acknowledged  that  tracheal  inflammation  and 
infection are prevalent in horses, especially young racehorses (Christley et al. 2001; Wood 
et al. 2005a) and that the narrow inclusion criteria proposed in the statement excluded 
these cases. The link between such cases, seen commonly in the United Kingdom, and IAD 
as defined above remains to be established. This and other controversies, most notably 
differing methods of diagnosis, definitions of cytological findings and the validity of TA 
findings have prevented the above recommendations from achieving universal acceptance. 
 
1.2.2 Epidemiology 
The prevalence and incidence of IAD is likely to vary between differing populations of 
horses  and  comparison  between  studies  is  difficult  due  to  differing  inclusion  criteria. 
Different sub-categories of IAD with different aetiologies likely exist and their prevalence 
is likely to depend upon the equine population under investigation (Christley and Rush 
2007). Prevalence of IAD in young racehorses is high and studies using mucus scores 
and/or  airway  neutrophilia  in  Thoroughbreds  and  Standardbreds  have  resulted  in  a 
prevalence  of  11-50%  (Burrell  1985;  MacNamara  et  al.  1990;  Sweeney  et  al.  1992a; 
Chapman  et  al.  2000).  In  older  horses,  prevalence  is  less  well  studied,  however  it  is 
reported that prevalence may be up to  70% in  horses  maintained permanently indoors 
(Robinson 2003). Incidence of IAD is also high especially in horses entering training. In 
one study of Thoroughbred racehorses, 41% of horses entering a training yard developed 
respiratory disease within 2 weeks (Malikides 2004). In the UK, incidence of IAD was 
reported to be 8.9 cases/100 horses/month (Wood et al. 2005b). Among young racehorses 
the risk of IAD decreases with age (Chapman et al. 2000; Christley et al. 2001; Wood et 16 
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al. 2005b) which may indicate tolerance to the change of environment or the development 
of immunity to micro-organisms.  
1.2.3 Aetiology 
A variety of infectious and/or non-infectious agents may be involved in the aetiology of 
IAD and various interactions maybe required for development of disease. It is likely that 
the relative importance of aetiological agents is population dependent and determined by 
feeding, housing, preventive medicine practices, differences in distribution of infectious 
agents and genetic influences (Couëtil et al. 2007). The introduction of horses to a stable 
environment has been identified as a risk factor for the development of IAD (Tremblay et 
al. 1993; Holcombe et al. 2001) however, little is known of the relative importance of 
different respirable allergens and irritants. Airborne particulates may be ten times more 
concentrated  in  a  stable  environment,  compared  to  outdoor  air  and  30-40%  of  the 
particulate matter may be sufficiently small to reach the pulmonary alveoli (Christley and 
Rush  2007).  Stable  management  practices  such  as  cleaning  and  feeding  and  horse 
movement  may  further  increase  the  concentration  of  airborne  particulates  within  the 
breathing zone (Christley and Rush 2007). Coughing, a sign of respiratory inflammation, 
persists  for  longer  in  a  high  dust  environment  (Burrell  et  al.  1996).  The  presence  of 
increased numbers of pulmonary mast cells and eosinophils in BALF from horses with 
IAD has been proposed to indicate the involvement of aeroallergens in development of the 
disease  (Hare  and  Viel  1998;  Hoffman  et  al.  1998),  however  specific  immunological 
mechanisms  have  yet  to  be  elucidated.  Endotoxin  has  been  studied  as  a  major  pro-
inflammatory  component  of  particulate  matter.  Inhaled  endotoxin  will  induce  airway 
inflammation in  horses formerly free of respiratory disease  (Pirie et  al. 2001)  and the 
concentration of endotoxin in the breathing zone is associated with the development of 
IAD  in  young  racehorses  (Malikides  2004).  Other  inhalants  such  as  sulphur  dioxide, 
nitrogen dioxide, ozone, carbon monoxide, ammonia, hydrogen sulphide, methane, glucan, 
ultrafine  organic  and  inorganic  dust  particles,  micro-organisms  and  mite  debris  are  all 
present  within  the  stable  environment  and  may  contribute  to  airway  inflammation 
(Christley and Rush 2007).  
Transportation is also associated with lower respiratory tract inflammation (Raidal et al. 
1995;  Moore et  al.  1996). Concentrations  of aeroallergens  can be as  high in  transport 
vehicles as they are in the stable environment. Head elevation during transit results in 
increased penetration of inhalants into the lower respiratory tract; as a result of reduced 
mucociliary  clearance  (Racklyeft  and  Love  1990).  Transport  stress  may  also  result  in 17 
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immunosuppression and reduction in pulmonary defence mechanisms (Raidal et al. 1995; 
Raidal et al. 1997). 
High intensity exercise is associated with respiratory tract inflammation (McCarthy et al. 
1991; Moore et al. 1996; Christley et al. 2001). The reason for this is unknown, however 
exercise results in increased inhalation of particulate matter, increased exposure of the 
distal airways to unconditioned air and exercise-induced pulmonary haemorrhage, all of 
which may contribute to development of inflammation of the lower airways (Christley and 
Rush  2007).  Exercise  is  also  reported  to  adversely  affect  immune  function  by 
compromising pulmonary macrophage and peripheral lymphocyte function and increasing 
serum cortisol and pulmonary oxidative stress (Raidal et al. 2000; Raidal et al. 2001).  
The  role  of  infectious  agents  in  the  aetiopathogenesis  of  IAD  is  unclear.  Whilst  there 
appears  to  be  a  clear  association  between  presence  of  bacteria  in  the  trachea  and 
inflammation  it  remains  to  be  clarified  whether  they  are  causal  or  merely  represent 
secondary opportunistic colonisation (Viel 1997; Christley et al. 2001). In several studies 
performed  in  the  United  Kingdom  and  Australia,  tracheal  inflammatory  changes  were 
found to be positively correlated with the number of bacterial colony forming units (CFU) 
in tracheal aspirates (Burrell 1985; Burrell et al. 1996; Chapman et al. 2000; Christley et 
al. 2001; Wood et al. 2005a, 2005b). In longitudinal studies performed in the UK, 80% of 
horses with IAD had in excess of 10
5 CFU per millilitre of tracheal aspirate fluid and 
tracheal washes failed to yield bacterial growth in only 4% of horses with IAD (Wood et 
al. 2005a). The bacterial species most frequently isolated from tracheal aspirate samples 
obtained  from  horses  with  IAD  are  Streptococcus  zooepidemicus,  Streptococcus 
pneumoniae, Pasteurella spp., Mycoplasma felis and Mycoplasma equirhinis with mixed 
infections  being  common  (Burrell  1985;  Burrell  et  al.  1996;  Chapman  et  al.  2000; 
Christley et al. 2001; Wood et al. 2005a, 2005b). Similarly, in a large study performed in 
Australia,  Thoroughbred  racehorses  which  were  coughing  were  more  likely  to  have 
intracellular  bacteria  identified  in  tracheal  aspirate  samples  (Christley  et  al.  2001). 
Conversely, bacterial involvement in horses with IAD in North America is reported less 
frequently (Robinson et al. 2006; Bedenice et al. 2008). The reason(s) for the geographical 
differences are not clear; however influences of study design, horse population differences 
and environmental differences may be involved. 
The role of viruses in the aetiopathogenesis of IAD is unclear also. While antibodies to 
equine herpes viruses and equine influenza virus have been detected in horses with chronic 
pulmonary inflammation, Burrell et al. (1996) and Christley et al. (2001) did not find an 18 
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association  between  IAD  and  viral  seroconversion.  However,  viruses  may  inhibit 
respiratory defence mechanisms and exacerbate airway hyper-responsiveness and hence 
may be a component of multi-factorial disease (Christley and Rush 2007). In a population 
of Standardbred racehorses, oral administration of interferon-α, an immune stimulant with 
anti-viral activity, was associated with a reduction in lower respiratory tract inflammation 
in racehorses with IAD (Rush 1997).  
1.2.4 Pathogenesis 
Given the lack of clear understanding of the potential aetiologies if IAD it is inevitable that 
the pathogenesis is similarly unclear. Couetil et al. (2007) defined IAD as a disease that “is 
characterised by nonseptic inflammation detected by cytologic examination of BALF or 
pulmonary  dysfunction  based  on  evidence  of  lower  airway  obstruction,  airway  hyper-
responsiveness, or impaired blood gas exchange at rest or during exercise”. It is likely that 
there are multiple innate and adaptive mechanisms important to the pathogenesis of IAD. 
Although  the  presence  of  inflammation  detected  by  cytologic  examination  of  tracheal 
aspirates is considered by some authors to be insufficient to diagnose IAD (Derksen et al. 
1989; Holcombe et al. 2006; Robinson et al. 2006), increased total nucleated cell counts 
(TNCC)  with  increased  proportions  of  neutrophils,  eosinophils  and  mast  cells  are 
commonly observed in  IAD (Burrell 1985; Christley et al. 2001; Wood et al. 2005b). 
Inflammatory  airway  disease  also  results  in  an  increased  TNCC  in  BALF  with  mild 
neutrophilia, lymphocytosis and monocytosis (Fogarty and Buckley 1991; Rush Moore et 
al. 1995; Couetil et al. 2001). Increases in mast cell and eosinophil counts are also detected 
in some horses with IAD (Hare et al. 1994; Hare and Viel 1998; Hoffman 1999). The 
presence  of  increased  numbers  of  eosinophils  and  mast  cells  may  suggest  a  type  I 
hypersensitivity response. In one study, horses with IAD had increased numbers of CD8+ 
lymphocytes in their airway secretions whereas RAO horses had increased numbers of 
CD4+ lymphocytes (Moore et al. 1995). It has also been suggested that IAD is neither an 
allergic disorder nor an early stage of RAO (Moore et al. 1995). The immunological basis 
to IAD is yet to be elucidated. 
 
Horses with IAD do not exhibit signs of respiratory dysfunction at rest, however they may 
exhibit abnormal responses to pulmonary function testing and reduced exercise tolerance 
(Couëtil et al. 2007). Accumulation of mucoid secretions may cause ventilation perfusion 
mis-match and impaired gaseous exchange (Couetil and Denicola 1999; Sanchez et al. 
2005) and result in reduced athletic performance (MacNamara et al. 1990; Holcombe et al. 19 
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2006).  The  presence  of  bronchoconstriction  and  airway  hyper-responsiveness  are  also 
likely to play a role in the pathogenesis of the disease as is the case with RAO; although 
the changes are less severe in IAD (Couëtil et al. 2007). 
1.2.5 Pathology 
The pathology of IAD has not been studied specifically. The pathological changes  are 
assumed  to  be  similar,  but  less  severe,  than  in  RAO  with  peribronchial  inflammation, 
accumulation  of  mucoid  secretions  with  plugging  of  distal  airways  and 
bronchoconstriction (Christley and Rush 2007). 
 
1.3   Haem Oxygenase Expression in the Respiratory Tract 
 
1.3.1 The Isoforms of Haem Oxygenase 
 
In 1968, Tenhunen and coworkers determined that the enzyme haem oxygenase (HO) was 
responsible for the degradation of haem to equimolar concentrations of iron, biliverdin and 
carbon  monoxide  by  cleavage  of  the  α-meso  carbon  bridge  of  haem  (Tenhunen  et  al. 
1968). The presence of NADPH and molecular O2 were determined to be required for this 
reaction (Tenhunen et al. 1968, 1969). Two further isoforms of HO that are products of 
different  genes  have  since  been  discovered.  The  second  form  of  HO  (HO-2)  is 
constitutively expressed in  most tissues;  highest  concentrations  are found in  the brain, 
testis and liver (Maines et al. 1986). The third isoform (HO-3) was discovered recently and 
has been identified in the brain, kidney, liver, heart, testis and spleen (McCoubrey et al. 
1997). The activity of HO-3 is poorly characterised but it is reported to have poor haem 
degrading  capacity  (McCoubrey  et  al.  1997).  All  3  isoforms  of  HO  are  located 
intracellularly; the enzymes are anchored to the endoplasmic reticulum with extensions 
into the cytoplasm.  
 
Haem oxygenase-1 is found at highest concentrations in the spleen and liver where it is 
important for the breakdown of haem released by erythrocyte destruction (Abraham et al. 
2006). Haem oxygenase-1 is also known as heat shock protein 32 (Maines 1997). The heat 20 
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shock  proteins  are  a  group  of  highly  conserved  proteins  that  have  been  identified  in 
virtually every prokaryotic and eukaryotic cell and are produced in response to heat stress 
or other events that are noxious to the cell (Wheeler and Wong 2007). Haem oxygenase is 
also known as the enzyme responsible for one of the best known colorimetric reactions in 
nature; namely the degradation of haem (purple) to biliverdin (green) and finally bilirubin 
(yellow) following sub-cutaneous haemorrhage or “bruising” (Otterbein and Choi 2000). 
 
1.3.2 Regulation of HO-1 Expression 
Haem oxygenase-2 is only expressed in response to a limited number of agents; opiates 
and adrenal glucocorticoids are the most important (Li and David-Clark 2000; Liu et al. 
2000).  In  contrast,  HO-1  is  expressed  in  low  concentrations  by  most  cells  under 
physiological  conditions.  Haem  oxygenase-1  is  highly  active  even  at  low  substrate 
concentrations  and  activity  increases  dramatically  in  response  to  increased  substrate 
concentration. To the author‟s knowledge Haem oxygenase-3 gene expression has not been 
characterised. 
 
Haem oxygenase-1 gene expression is induced via a diverse range of signalling pathways 
(Maines 1997) and notably it is induced strongly by agents and conditions associated with 
oxidative stress. In addition, a number of important redox-independent pathways are also 
involved  in  up-regulating  HO-1  gene  expression.  These  include  the  mitogen-activated 
protein kinases (Elbirt et al. 1998; Oguro et al. 1998), protein kinase A (Immenschuh et al. 
1998), cGMP-dependent protein kinase G (Polte et al. 2000) and  protein phosphatases 
(Immenschuh and Ramadori 2000). The following agents have been identified as inducers 
of HO-1 expression: 
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Table 1.3.2 Inducers of HO-1 expression and references in the literature. Modified from 
Wagener et al. (2003) 
 
HO-1 Inducer  References 
Angiogenesis  (Deramaudt et al. 1998; Nishie et al. 1999) 
Cytokines  (Abraham et al. 1988; Cantoni et al. 1991)  
Endotoxin  (Camhi et al. 1995; Otterbein et al. 1995; Carraway et al. 1998) 
Growth Factors  (Durante et al. 1999) 
Heat Shock  (Shibahara et al. 1987; Stuhlmeier 2000) 
Heavy Metals  (Eyssen-Hernandez et al. 1996; Elbirt et al. 1998) 
Haem  (Tenhunen et al. 1968, 1969; Bakken et al. 1972) 
Hyperoxia  (Choi et al. 1995; Lee et al. 1997;  Dennery et al. 1998; Taylor et al. 
1998) 
Hypoxia  (Carraway et al. 2000; Motterlini et al. 2000; Panchenko et al. 2000) 
H2O2  (Keyse and Tyrrell 1987, 1989; Lautier et al. 1992) 
Nitric Oxide  (Datta and Lianos 1999; Doi et al. 1999; Hara et al. 1999; Polte et al. 
2000; Willis 1995; Wang et al. 2003) 
Phorbol Esters     (Abraham et al. 1988; Kurata and Nakajima 1990; Alam and Den 1992) 
Prostaglandins  (Koizumi et al. 1992; Rossi and Santoro 1995) 
Shear Stress  (Wagner et al. 1997) 
Sodium Arsenite    (Sardana et al. 1981; Elbirt et al. 1998) 
GSH depletion      (Ewing and Maines 1993; Oguro et al. 1996) 
Ultraviolet A  (Keyse and Tyrrell 1987; Ossola and Tomaro 1998) 
 
   
Haem oxygenase-1 is the major stress protein induced by hydrogen peroxide, ultraviolet 
radiation  and  sodium  arsenite  (Keyse  and  Tyrrell  1989).  In  addition,  any  agents  that 
directly  or  indirectly  generate  ROS  or  alter  the  redox  equilibrium  will  induce  HO-1 
expression. HO-1 is therefore a general marker of oxidative stress (Applegate et al. 1991).  
 
Ultraviolet  radiation  stimulates  chromophores  to  produce  ROS  (Tyrrell  1996)  and  the 
induction of HO-1 mRNA and protein has been demonstrated following cellular exposure 
to photosensitisers (Basu-Modak and Tyrrell 1993; Gomer et al. 1991; Ryter and Tyrrell 
1998).  Substances  such  as  sodium  arsenite  and  heavy  metals  that  complex  with 
intracellular reduced glutathione result in increased HO-1 expression (Ryter et al. 2002). 22 
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Nitric oxide reacts with thiols to form S-nitrosothiols and with O2
- to form peroxynitrite 
(section 1.4). A number of studies have demonstrated that exogenous NO and NO donors 
activate HO-1 (Marquis and Demple 1998; Bouton and Demple 2000; Chen and Maines 
2000) suggesting that there are complex interactions between different systems of anti-
oxidant defence. 
 
Inflammation, infection, sepsis and endotoxaemia all result in ROS production and in these 
conditions  HO-1  induction  may  be  protective  via  the  biological  roles  of  its  products 
(section  1.3.4)  (Rizzardini  et  al.  1993;  Rizzardini  et  al.  1994).  In  vitro,  the  pro-
inflammatory cytokines IL-1, IL-6 and TNF-α induce HO-1 expression (Rizzardini et al. 
1993; Terry et al. 1999). In addition, growth factors (including transforming growth factor-
β  and  platelet  derived  growth  factor)  induce  HO-1  expression  in  association  with  the 
generation of ROS (Kutty et al. 1994; Durante et al. 1999).  
 
In addition to cytokine and growth factor influences on HO-1 expression, hypoxia alters 
the iron and intracellular redox equilibrium activating HO-1 gene expression (Motterlini et 
al. 2000). Conversely, hyperoxia is associated with increased production of mitochondrial 
ROS and oxidative lung injury (Freeman and Crapo 1981). 
 
The  p38  Mitogen  Activated  Protein  Kinase  Pathway  (MAPK),  extracellular  regulated 
kinases (ERK) pathway and tyrosine kinase pathways have all been variously implicated as 
signal transduction pathways important in the induction of HO-1 (Alam et al. 2000; Chen 
and  Maines  2000;  Elbirt  et  al.  1998);  however  the  precise  importance  of  different 
transduction pathways remains to be elucidated fully (Ryter et al. 2002).  
 
HO-1 gene induction is inhibited by the reduction of oxidative stress; scavengers of ROS  
act as negative regulators (Lautier et al. 1992). Other biologically active molecules that 
inhibit HO-1 include angiotensin II (Ishikawa et al. 1997), interferon –γ (Takahashi et al. 
1999), prostaglandin E2 (Tetsuka et al. 1995), transforming growth factor-β (Pellacani et 
al. 1998) and IL-10 (Immenschuh et al. 1999). 
 
1.3.3 Expression of HO-1 in the Lower Respiratory Tract 
In the face of acute inflammation, HO activity initially decreases with the highest levels of 
expression being recorded as inflammation is resolving (Willis et al. 1996). Willis et al. 
(1996) speculated that during tissue inflammation there may be sequential induction of 23 
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enzymes  with  pro-inflammatory  effects,  for  example  cyclo-oxygenase-2  (COX-2)  and 
inducible nitric oxide synthase (iNOS), followed by increased expression of enzymes with 
anti-inflammatory  effects,  including  HO-1,  which  are  responsible  for  the  resolution  of 
inflammatory lesions and aimed at preventing a chronic inflammatory response.    
 
In human airways the distribution of HO-1 has been investigated using immunostaining 
and western blot techniques. In one study, HO-1 was widely distributed in the airway 
submucosa, particularly the airway epithelium and submucosal macrophages (CD68+) as 
determined by double immunostaining (Brunetti et al. 2006). There was marked staining in 
alveolar macrophages from both normal and asthmatic humans and there was no statistical 
difference between the 2 groups (Brunetti et al. 2006). In a further study of normal patients 
and  smokers,  immunostaining  was  observed  in  the  alveolar  spaces  whereas  there  was 
virtually no staining in the bronchial epithelium and vessels (Maestrelli et al. 2001). In that 
study, the majority of HO-1 positive cells were macrophages. Smokers showed an overall 
increase in the numbers of alveolar macrophages and an increase in the number of HO-1 
positive macrophages (Maestrelli et al. 2001). Further evidence for macrophages being the 
predominant  source  of  HO-1  was  provided  in  a  mouse  model  of  asthma  with 
immunofluorescence occurring mostly in the cytoplasm and particularly in the perinuclear 
region (Kitada et al. 2001). In another study, no HO-1 reactivity was detected in healthy 
lung tissue from mice (Minamino et al. 2001). In a model of inflammation in the pleural 
cavity, western blot analysis revealed an increase in HO-I protein in macrophages but not 
in neutrophils (Willis et al. 1996). Haem oxygenase-1 expression has been demonstrated in 
alveolar macrophages, neutrophils and type II epithelial cells from normal equine lungs 
(Wyse et al. 2006). Wyse et al. (2006) found detectable activity in both the cranioventral 
and caudodorsal lung lobes; with activity being comparable between the 2 regions and the 
level of activity being intermediate between that reported for healthy rats (Carraway et al. 
1998) and mice (Minamino et al. 2001).  
 
In one study there was no difference in HO-1 immunostaining between normal humans and 
patients with asthma and there was also no significant change following treatment with 
inhaled corticosteroids (Brunetti et al. 2006). A glucocorticoid response element is present 
in the HO-1 promoter, and gene expression of HO-1 is inhibited by corticosteroids in vitro 
(Cantoni et al. 1991; Lavrovsky et al. 1996). The reduction in iNOS expression known to 
result from corticosteroid therapy would be expected to result in reduced expression of 
HO-1 (Saleh et al. 1998).   
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1.3.4 Physiological and Cytoprotective Roles of HO-1 and its 
Products 
 
The  strong  adaptive  response  of  HO-1  and  diverse  array  of  stress  stimuli  have  been 
interpreted to suggest roles for HO-1 in addition to haem degradation (Willis et al. 1996). 
Haem oxygenase-1 is highly conserved between species suggesting a vital role in cellular 
homeostasis (Lee et al. 1996). Haem oxygenase enzymes perform a vital physiological role 
in the turnover of haemoglobin-haem during the breakdown of senescent erythrocytes in 
reticuloendothelial  cells  and  in  the  turnover  of  intracellular  haemoproteins  and 
cytochromes, thereby ensuring redistribution of haem and iron to the tissues (Maines 1988; 
Poss and Tonegawa 1997).  
 
A cytoprotective function for HO-1 in the face of oxidative stress was first identified by 
(Keyse and Tyrrell 1987, 1989) with an increasing body of supporting evidence having 
been  accumulated  subsequently  in  various  models.  Haem  oxygenase-1  induction  by 
haemoglobin  infusion  was  demonstrated  to  be  protective  in  a  rat  model  of 
lipopolysaccharide  induced  inflammatory  lung  injury  (Otterbein  et  al.  1995).  The 
protective  role  of  HO-1  has  also  been  demonstrated  in  multiple  experiments  utilising 
homozygous HO-1. Knockout mice showed increased mortality in the face of pulmonary 
ischaemia-reperfusion (Fujita et al. 2001), increased vascular hyperplasia in the face of 
arterial injury (Duckers et al. 2001) and increased myocardial infarction in the face of 
hypoxia (Yet et al. 1999). Chemical induction of HO-1 has been shown to be protective 
against hypertension and inflammation in the face of induced hypoxia in rats and mice 
(Christou et al. 2000; Minamino et al. 2001). Haem oxygenase-1 was protective against 
lung apoptosis and inflammation during hyperoxia in rats (Otterbein et al. 1999a).  
 
The importance of HO-1 to human health was demonstrated when the first known human 
case of HO-1 deficiency was diagnosed in a 6-year old boy. The boy died having suffered 
growth  retardation,  anaemia,  leukocytosis,  thrombocytopaenia,  coagulopathy,  increased 
blood  concentrations  of  haptoglobin,  ferritin,  haem  and  lipid  and  a  decreased  serum 
bilirubin concentration (Kawashima et al. 2002; Yachie et al. 1999). At necropsy, findings 
were similar to those in HO -1 knockout mice; amyloid deposits, foamy macrophages, fatty 
streaks and fibrous plaques were identified (Wagener et al. 2001).  
 25 
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In  vitro  studies  in  which  HO-1  was  produced  in  excess  of  physiological  requirements 
provided  evidence  of  conferred  protection  against  haem  and  haemoglobin-mediated 
toxicity  (Abraham et  al. 2006), resistance to  glutamate toxicity  (Bureau et  al. 2000b), 
resistance to hyperoxia (Lee et al. 1996; Suttner et al. 1999), inhibition of TNF-α induced 
apoptosis (Petrache et al. 2000) and protection against ultraviolet radiation (Vile et al. 
1994).  
 
The  mechanisms  by  which  HO-1  exerts  its  cytoprotective  effects  are  incompletely 
understood. It has been suggested that a number of mechanisms may be important and 
differential mechanisms may exist according to the inciting injury (Zampetaki et al. 2003). 
A possible candidate for the regulation of many of these effects is NF-κβ (Zampetaki et al. 
2003).  The  products  of  HO  activity;  iron,  ferritin,  biliverdin,  bilirubin  and  CO  have 
specific roles in cellular defences. By removing haem and synthesising CO and bilirubin, 
HO is removing a pro-oxidant compound and synthesising anti-oxidant molecules. As well 
as providing protection at cell level, the shift in the oxidant-antioxidant balance provides 
protection  by  reducing  the  expression  of  adhesion  molecules,  especially  ICAM-1,  and 
thereby reducing trafficking of activated leukocytes (Hayashi et al. 1999; Vachharajani et 
al. 2000). 
 
1.3.4.1 Haem 
Haem  (or  ferroprotoporphyrin  IX)  is  an  essential  component  of  numerous  functional 
proteins  such  as  haemoglobin,  myoglobin,  nitric  oxide  synthase  (NOS),  cytochromes, 
cyclooxygenase, catalases and peroxidises (Abraham et al. 1988; Wagener et al. 2003). 
These proteins are fundamental in processes such as energy production, gene induction, 
transcription and translation, cell differentiation and proliferation and protein synthesis, 
splicing and modification (Wagener et al. 2003). The requirement for haem varies between 
cells and tissues but it is probable that all cells have a free haem pool responsible for 
regulatory functions in addition to acting as a precursor for other molecules (Wagener et 
al. 2003). The highest rates of haem synthesis occur in haemopoietic tissues such as the 
spleen, liver and bone marrow (Abraham et al. 2006). Haem turnover is high in these 
tissues where it is continually released from senescent erythrocytes. Haem derived from 
proteins  other  than  haemoglobin  is  thought  to  be  degraded  in  the  tissues  where  it  is 
produced but the majority of haemoglobin denaturation takes place within the organs of the 
reticuloendothelial system (RES) (Wagener et al. 2003). 
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Haem has important effects on gene expression and protein synthesis and also regulates 
differentiation and proliferation of various cell types (Wagener et al. 2001). In addition to 
these positive physiological effects, haem catalyses the formation of ROS thereby inducing 
oxidative  stress  and  cell  damage  (Jeney  et  al.  2002).  Haem  is  highly  lipophilic  and 
intercalates readily with the lipid membranes of cells and intracellular organelles, thereby 
rendering them unstable (Balla et al. 1991). Exposure to haem in vitro has been observed 
to stimulate the expression of adhesion molecules ICAM-1, VCAM-1 and E-selectin on 
endothelial  cells  in  vitro  probably  via  the  formation  of  ROS  (Wagner  et  al.  1997). 
Activation  of  these  adhesion  molecules  results  in  the  recruitment  of  leukocytes  to  the 
surrounding tissues and upregulation of the inflammatory response. During in vivo studies, 
the administration of haem resulted in increased vascular permeability, adhesion molecule 
expression and migration of leukocytes from the vascular compartment (Wagener et al. 
2001).  
 
There are a number of endogenous mechanisms to reduce free haem, suggesting it has an 
important role in the inflammatory process (Wagener et al. 2003). Intracellular proteins 
such  as  haem  binding  protein  23,  HO-2  and  HO-3  and  extracellular  proteins  such  as 
albumin, haemopexin and HO-1 scavenge free haem (Muller-Eberhard and Fraig 1993; 
Maines  1997).  Haptoglobin  transports  free  vascular  haemoglobin  to  the  RES  (Muller-
Eberhard and Fraig 1993). Free vascular haem is transported to the liver bound to albumin 
or haemopexin (Muller-Eberhard and Fraig 1993).  
 
1.3.4.2 Iron  
Free iron has two free electrons and is therefore a powerful pro-oxidant capable of reacting 
with organic molecules to generate ROS via the Fenton reaction. To protect against these 
effects, iron is sequestered into the iron storage protein ferritin. The sequestration of iron as 
ferritin has been demonstrated to lower the pro-oxidant state of cells and the induction of 
ferritin  was  cytoprotective  in  a  model  of  oxidative  stress  (Balla  et  al.  1992).  Ferritin 
concentrations increase in the presence of oxidative stress (Vile and Tyrrell 1993) and 
furthermore  increase  and  decrease  in  response  to  HO-1  induction  and  inhibition, 
respectively (Eisenstein et al. 1991). In addition, HO-1 upregulates an iron ATPase in the 
endoplasmic reticulum to limit levels of intracellular free iron (Baranano et al. 2000). 
 
Reduction of intracellular free iron has  been suggested  as  an explanation  for the anti-
apoptotic effects of HO-1 (Chen et al. 2000; Petrache et al. 2000). Over-expression of HO-
1 in endothelial cells (Soares et al. 1998) and fibroblasts (Petrache et al. 2000) protects 27 
  27 
them from TNF-α mediated apoptosis. Proposed mechanisms for this protective effect are 
induction of ferritin synthesis and upregulation of iron ATPase activity in the membrane of 
the endoplasmic reticulum,  limiting cytoplasmic iron concentration  (Ferris et  al. 1999; 
Chen et al. 2000; Petrache et al. 2000). 
 
1.3.4.3 Bilirubin 
Biliverdin  generated  by  HO  is  rapidly  reduced  to  bilirubin  by  the  enzyme  biliverdin 
reductase  to  facilitate  its  excretion  within  bile.  The  importance  of  bilirubin  as  an 
antioxidant was recognised following the observation that bilirubin and biliverdin were 
highly efficient  at  scavenging peroxyl  radicals,  thereby inhibiting lipid  peroxidation in 
vitro,  even  at  micromolar  concentrations  (Stocker  et  al.  1987).  In  liposomes,  bilirubin 
suppressed oxidation more effectively than either α-tocopherol or vitamin E.  
 
Bilirubin is now recognised as the most abundant endogenous antioxidant in mammalian 
tissues and the dominant antioxidant in human serum (Gopinathan et al. 1994).  In studies 
utilising models of ischaemic heart injury and oxidative damage, the administration of 
bilirubin was shown to be cytoprotective (Ishikawa et al. 1997; Dore et al. 1999; Clark et 
al. 2000; Vachharajani et al. 2000). These effects have been shown to be independent of 
HO-1,  carbon  monoxide  (CO)  and  ferritin  (Vachharajani  et  al.  2000).  In  guinea  pig 
tracheal  muscle,  bilirubin  decreases  smooth  muscle  contractility  via  a  reduction  in 
intracellular  ROS  (Samb  et  al.  2001).  Oxidative  stress  and  airway  inflammation  are 
reduced when HO-1 expression and subsequent bilirubin production are induced by haem 
(Almolki et al. 2004). 
 
Haem oxygenase-1 activity decreases inflammatory cell rolling, adhesion and migration 
from the vascular compartment (Wagener et al. 2001).  In vivo evidence for the role of 
bilirubin in the inhibition of leukocyte rolling following oxidative stress indicated an anti-
inflammatory role for bilirubin in addition to its anti-oxidant activity (Hayashi et al. 1999). 
Superfusion of bilirubin decreased leukocyte recruitment when HO-1 was inhibited with 
zinc protoporphyrin-IX, suggesting a role for bilirubin in leukocyte trafficking independent 
of HO-1.  Other anti-inflammatory functions of bilirubin include increased stability of mast 
cell membranes resulting in reduced degranulation (Hayashi et al. 1999) and decreased 
TGF-β expression (Wang et al. 2002). Bilirubin also has inhibitory effects on contractility 
(Samb et al. 2001) and proliferation (Taille et al. 2001) of smooth muscle.  
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1.3.4.4 Carbon Monoxide 
Carbon Monoxide (CO) is a ubiquitous atmospheric pollutant with a strong affinity for 
haemoglobin,  forming  carboxyhaemoglobin,  making  it  a  lethal  agent  at  high 
concentrations due to its disruption of oxygen transport. A considerable body of evidence 
now indicates that at lower concentrations CO exerts important physiological functions. In 
man, HO generates in excess of 86% of the body‟s CO making it the primary source of 
endogenous CO (Ryter et al. 2002). CO exerts its physiological effects by binding to the 
haem moiety of guanylyl cyclase resulting in cGMP generation (Cardell et al. 1998a). By 
activating this messenger system, CO has the potential to mediate numerous physiological 
processes. Guanylyl cyclase is a common mediator to both CO and NO in modulating 
smooth muscle relaxation and vasodilation. However, CO is 30 -100 times less potent than 
NO  (Furchgott  and  Jothianandan  1991).  Physiological  roles  for  CO  include 
neurotransmission,  vasodilation,  bronchodilation,  inhibition  of  platelet  aggregation  and 
anti-proliferative effects on smooth muscle (Furchgott and Jothianandan 1991; Morita et 
al. 1995; Maines 1997). Carbon monoxide has functional as well as structural similarities 
with NO therefore. However, unlike NO, CO is not a radical, is chemically very stable and 
reacts exclusively with haem. It may therefore reach higher intracellular concentrations 
than NO, particularly in the face oxidative stress and take over the role of NO signalling 
under  oxidative  conditions  when  HO-1  is  induced  and  the  bioavailability  of  NO  is 
decreased (Ryter et al. 2002; Wagener et al. 2003). 
1.3.4.4.1 Vascular Effects 
Modulation  of  cGMP  levels  affects  vascular  function  by  influencing  vasomotor  tone, 
platelet  aggregation,  coagulation  and  smooth  muscle  proliferation  (Morita  et  al.  1995; 
Motterlini  et  al.  1998;  Sammut  et  al.  1998).  The  vasodilatory  effect  of  CO  may  be 
important for maintaining tissue perfusion in the lungs during normal and hypoxic states 
(Morita et al. 1995). Haem oxygenase-1 knockout mice exhibited a maladaptive response 
to chronic hypoxia and developed thrombi and hypertension (Yet et al. 1999). Carbon 
monoxide  may  also  dilate  blood  vessels  by  direct  activation  of  calcium-dependent 
potassium channels (Koehler and Traystman 2002).  
1.3.4.4.2 Anti-inflammatory effects 
Carbon monoxide acts as an anti-inflammatory mediator by selectively activating several 
p38  mitogen-activated  protein  kinase  (MAPK)  signalling  pathways  independent  of 
guanylyl cyclase (Otterbein et al. 2000). It is improbable that CO directly activates any one 
of  the  p38  family  members  and  the  precise  biochemical  mechanisms  by  which  CO 
modulates the MAPKs are not clear. One hypothesis is that a haem-containing protein acts 29 
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as a proximal effector and initiates the signal upon binding to CO (Ryter and Otterbein 
2004). Both in vivo and in vitro, low concentrations of CO differentially and selectively 
inhibited  expression  of  the  LPS-induced  pro-inflammatory  cytokines  tumour  necrosis 
factor-α, interleukin-1β and macrophage inflammatory protein-1β (Otterbein et al. 2000). 
Expression of the anti-inflammatory cytokine interleukin-10 (IL-10) was also increased 
(Otterbein et al. 2000). In addition, it has been suggested that IL-10 mediates many of its 
anti-inflammatory  effects  via  induction  of  HO-1  (Giguere  et  al.  2002).  Inhibition  of 
platelet  aggregation  and  activation  through  the  activation  of  guanylyl  cyclase  and 
subsequent cGMP generation may also contribute to the anti-inflammatory effects of CO 
(Otterbein et al. 2000). 
1.3.4.4.3 Effects in Oxidative Lung Injury 
Carbon monoxide protects against the lethal and inflammatory hyperoxic lung injury by 
down-regulation  of  the  expression  of  pro-inflammatory  cytokines.  In  a  model  of 
hyperoxia-induced lung injury the presence of CO prolonged survival, likely as a result of 
its  anti-inflammatory  actions  (Ryter  et  al.  2002).  Carbon  monoxide  inhibited  the 
appearance of markers of lung injury (haemorrhage, fibrin deposition, oedema, protein 
accumulation in the airway) and oxidative damage (lipid peroxidation) (Ryter et al. 2002). 
Carbon monoxide also inhibited the influx of neutrophils in BALF (Ryter et al. 2002). 
Carbon monoxide production correlated with inhibited expression of the pro-inflammatory 
cytokines IL-1β, TNF-α and IL-6 (Ryter et al. 2002). 
 
Beneficial  effects  of  CO  have  been  demonstrated  in  models  of  ischaemia-reperfusion 
injury of the heart, kidney, small bowel and liver (Amersi et al. 2003; Nakao et al. 2003). 
In a model of lung ischaemia-reperfusion injury, HO-1 knockout mice displayed increased 
mortality. Inhalation of CO partially compensated for the deficiency and improved survival 
(Fujita et al. 2001).  
 
1.3.4.4.4 Bronchodilatory effects 
Carbon  monoxide  modulates  airway  responsiveness  by  acting  as  a  neurotransmitter  in 
parasympathetic ganglia of human and guinea pig airways (Kinhult et al. 2001) and by 
direct effects on smooth muscle (Morita et al. 1995). In guinea pigs, inhalation of CO at 
low concentrations results in bronchodilation via cGMP pathways (Cardell et al. 1998b). 
Carbon  monoxide  is  effective  in  reducing  airway  hyperresponsiveness  in  mice  with 
induced  airway  inflammation  and  in  normal  animals  (Ameredes  et  al.  2003).  Haem 
oxygenase activation in ovalbumin sensitised and challenged guinea pigs prevented airway 30 
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hyperresponsiveness (Amolki et al, 2004) which the authors postulated could be secondary 
to a reduction in inflammation or a direct effect on smooth muscle.  
 
1.3.4.4.5 Anti-apoptotic effects 
In organ transplantation, exposure to CO has been shown to have anti-apoptotic effects 
both in vitro and in vivo. In vitro, exogenous administration of CO or the overexpression of 
HO-1  prevented  TNFα-induced  apoptosis  of  murine  fibroblasts  by  stimulating  the 
p38MAPK pathway (Brouard et al. 2000; Petrache et al. 2000) and co-operated with NF-
κB  dependent  anti-apoptotic  genes  to  protect  against  TNFα-mediated  endothelial  cell 
apoptosis  (Brouard  et  al.  2000).  Carbon  monoxide  exogenously  applied  at  low 
concentrations inhibited ischaemia-reperfusion induced apoptosis in endothelial cell and 
smooth muscle cells (Liu et al. 2003; Zhang et al. 2003). Anti-apoptotic effects may be 
modulated by different transduction pathways depending upon cell type. 
 
1.3.4.4.6 Anti-proliferative effects 
Carbon monoxide has been shown to block cell proliferation of a number of cell types 
including neoplastic cells, T-cells and vascular smooth muscle cells (Morita et al. 1995; 
Song et al. 2002) but conversely has been shown to induce proliferation in endothelial cells 
(Jozkowicz et al. 2003).  
 
 
1.3.5 Haem Oxygenase Expression and Lower Airway 
Inflammation 
 
Evidence for a role of HO-1 activity has been identified in the pathogenesis of numerous 
pulmonary  diseases  in  man  including  acute  respiratory  distress  syndrome  (ARDS), 
interstitial  pulmonary  fibrosis,  COPD  and  asthma.  Asthma  is  a  chronic  inflammatory 
airway disease associated with increased ROS and inflammatory mediators, all of which 
have been demonstrated to induce expression of HO-1 (Barnes 1990).  The pathogenesis of 
RAO has some parallels with the pathogenesis of asthma, and oxidative stress has been 
identified in horses during exacerbation of RAO  (Art et al. 1999; Deaton et al. 2006; 
Deaton et al. 2004a; Deaton et al. 2004b). Haem oxygenase-1 is induced in airways during 
asthma (Carter et al. 2004) and it is possible that it will be similarly induced in the airways 
of horses with RAO (Wyse et al. 2006). In an aeroallergen–induced model of asthma, 31 
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exogenous  CO  ameliorated  inflammation;  specifically  by  reducing  BALF  eosinophilia, 
reducing  the  expression  of  IL-5,  PGE2  and  LTB4  and  by  reducing  MUC5AC  gene 
expression  and  mucus  production  (Chapman  et  al.  2001;  Almolki  et  al.  2004). 
Concentrations  of  exhaled  CO  have  been  identified  to  be  associated  with  the  clinical 
severity of asthma  (Zayasu et  al. 1997;  Horvath et  al. 1998;  Yamaya  et  al. 2001).  In 
addition, a positive association between concentrations of exhaled CO and stabling has 
been demonstrated in horses with RAO (Wyse et al. 2005). Increased HO-1 expression has 
been identified in the sputum of asthmatic patients (Horvath et al. 1998). Concentrations of 
exhaled CO are reduced in patients receiving corticosteroid therapy (Horvath et al. 1998) 
and are significantly related to eosinophil counts in sputum (Zayasu et al. 1997). 
 
 
1.4 Inducible Nitric Oxide Synthase (iNOS) in the Respiratory Tract 
 
Nitric Oxide (NO) was regarded as a noxious environmental pollutant present in cigarette 
smoke and exhaust fumes until several researchers in the late 1980‟s demonstrated the 
physiological importance of the molecule. Endothelial cells had been known to release a 
labile factor known as endothelium derived relaxing factor (EDRF) that diffused to the 
adjacent muscle layer resulting in relaxation. Following the discovery that EDRF was NO 
(Ignarro et al. 1987; Palmer et al. 1987), the diverse roles of NO and other nitrogen oxides 
in other body functions emerged. Nitric oxide was found to act as a pulmonary vasodilator 
(Pepke-Zaba et al. 1991) and shortly thereafter a number of research groups discovered 
exhaled NO concentrations were higher in patients with asthma than in normal subjects 
(Alving et al. 1993; Gaston et al. 1994; Kharitonov et al. 1994; Persson et al. 1994). 
Further  research  activity  has  demonstrated  numerous  physiological  and  pathological 
functions of NO.   
 
1.4.1 The Isoforms of Nitric Oxide Synthase  
Nitric oxide is produced by a diverse range of resident and inflammatory cell types within 
the respiratory tract by oxidation of the amino acid L-arginine (Vaughan et al. 2003b). 
This reaction is catalysed by nitric oxide synthase (NOS) which exists in both constitutive 
(cNOS) and inducible forms (iNOS; Bult et al. 1990). Both forms of NOS are present 
within the airways (Ricciardolo et al. 2004). Constitutive forms have a characteristic tissue 
expression and may be neural (NOS-1 or nNOS) or endothelial/epithelial (NOS3 or eNOS) 32 
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in  origin.  Constitutive  NOS  is  Ca
2+-
  and  calmodulin-dependant  and  releases  small 
quantities (fmol or pmol) of NO within seconds in response to receptor agonists such as 
acetylcholine and bradykinin.  
 
1.4.2 Regulation of iNOS Expression 
Expression  and  synthesis  of  iNOS  is  regulated  at  a  pre-translational  level  and  can  be 
induced by endogenous factors including pro-inflammatory cytokines TNFα, IFN-γ and 
interleukin1-β (IL-1 β) or exogenous factors such as bacteria, bacterial toxins (especially 
lipopolysaccharide), viruses, allergens and environmental pollutants  (Morris and Billiar 
1994;  Yan  et  al.  1995;  Yeadon  and  Price  1995;  Goldman  et  al.  1996).  By  contrast, 
transforming  growth  factor-β  (TGF-β)  suppresses  expression  of  iNOS  in  macrophages 
(Morris et al. 1994). Exogenous corticosteroids also reduce expression of iNOS (Haddad et 
al. 1995). In addition, hypoxia, oxidative injury and tumour cells may stimulate iNOS 
expression (Yan et al. 1995; Yeadon and Price 1995; Goldman et al. 1996). By contrast to 
cNOS, iNOS releases large quantities (nmol) of NO in a sustained manner which may last 
for hours or days (Ricciardolo et al. 2004).  
 
1.4.3 Expression of NOS in the Lower Respiratory Tract 
In humans eNOS is constitutively expressed in bronchial epithelium (Shaul et al. 1994), 
type II alveolar epithelial cells (Pechkovsky et al. 2002) and the basement membrane of 
ciliary microtubules (Xue et al. 1996). In both humans and animals, nNOS is localised in 
nerve  fibres  of  airway  smooth  muscle,  however  substantial  species  differences  exist 
(Ricciardolo et al. 2004). Nitric oxide is a major mediator of smooth muscle relaxation (Li 
and Rand 1991; Belvisi et al. 1992). Density of nerve fibres decreases from trachea to 
bronchi  (Fischer  and  Hoffmann  1996)  with  an  associated  reduction  in  neural 
bronchodilation (Ellis and Undem 1992; Ward  et al. 1995) mediated by the inhibitory 
nonadrenergic noncholinergic (iNANC) system  (Widdicombe 1998). Similarly, iNANC 
fibres, mediated by NO, decreased in number from the trachea to the terminal bronchi in 
equine airways  (Yu et  al. 1994).  In human  airways,  NOS-containing  fibres  have been 
identified  around  submucosal  glands  but  their  importance  is  uncertain  (Fischer  and 
Hoffmann 1996). Within the lamina propria, NO is a potent vasodilator and important 
regulator  of  plasma  extravasation  (Erjefalt  et  al.  1994).  Nitric  oxide  synthase 
immunoreactive neurons are also present within the vagal sensory and sympathetic ganglia 
(Fischer et al. 1996) and within the central nervous system  (Forstermann et al. 1998). 33 
  33 
Neuronal NOS has been identified in non-neural tissues of laboratory animals, namely 
within the cytoplasm of the respiratory epithelium and vascular endothelium (Ellis and 
Undem 1992).  
 
Inducible NOS was first identified in macrophages (Pechkovsky et al. 2002), however it 
was soon realised that it was present within the cytosol of a diverse range of cell types 
(Fischer et al. 2002). To date, iNOS has been reported in alveolar type II epithelial cells 
(Warner et al. 1995), lung fibroblasts (Romanska et al. 2002), airway and vascular smooth 
muscle  cells  (Thomae  et  al.  1993;  Xue  et  al.  1994;  Griffiths  et  al.  1995),  bronchial 
epithelial cells (Adcock et al. 1994; Robbins et al. 1994; Watkins et al. 1997; Pechkovsky 
et  al.  2002),  mast  cells  (Gilchrist  et  al.  2002),  endothelial  cells  (Ermert  et  al.  2002), 
neutrophils (Boucher et al. 1999) and chondrocytes (Kobzik et al. 1993; Ricciardolo et al. 
2006).  Under  healthy  conditions  iNOS  expression  may  not  be  detected  (Buttery  et  al. 
1994). 
 
1.4.4 Functions of NO within the Lower Respiratory Tract 
Nitric oxide has a half life of only 1-5 seconds which is of importance given it possesses an 
unpaired electron and therefore reacts readily with a range of other molecules such as 
oxygen, superoxide radicals and transition metals. Nitric oxide may be bioactivated as 
nitroxyl (NO
-) or nitrosonium (NO
+). The activities of NO are commonly categorised as 
cyclic  GMP-dependant  or  independent,  however  with  improved  understanding  of  the 
actions of NO, it is becoming apparent that many of the actions of NO occur via cGMP-
dependant and independent mechanisms.  
 
Nitric  oxide  is  a  ubiquitous  messenger  molecule  that  readily  diffuses  across  cell 
membranes  and  the  cytoplasm  to  reach  its  target  receptors  alleviating  the  need  for 
extracellular  receptors.  Binding  to  iron  within  the  haem  component  of  soluble  guanyl 
cyclase stimulates conversion of GTP to cGMP and generation of cGMP-mediated effects. 
Cyclic GMP initiates airway smooth muscle relaxation by reducing the concentration of 
intracellular  Ca
2+  via  stimulation  of  activated  K
+  channels,  inhibiting  membrane  Ca
2+ 
channels,  activating  the  Ca
2+/ATPase  pump  in  the  cell  membrane  and  sarcoplasmic 
reticulum and inhibiting inositol triphosphate generation (Carvajal et al. 2000). In addition, 
cGMP reduces sensitivity of smooth muscle cells to intracellular Ca
2+ by stimulation of 
myosin light chain phosphatase activity (Sauzeau et al. 2000). 
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Nitric oxide released from iNOS acts as an immune effector molecule in the killing of 
tumour cells (Hibbs et al. 1988), halting of viral replication (Karupiah et al. 1993) and 
elimination of bacterial, parasitic and fungal, pathogens (Denis 1991). These actions may 
be accomplished by deamination of pathogen DNA or S-Nitrosylation of cysteine proteases 
which are critical for virulence and replication of viruses, bacteria and parasites (Saura et 
al. 1999). 
 
Products of NOS activation such as S-nitrosothiols act as signalling molecules within the 
lung, resulting in relaxation of pulmonary vascular smooth muscle and increased minute 
ventilation in response to hypoxia (Lipton et al. 2001). S-Nitrosothiols are present in the 
airways of normal humans in concentrations sufficient to influence airway tone and are 
decreased  in  the  lungs  of  patients  with  asthma  (Vaughan  et  al.  2003b).  S-Nitrosothiol 
induced bronchodilation is cGMP-independent and mediated by reversible oxidation of 
thiols on proteins integral to muscular contraction.  
 
1.4.4.1 NO and Bronchodilation 
Bronchomotor  tone  is  under  the  control  of  cholinergic  and  adrenergic  systems  in 
combination with excitatory and inhibitory non-adrenergic, non-cholinergic mechanisms 
(eNANC and iNANC). The iNANC represents a parasympathetic pathway distinct from 
the cholinergic pathway. Nitric oxide is responsible for mediating approximately half of 
the iNANC response in guinea pig and human airways (Kobzik et al. 1993). In humans, 
the iNANC response in central and peripheral airways is mediated solely by NO (Belvisi et 
al.  1992;  Ellis  and  Undem  1992).  Inhibition  of  NOS  potentiates  cholinergic  neural 
bronchoconstriction  via  functional  antagonism  at  a  postjunctional  level.  The  apparent 
importance of the iNANC in human airways has led to the hypothesis that impairment of 
iNANC  function  in  inflammatory  disease  states  may  result  in  bronchoconstriction.  In 
cystic fibrosis (a condition characterised by neutrophilic airway inflammation) and asthma, 
NO-induced  bronchodilation  is  reduced  (Mackay  et  al.  1991;  Barnes  and  Liew  1995; 
Miura et al. 1997). In addition, NO has been demonstrated to have a role in the regulation 
of  motility  of  the  equine  jejunum  and  ventral  colon  (Rakestraw  et  al.  1996;  Van 
Hoogmoed et al. 2000). 
 
A number of studies have demonstrated that nitrovasodilators reduce bronchoconstriction 
both  at  baseline  and  following  bronchoconstriction  induced  to  mimic  disease  states 
(Aviado  et  al.  1968;  Dupuy  et  al.  1992;  Gruetter  et  al.  1989;  Hogman  et  al.  1993). 
However, effects on pulmonary compliance are minimal, suggesting a greater effect on the 35 
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larger  airways  (Hogman  et  al.  1993)  that  is  consistent  with  the  distribution  of  the 
distribution  of  iNANC  fibres.  Following  allergen  or  viral  challenge,  eNOS  activity  is 
transiently  (4-6  hours)  reduced,  resulting  in  airway  hyperresponsiveness  and 
bronchoconstriction possibly as a result of limited availability of substrate (de Boer et al. 
2001).  A  subsequent  increase  in  iNOS  expression  results  in  attenuated  airway 
hyperresponsiveness,  reduced  bronchoconstriction  and  a  detectable  increase  in  NO 
metabolites in BALF (Liu et al. 1993; Schuiling et al. 1998; Toward and Broadley 2000; 
Samb et al. 2001; Hjoberg et al. 2004). Inhibition of NOS (Filep et al. 1993; Figini et al. 
1996a; Figini et al. 1996b; Ninomiya et al. 1996; Ali et al. 1997; Emanueli et al. 1998) or 
removal of the airway epithelium (Folkerts and Nijkamp 1998) results in smooth muscle 
contraction and bronchoconstriction. Airway epithelium is therefore central to maintenance 
of airway reactivity and is not merely a protective barrier. 
 
1.4.4.2 NO and Circulation within the Lower Respiratory Tract 
Nitric oxide is released from the endothelium of the pulmonary vasculature (Ignarro 1989; 
Persson et al. 1990). Release of NO in the pulmonary circulation is reduced in chronic 
hypoxia (Adnot et al. 1991) and has been identified in human patients with COPD and 
cystic fibrosis (Dinh-Xuan et al. 1991). Endogenous and exogenous NO have a significant 
influence on bronchial vasodilation (Sasaki et al. 1995; Charan et al. 1997). Endogenous 
NO has been shown to have a role in the regulation of plasma extravasation in response to 
certain allergens (Miura et al. 1996), inflammatory mediators (Kageyama et al. 1997) and 
lipopolysaccharide (Bernareggi et al. 1997). However, alteration of blood flow as a result 
of NO release may be a confounding factor in the assessment of plasma extravasation. 
 
1.4.4.3 NO and Airway Secretion 
Airway  secretion  in  response  to  inflammatory  mediators  such  as  histamine,  TNF-α, 
methacholine and bradykinin is mediated by a mechanism involving NO signalling (Adler 
et  al.  1995).  Furthermore,  administration  of  the  NO  generator  isosorbide  dinitrate 
significantly increases mucosal gland secretion (Nagaki et al. 1995). 
 
In bovines, ciliary motility is enhanced by iNOS induction (Jain et al. 1995). Ion channels 
within the airways are modulated by NO which may have implications for the constituents 
of epithelial lining fluid (Duszyk and Radomski 2000).   
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1.4.4.4 NO and Oxidative Stress: “Nitrosative Stress” 
Nitric oxide radicals are produced in a range of cell types including nerves, macrophages, 
fibroblasts, airway and vascular smooth muscle cells. Enzyme systems involving xanthine 
oxidase, P-450 monooxygenase, cyclooxygenase, lipoxygenase, indole amine dioxygenase 
and monoamine oxidase produce large quantities of ROS (Fridovich 1984; Vallyathan and 
Shi 1997). Inhaled noxious substances such as ozone, nitrogen dioxide, cigarette smoke 
and dust are potent stimuli for the release of RNS and deplete anti-oxidants within the 
epithelial lining fluid (Vallyathan and Shi 1997; Krishna et al. 1998).  
 
Measuring nitrosative stress can be challenging as the fate of reactive nitrogen species is 
often unclear, metabolites are unstable and their half lives are short. Some products, for 
example nitrate and nitrite, are more stable and can be measured in plasma (Kelm 1999); 
however  levels  of  both  these  products  are  influenced  by  dietary  intake,  reducing  their 
diagnostic value. Under conditions of low airway pH, for example asthma, nitrite may be 
converted back into NO (Hunt et al. 2000). Increased NO production in the airways and 
release in breath may therefore represent nitrite conversion as well as iNOS activity. 
 
Immunohistochemistry  has  been  used  to  identify  3-nitrotyrosine  residues  within  tissue 
samples (Saleh et al. 1998) and biological fluids (Ohshima et al. 1999). 3-Nitrotyrosine is 
formed  readily  from  hydrogen  peroxide  and  nitrite  in  a  process  mediated  by 
myeloperoxidase and eosinophil peroxidise (Kettle et al. 1997; Eiserich et al. 1998; Wu et 
al. 1999). 3-Nitrotyrosine contributes to cellular dysfunction and is a specific biomarker of 
nitrosative stress. 
 
Reactive nitrogen species have an array of potential targets; some of the most biologically 
important  are  tyrosine  residues,  thiols  and  haem  groups  within  proteins  (Fang  1997; 
Gaston 1999; van der Vliet et al. 1999). Incorporation of the NO2 group alters the stearic 
and electronic properties of proteins affecting their ability to act as enzymes and structural 
molecules. Protein  binding  can be reversible  and therefore  a potential  signalling  event 
(Kamisaki et al. 1998). Reactive nitrogen species alter lipid oxidation pathways (Rana et 
al.  2001),  damage  DNA  (Zingarelli  et  al.  1996)  and  inhibit  mitochondrial  respiration 
(Packer and Murphy 1995) by mechanisms that remain to be elucidated. The end result of 
these  effects  may  be  apoptosis  or  necrosis,  dependent  upon  the  severity  of  damage 
(Murphy 1999). The effects of reactive nitrogen species in both host and pathogen may be 
mediated by the mitogen-activated protein kinase (MAPK) pathway (Nabeyrat et al. 2003). 
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Peroxynitrite  increases  airway  hyper-responsiveness,  respiratory  epithelial  damage  and 
eosinophil  activation  in  guinea  pigs  (Sadeghi-Hashjin  et  al.  1996).  In  addition,  it 
inactivates surfactant (Haddad et al. 1994) and inhibits protein phosphorylation by tyrosine 
kinases interfering with signal transduction mechanisms (Gow et al. 1997). Peroxynitrite 
may  also  contribute  to  airway  inflammation  by  activating  matrix  metalloproteinases 
(Okamoto et al. 1997), inactivating α1-antiprotease (Whiteman et al. 1999) and enhancing 
production of the neutrophil chemoattractant IL-8 (Filep et al. 1998). Peroxynitrite has 
effects on the function of eNOS with the net result being increased release of NO and 
enhanced release of O2
- amplifying oxidative stress (Zou et al. 2002).  
 
Whilst pro-oxidants are generally considered detrimental, reduction in reactive nitrogen 
species  may  result  in  reduced  defence  against  invading  pathogens  and  compromised 
function of NO as a paracrine messenger (Swislocki et al. 1995). Generalised inhibition of 
NOS  is  likely  to  result  in  deleterious  effects;  however  targeted  inhibition  of  NADPH 
oxidase  and  reduced  production  of  super  oxide  (the  precursor  for  production  of  many 
reactive nitrogen species) may have significant beneficial effects (Ricciardolo et al. 2006). 
 
1.4.4.5. NO and Immune-Inflammatory Responses  
Production  of  NO  is  increased  in  response  to  inflammatory  cytokine  production.  In 
laboratory animals, macrophages have been shown to produce nitrite in a dose- and time- 
dependent manner following activation with lipopolysaccharide and IFN-γ, a process that 
is  blocked  by  glucocorticoids  (Jorens  et  al.  1991).  Granulocyte-macrophage  colony 
stimulating  factor  (GM-CSF)  and  muramyl  dipeptide,  a  bacterial  cell  wall  component, 
enhance IFN-γ-induced nitrite production (Jorens et al. 1993). Other cytokines, including 
TGF-β, IL-4 and IL-10 inhibit the expression of iNOS (Nijkamp and Folkerts 1994). In 
addition, NO reduces the production the inflammatory cytokines TNF, IL-1, MIP-1a from 
human  macrophages  during  inflammatory  conditions,  suggesting  a  modulatory  role  in 
disease  (Thomassen  et  al.  1997).  Nitric  oxide  also  suppresses  antigen-induced 
degranulation, mediator release and cytokine expression by mast cells. In vivo, NO inhibits 
mast  cell  dependant  histamine-induced  vasodilation,  vasopermeation  and  leukocyte-
endothelial cell attachment (Coleman 2002). 
 
T-helper type 1 cells (in contrast to Th2 cells) can be activated by specific antigens to 
produce  large  quantities  of  NO  (Barnes  and  Liew  1995).  Nitric  oxide  inhibits  further 
interleukin production from Th1 cells whilst perpetuating Th2 cell-mediated inflammation 
in allergic and non-allergic disease. In models of allergic airway disease, iNOS knockout 38 
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mice  show  reduced  eosinophil  tracking,  plasma  extravasation  and  airway  obstruction 
(Xiong et al. 1999). Increases in IFN-γ were identified in the knockout mice; however 
there  was  no  reduction  in  IL-4  or  Il-5,  suggesting  that  iNOS  induction  results  in 
perpetuation  of  antibody-mediated  allergic  inflammation  by  downregulation  of  IFN-γ 
activity. In addition, IL-4 increases in response to NO (Slater et al. 2006). Furthermore, 
NO inhibits macrophage-derived IL-12 release, reducing induction and amplification of the 
Th1 response (Huang et al. 1998). 
 
Nitric oxide promotes production of chemokines for eosinophils in mice indicating the 
possibility  of  a  positive-feedback  loop  with  inflammatory  cells  producing  NO  that 
promotes further leukocyte recruitment (Ricciardolo et al. 2004). 
 
1.4.4.6 NO and Airway Hyperresponsiveness 
 Pre-treatment with NOS inhibitors results in potentiation of bradykinin and methacholine-
induced  airway  hyperresponsiveness  (AHR)  consistent  with  a  protective  role  for 
endogenous  NO  in  allergic  airway  disease  (Ricciardolo  et  al.  1996).  However,  NO 
synthesis  was  impaired  following  AHR  induced  by  bradykinin  in  patients  with  severe 
asthma. The authors proposed that this might be due to a reduction in eNOS in severely 
asthmatic patients (Ricciardolo et al. 1997). Airway hyperresponsiveness to bradykinin 
due to allergen exposure in asthma is a result of impaired production of NO subsequent to 
downregulation  of  eNOS  and  upregulation  of  iNOS  within  the  respiratory  epithelium 
(Ricciardolo  et  al.  2001).  Polymorphisms  of  the  eNOS  gene  may  be  associated  with 
predisposition to asthma in humans (Lee et al. 2000; Storm van's Gravesande et al. 2003). 
Restoration  of  eNOS  has  been  advocated  as  a  potential  treatment  strategy  for  asthma 
(Ricciardolo et al. 2001).  
 
Treatment  with  corticosteroids  has  been  demonstrated  to  have  a  protective  effect  in 
severely asthmatic patients, presumably as a result of suppression of iNOS and renewed 
activity of eNOS (Redington 2006). 
   
1.4.4.7. NO and Cell Proliferation/Neoplasia  
The effects of nitrogen oxides on cell division, survival and cell death are dependent upon 
chemical species, redox state, concentration and target type; the results of studies into these 
effects being complex and paradoxical (Lipton et al. 1993). Administration of NO donors 
has been shown to reduce proliferation of human airway smooth muscle cells (Hamad et 39 
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al. 1999; Patel et al. 1999). In bronchiolitis, NO has been suggested to increase destruction 
of epithelium and stimulate fibroblast activity (Romanska et al. 2000). At physiological 
concentrations  NO  appears  to  protect  against  apoptosis  by  augmenting  antioxidant 
defences and inactivating caspases (Hoffmann et al. 2001; Haendeler et al. 2002).  
 
1.4.5 NO and Respiratory Tract Inflammation 
Levels of NO in exhaled breath are determined by a number of factors; NO production by 
multiple cell types  in  the airways and parenchyma, diffusion of NO into  the capillary 
circulation,  alveolar  ventilation  and  bronchial  airflow  (Hyde  et  al.  1997).  All  3  NOS 
isoforms contribute to the production of exhaled NO and results of studies performed are 
conflicting as to which isoform is the most important. In asthma, both iNOS (Saleh et al. 
1998) and eNOS (Storm van's Gravesande et al. 2003) are upregulated with the assumption 
that iNOS in the epithelium is the main source. However, data from animal models have 
indicated the importance of cNOS in disease states (De Sanctis et al. 1997; Vaughan et al. 
2003a).  
 
Rate of NO production is  dependent  upon numerous  factors including the  presence of 
prokaryotic denitrifying bacteria within both  upper and lower  airways  (Vaughan  et  al. 
2003b), S-nitrosothiols, catabolic enzymes (Dweik et al. 2001) and effects of enzymatic 
and other processes that regulate airway pH and nitrite reduction (Hunt et al. 2002). In 
addition,  rate  of  NO  production  will  be  influenced  by  the  activity  of  arginase  2  and 
metabolic  enzymes  that  regulate  the  endogenous  NOS  inhibitor  asymmetric  dimethyl 
arginine (Nelin et al. 2002). 
 
Nitric oxide concentrations in exhaled breath collected from humans can be measured by 
chemilluminescence  analysers  (Nyman  et  al.  1991), however concentrations  are highly 
dependent upon expiratory flow rate (Phillips et al. 1996) such that careful standardisation 
of measurement is required (Kharitonov et al. 1997; American Thoracic Society 1999; 
Baraldi  and  de  Jongste  2002).  Patients  with  asthma  exhale  greater  levels  of  NO  than 
unaffected  subjects  (Kharitonov  et  al.  1994;  Gratziou  et  al.  1999)  and  the  increase  is 
predominantly of lower airway origin (Massaro et al. 1995; Kharitonov et al. 1996a). In 
asthma, exhaled NO has been used to assess disease severity and response to treatment 
with corticosteroids (Kharitonov et al. 1996b; Sippel et al. 2000). Corticosteroids have a 
direct inhibitory effect on iNOS expression in addition to general downregulation of the 
inflammatory response. Exhaled NO concentrations in asthmatic patients correlated with 40 
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AHR (Jatakanon et al. 1998) and peak flow variability  (Lim et al. 1999). In addition, 
correlation  of  exhaled  NO  with  eosinophil  counts  in  peripheral  blood  (Silvestri  et  al. 
1999), BALF (Lim et al. 1999), saliva and bronchial biopsies has been identified (Payne et 
al.  2001).  From  the  results  of  these  studies  it  has  been  suggested  that  production  of 
endogenous NO may be contributory to eosinophilic inflammation and be deleterious in 
allergic  airway  disease.  Alternatively,  production  of  NO  and  eosinophilia  may  be 
stimulated by similar pathological processes within disease states. Increased concentrations 
of exhaled NO have been demonstrated in other respiratory diseases in humans including 
COPD,  rhinitis,  bronchiectasis,  pulmonary  sarcoidosis  and  active  fibrosing  alveolitis. 
Conversely,  reduced  concentrations  of  NO  have  been  identified  in  primary  ciliary 
dyskinesia,  cystic  fibrosis  and  pulmonary  hypertension  (Ricciardolo  et  al.  2004).  The 
reasons for reduced production of NO in these conditions are unknown (Ricciardolo et al. 
2004).  
 
Therapeutic  benefits  of  inhaled  NO  in  humans  with  respiratory  disease  have  been 
investigated. Inhaled NO diffuses into and selectively dilates the pulmonary vasculature of 
ventilated lung regions resulting in a selective increase in blood flow to better ventilated 
regions  (Fratacci  et  al.  1991;  Frostell  et  al.  1991).  Nitric  oxide  rapidly  binds  to 
haemoglobin within the circulation preventing systemic effects of inhaled NO in contrast 
to  other  vasodilators.  These  properties  have  resulted  in  the  use  of  inhaled  NO  in  the 
treatment of pulmonary hypertension. Though the potential benefits in respiratory disease 
are yet to be fully investigated (Bates and Silkoff 2003), NO is used at 5-30ppm in human 
patients with severe respiratory disease such as ARDS (Zapol and Hurford 1994). 
 
Potentially  beneficial  effects  of  NO  include  neuromodulation  by  mediation  of  iNANC 
nerve  activity,  smooth  muscle  relaxation,  attenuation  of  bronchoconstrictor  stimuli, 
downregulation of mast cell and Th1 cell-mediated inflammatory responses and the killing 
of invading microorganisms.  
 
Potentially  deleterious  effects  of  NO  and  RNS  include  vasodilation  and  plasma 
extravasation,  increased  airway  secretions,  impaired  ciliary  motility,  increased  Th2-
mediated eosinophilic inflammation, necrosis and apoptosis. A selective inhibitor of iNOS 
[L-N
6-(1-iminoethyl)-lysine] has been shown to reduce exhaled NO in healthy volunteers 
and asthmatics. In rodent models of allergic airway inflammation iNOS inhibitors have 
been shown to decrease eosinophil infiltration and cytokine release. Some authors have 41 
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suggested that iNOS inhibitors may have a therapeutic benefit in cases of allergic airway 
disease that are refractory to corticosteroid treatment (Hansel et al. 2003).  
 
1.4.6 NO in Equine Health and Disease 
Little research has been performed into the expression of NOS and synthesis of NO in the 
horse. Increased expression of iNOS has been identified in leukocytes within the mucosa 
and submucosa of the intestine and vasculature of horses with ischaemic intestinal injury 
(Mirza et al. 1999; Mirza et al. 2005). Plasma and peritoneal fluid NO concentrations were 
increased in horses with strangulating lesions of the small intestine but not in those with 
colon volvulus (Mirza et al. 1999; Mirza et al. 2005); the reasons for this discrepancy are 
uncertain. Increased nitrotyrosine staining was also identified, consistent with the presence 
of peroxynitrite secondary to increased NO and superoxide production (Mirza et al. 1999; 
Mirza  et  al.  2005).  Evidence  of  NO  synthesis  within  the  endothelium  has  also  been 
identified in studies performed to enhance understanding of the pathogenesis of laminitis 
(Cogswell  et  al.  1995;  Moore  et  al.  2005).  Infusion  of  lipopolysaccharide  and 
administration of Strongylus vulgaris larvae both failed to induce an increase in plasma 
NO despite an increases in serum TNF and IL-6 concentrations (Bueno et al. 1999; Hubert 
et  al.  2004).  Proposed  explanations  for  the  absence  of  a  detectable  increase  in  NO 
concentration  in  these  horses  were  an  insufficient  inflammatory  stimulus,  insufficient 
cytokine expression, sample degradation prior to analysis and a different mechanism and 
time course of iNOS expression than seen in other species (Hubert et al. 2004).  
 
Nitric  Oxide  concentration  has  been  shown  to  increase  from  1ppb  at  rest  to  7ppb  in 
exercising  horses  (Mills  et  al.  1996a)  and  the  administration  of  inhaled  NO  reduced 
pulmonary arterial pressure (Mills et al. 1996b). Inhibition of NOS in exercising horses 
resulted in an increase in plasma lactate in one study, suggested to be a result of changes in 
skeletal blood  flow and/or metabolic activity  (Mills  et  al. 1999). In addition,  NO was 
shown to be important in thermoregulation during exercise (Mills et al. 1997).  
 
To the author‟s knowledge investigation of NOS expression and NO production in equine 
respiratory disease is  limited to  the findings  of a single study in  which 7 horses  with 
SPARAO  and  6  normal  horses  were  compared  (Costa  et  al.  2001).  Nitric  oxide 
concentrations in plasma, BALF and ELF were determined using a chemilluminescence 
method whilst iNOS, nitrotyrosine and nicotinamide (NT) adenine dinucleotide phosphate 
diaphorase  (NADPHd)  were  localised  in  formalin-fixed  lung  specimens  using 42 
  42 
immunohistochemical and histochemical staining. Plasma concentration of NO in affected 
horses  was  non-significantly  increased  over  non-affected  controls.  Nitric  oxide 
concentrations in BALF and ELF were not different between groups. Immunoreactivity of 
iNOS was increased in bronchial epithelial cells in 3 of 5 lung lobes. Staining for NT and 
NADPHd did not differ between the two groups. Staining of peribronchiolar leukocytes for 
iNOS,  NT  and  NADPHd  activity  was  also  assessed  and  did  not  differ  significantly 
between groups. Statistical models showed that plasma NO concentrations could best be 
modelled by 3 variables; percentage of mast cells in BALF, percentage of lymphocytes in 
BALF and changes in pleural pressure (Costa et al. 2000b).  
 
The absence of a detectable increase in NO production in the lower respiratory tract in the 
study by Costa et al. (2000) was unexpected given an increase in exhaled NO has been 
reported in multiple studies of human patients suffering from asthma (Alving et al. 1993; 
Kharitonov et al. 1994; Massaro et al. 1995; Kharitonov et al. 1996a). The effects of 
inhaled NO at a concentration of 5ppm on pulmonary mechanics in horses with histamine-
induced bronchoconstriction have been investigated (Sweeney et al. 1999). Nitric oxide at 
this  concentration  (approximately  1000x  higher  than  that  reported  for  normal  resting 
horses)  partially  reversed  the  changes  in  dynamic  compliance  and  airway  resistance 
induced  by  histamine.  However,  effects  were  short-lived  and  changes  in  pulmonary 
function  were  only  partially  reversed.    This  was  not  unexpected  as  in  addition  to 
bronchoconstriction, histamine induces mucosal oedema and increased airway secretions. 
 
One of the aims of the current study was to further investigate the production of NO in the 
lower  airways  of  horses  with  respiratory  disease;  specifically  to  characterise  the 
investigation of iNOS in leukocytes of BALF.  
 
 
1.4.7 Interactions of NO and HO-1 
As understanding of the HO and NOS enzymes increases, it is increasingly clear that there 
are significant, and complex, interactions between the two systems (Ryter and Otterbein 
2004).  Understanding  of  these  interactions  remains  limited;  however  some  of  the 
suggested mechanisms are listed below: 
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1.4.7.1 HO Regulation of NOS 
Induction of HO-1 may inhibit production of NO in a number of ways (Maines 1997): 
1.  NO is a haemoprotein. Activation of HO-1 and reduction in available haem may 
result in decreased synthesis of NOS. 
2.  Induction  of  HO-1  may  result  in  increased  turnover  of  NOS.  Increased 
concentration of HO-1 has been associated with decreased P450.  
3.  CO is known to bind to NOS and may result in deactivation of the enzyme. 
4.  Iron may inhibit NOS transcription. 
5.  Both systems require NADPH and electrons therefore competition may exist. HO-
1 is likely to function at the expense of NOS. 
By contrast, NO and peroxynitrite have been demonstrated to up-regulate HO-1 expression 
(Foresti  et  al.  1999;  Foresti  and  Motterlini  1999;  Liang  et  al.  2000)  and  it  has  been 
suggested  that  CO  may  assume  many  of  the  roles  of  NO  under  oxidative  conditions 
(Foresti  and  Motterlini  1999).    In  addition,  CO  has  been  shown  to  induce  iNOS  in 
hepatocytes which in turn induces HO-1 (Zuckerbraun et al. 2003). The authors of this 
study suggested that the effect may be tissue specific as CO was associated with inhibition 
of NOS in other models of tissue injury (Nakao et al. 2003). 
  
1.4.7.2 NOS regulation of HO-1 
Nitric oxide has been shown both to inhibit (Willis 1995; Wang et al. 2003) and activate 
(Motterlini et al. 1996) HO activity. Nitric oxide has been suggested to be the strongest 
inducer of HO-1 (Motterlini et al. 1996). It is therefore possible that many of the effects of 
NO may be modulated via HO-1 (Ryter and Otterbein 2004). Nitric oxide may also induce 
HO-1 activity by modulating the activity of enzymes responsible for regulating levels of 
free iron and the synthesis of haem and ferritin. 
 
Inhibitory activity may be due to NO orchestrated damage (due to free radical properties) 
to the proteins of haem-oxygenase and its substrate haem. Nitric oxide has a higher affinity 
for haem than that demonstrated by oxygen and the presence of NO prevents oxidation 
(Ryter and Otterbein 2004).  
 
It has been suggested that NOS and NO will have varied effects according to the type of 
HO isoform and tissue type.  
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1.5 Evaluation of Inflammation in the Equine Lower Respiratory Tract 
 
 
1.5.1 History, Clinical Signs and Scoring Systems 
The history of disease and timing of clinical signs are often strongly suggestive of the type 
of  respiratory  disease  present.  Recurrent  airway  obstruction  and  SPARAO  are  both 
seasonal  disorders;  RAO  typically  is  associated  with  periods  of  winter  housing  and 
SPARAO is associated with warmer drier weather when horses are at pasture. However, it 
is  likely  that  there  is  a  spectrum  of  disease  with  considerable  cross-over  between  the 
conditions. For example, it has been reported that 10% of horses with RAO also suffer 
from  SPARAO  and  approximately  50%  of  horses  with  SPARAO  demonstrate 
hypersensitivity to hay and straw (Mair 1996). Both conditions occur in horses over 5 
years of age at a median of 12 years  (Aviza et al. 2001). All breeds may be affected 
(McPherson et al. 1979a; Couetil and Ward 2003). History is important in differentiating 
RAO from IAD; the latter typically affects younger horses in training and is not seasonal 
or recurrent in nature (Couëtil et al. 2007).  
 
Horses with RAO may present with a range of clinical signs according to disease severity. 
The typical clinical signs of RAO are coughing and nasal discharge which occur in up to 
84% and 54% of clinical cases respectively (Dixon et al. 1995b). Respiratory rate may be 
normal or increased, whilst temperature, heart rate and general attitude are normal in all 
but severe acute disease. Respiratory distress, characterised by a biphasic forced abdominal 
effort accompanied by forced expiration, nostril flaring and an outstretched neck may be 
apparent in acute exacerbations of disease (Couetil and Hinchcliff 2004; Lavoie 2007). 
With chronicity, hypertrophy of the external abdominal oblique muscles may result in a 
visible “heave line”. Recurrent airway obstruction may also be subclinical with the only 
presenting  complaint  being  a  reduction  in  performance.  A  tentative  diagnosis  in  acute 
cases  can  usually  be  made  easily  from  the  clinical  signs  and  history.  Auscultation  is 
insensitive and findings may be abnormal in less than 50% of horses with RAO (Dixon et 
al. 1995b); however expiratory wheezes indicative of intra-thoracic airway obstruction and 
crackles  indicative  of  fluid  within  the  airways  may  be  audible.  The  sensitivity  of 
auscultation may be increased by increasing the depth of breathing by applying a “re-
breathing bag” over the nostrils and in so doing limiting the supply of oxygen, increasing 
inspired carbon dioxide and inducing hypercapnia (Roy and Lavoie 2003). In less severe 
and  subclinical  cases,  diagnosis  may  require  further  diagnostic  modalities  and 45 
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differentiation from IAD may be challenging. A comparison of the typical features of RAO 
and IAD are presented in Table 1. 
Table 1.5.1 Comparison of clinical findings of RAO and IAD. Adapted from Couetil and 
Hinchcliff (2004).  
  RAO  IAD 
Age  >5 years  > 1 year 
Activity Level  any  moderate/high 
Duration  months/years 
recurrent 
1-6 months 
not recurrent 
Cough  chronic intermittent  1/3 cases 
Exudate  moderate/marked 
mucopurulent 
mild/moderate 
mucoid 
Lung sounds  Increased breath 
sounds, wheezes, 
crackles 
normal 
Increased 
respiratory effort 
often evident  sometimes evident, 
less severe 
Exercise intolerance  moderate/marked  mild/moderate 
BALF cytology  Neutrophilia >25%  Neutrophilia >5% 
Eosinophilia >1% 
Mastocytosis >2% 
 
Clinical scoring systems have been developed to allow comparison of airway obstruction 
between  groups,  primarily  for  research  purposes.  Grades  are  assigned  to  the  common 
clinical signs such as cough, nasal flaring, abdominal excursions and movement of the 
anus. Simple scoring systems grading nasal flaring and abdominal effort have been shown 
to correlate with more objective measures of pulmonary function (Rush et al. 1998; Costa 
et al. 2000b; Robinson et al. 2000).  
 
As the clinical signs of RAO are often apparent to owners, questionnaire methods have 
been used in the diagnosis of RAO for the purposes of epidemiological studies and also in 
the investigation of risk factors for development of disease. A risk-screening questionnaire 
(RSQ) for RAO was constructed and validated in order to investigate RAO in Great Britain 
(Hotchkiss et al. 2006; Hotchkiss et al. 2007). The questions included in the RSQ were 
derived from a review of the scientific literature, survey of equine practitioners in the UK 
and  consultation  with  19  experts  using  a  modified  Delphi  technique.  The  RSQ  was 
validated  against  a  reference  standard  of  a  veterinary  diagnosis  including  respiratory 
cytology. A receiver-operating characteristic (ROC) curve was used to select a positive 
cut-off of 0.87 for the RSQ for RAO. This suggested that the RSQ had a sensitivity of 0.83 
(95% confidence interval=0.59-0.96) and specificity of 0.85 (0.74-0.93) for the diagnosis 
of apparent RAO (compared to all other diagnoses) (Hotchkiss et al. 2006). A horse owner 
assessed respiratory signs index (HOARSI) was developed by one group to determine the 46 
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severity of clinical signs in a related population known to have a high prevalence of RAO 
(Jost et al. 2007; Ramseyer et al. 2007). 
 
1.5.2 Endoscopy 
Endoscopic maps of the equine bronchial tree have been reported  (Smith et al. 1994); 
however clinical assessment is generally limited to the trachea by the small size of the 
bronchi relative to the endoscopes used in practice. Endoscopy of the lower airways in 
horses with RAO generally reveals mucopus of varying quantities within the trachea. The 
presence of mucus is a characteristic sign of RAO (Robinson et al. 1996) but is not specific 
for  the  disease  (Dixon  et  al.  1995b).  There  may  be  considerable  overlap  between  the 
degree of mucus accumulation  in  healthy horses,  stabled horses,  horses with  IAD  and 
horses with RAO. Whilst the presence of isolated droplets of mucus may be considered 
normal, rarely do horses with RAO have no or only a few droplets of mucus (Gerber 
2001). Mucus accumulation has been found to be associated with coughing (Dixon et al. 
1995c; Christley et al. 2001; Robinson et al. 2003). Further, mucus scores increase in 
horses with RAO (but not in healthy horses), with stabling and feeding of hay (Gerber et 
al. 2004a). A number of authors have developed systems for grading mucus accumulation 
(Burrell 1985; Dixon et al. 1995c; Gerber et al. 2001; Gerber et al. 2003a; Gerber et al. 
2004a) but the best validated and now most widely accepted is that reported by Gerber et 
al. (2004). In that study mucus grading correlated with neutrophilic airway inflammation 
as defined by cytology of bronchoalveolar lavage fluid. The significance of mucus within 
the airways is undetermined, however an association between mucus scores of grade 2 or 
higher and reduced racing performance has been demonstrated (Holcombe et al. 2006). 
 
Endoscopic evidence of oedema and blunting of the carina has been described as a measure 
of pulmonary disease (Dixon et al. 1995c; Mair 1996) and the presence of distended and 
irregular bronchial walls thought to be suggestive of bronchiectasis (Lavoie et al. 2004). 
Airway erythema may also be evident (Dixon et al. 1995c). However, a recent study cast 
doubt on the value of assessing the tracheal septum by failing to demonstrate correlation 
with  mucus  accumulation  and  airway  neutrophilia  (Koch  et  al.  2007).    Although 
endoscopic findings are frequently indicative of airway inflammation, findings rarely allow 
diagnosis of specific diseases: for further characterisation collection of airway secretions is 
generally required.  
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1.5.3 Cytological Examination of Tracheo-Bronchial Secretions 
Cytological examination of airway secretions is arguably the most useful single diagnostic 
test  for  differentiating  lower  airway  diseases.  The  timing  of  sampling  is  important  as 
increases in inflammatory cells and bacteria may be identified within 6 hours of transport, 
tying up or head elevation (Raidal et al. 1995). In such situations, provided the horse is not 
dehydrated, mucociliary clearance should ensure a return of airway secretions to normal 
within 12 hours. Exercise may result in an increase in secretions that are probably more 
representative of the lower airways than samples collected prior to exercise (Martin et al. 
1999; Malikides 2004; Malikides et al. 2007). In comparison to relative percentages of 
neutrophils in pre-exercise samples, higher neutrophil percentages have been identified 
after exercise in TAs (Malikides et al. 2003) but not in BALF (Clark et al. 1995). 
 
1.5.3.1 Tracheal aspirates 
Tracheal aspirates may be obtained by a number of techniques, each having advantages 
and disadvantages. Transtracheal aspiration was adapted from a human technique prior to 
the availability of endoscopy (Mansmann and Knight 1972). This technique is still relevant 
as it is less likely to result in contamination of the sample than endoscopic techniques and 
is performed when infectious disease is suspected and contamination by oropharyngeal 
flora is undesirable. The major disadvantages of the transtracheal technique are inability to 
visualise  the  airways  (allowing  assessment  of  pathology  and  aiding  collection  of  the 
sample) and the potential for cellulitis/chondritis at the entry site (Mair 1987). Fibreoptic 
and videoendoscopic techniques are less invasive, associated with fewer complications and 
preferred  by  most  clinicians.  However,  endoscopic  techniques  inevitably  result  in 
contamination  of  the  sample  by  oropharyngeal  secretions  unless  guarded  and  plugged 
catheter systems are used in the hands of an experienced clinician (Sweeney et al. 1989; 
Darien et al. 1990). Plugged guarded catheters were shown to be effective in preventing 
bacterial contamination in 15 of 18 samples collected in one study (Christley et al. 1999). 
Risk  of  contamination  increases  if  the  horse  is  refractory  to  the  procedure  or  coughs 
frequently.  If the operator is inexperienced contact may be more likely to occur between 
the contaminated endoscope and the sample. Endoscopic techniques are preferred for the 
investigation of non-infectious lower airway diseases as visualisation of the airways is 
advantageous. 
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Neutrophil percentages  in TAs have been shown to  correlate with  signs  of respiratory 
disease, the presence of bacteria, the presence of mucus and the presence of an increased 
leucocyte count (Chapman et al. 2000; Christley et al. 2001; Gerber et al. 2004a). Whilst 
neutrophilia is consistent with respiratory disease of either infectious or non-infectious 
origin, interpretation is complicated by the wide range of results found in normal horses (3-
83%) (Larson and Busch 1985; Derksen et al. 1989) and in horses with RAO (7-96%) 
(Mair et al. 1987; Winder et al. 1990; Dixon et al. 1995c). In RAO, correlation with TA 
cytology results and lung histology is poor and the validity of the technique for diagnosing 
RAO has been questioned (Larson and Busch 1985; Derksen et al. 1989; Winder et al. 
1990; Traub-Dargatz et al. 1992). The major advantage of TA over BAL is the collection 
of samples for bacterial culture (Rush and Mair 2004).  
 
1.5.3.2 Bronchoalveolar Lavage (BAL) 
Bronchoalveolar  lavage  was  adapted  for  use  in  the  horse  following  successful  use  in 
human medicine (Viel 1983) and was subsequently validated for the detection of lower 
airway  inflammatory  changes  in  horses  (Derksen  et  al.  1985b;  Derksen  et  al.  1989; 
Fogarty and Buckley 1991; Sweeney et al. 1992a). 
 
Initially  the  procedure  was  performed  under  general  anaesthesia  (Viel  1983)  using 
fibreoptic  endoscopes.  The  methods  of  BAL  have  since  been  modified  such  it  can  be 
performed under standing sedation. Sedation with α-2 agonists combined with butorphanol 
are recommended as they have an anti-tussive effect and reduce discomfort experienced by 
some horses. Coughing may still be elicited by contact with the larynx, carina or major 
bronchi resulting in distress to the horse and added difficulty in obtaining a sample: in such 
cases lignocaine may be instilled into the trachea. Both lignocaine and butorphanol have 
been demonstrated to reduce coughing prior to BAL (Westermann et al. 2005). 
 
Endoscopes must be at least 1.5m in length in order to reach the lower airways and an 
external  diameter  of  8  mm  is  desirable  to  permit  wedging  of  the  endoscope  in  a  4th 
generation  bronchus  (Sweeney  and  Beech  1991).  Development  of  a  BAL  technique 
utilising sterile siliconised polypropylene tubing is an alternative to the use of fibreoptic 
endoscopes (Fogarty 1990a, 1990b). The structure of the bronchial tree is such that in most 
cases the tube passed into the right or left caudodorsal lobe. Samples obtained showed 
good  qualitative  correlation  with  pathological  changes  (Fogarty  1990b).  Commercially 
available BAL tubes measure 2.5 - 3m in length, 10mm in external diameter and are cuffed 
at  the  distal  end  allowing  an  improved  seal  to  that  which  can  be  achieved  with  an 49 
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endoscope. Most clinicians find that the improved seal makes collection of a diagnostic 
sample easier than with an endoscope, however it is advantageous to visualise the airways 
prior to BAL and endoscopic collection may be preferable if a sample from a specific 
bronchus is required. Recurrent airway obstruction diffusely affects the lower airways so 
lavage  of  specific  airways  is  not  generally  indicated.  In  IAD  changes  are  generally 
considered to be diffuse and BAL is preferred for diagnosis (Couëtil et al. 2007).  
 
There is no standardised protocol for performing BAL and variation in BALF collection 
methods may influence the results of subsequent BALF analysis. Fogarty (1990a) showed 
that when BAL was performed, an area of lung surface measuring 12cm in diameter was 
infused which represented only a fraction of the total lung volume. Further investigations 
have demonstrated cytological findings of a BALF sample are comparable regardless of 
the  region  from  which  samples  are  collected  (Sweeney  et  al.  1992b;  McGorum  et  al. 
1993e) and it is accepted that the site of BAL is not critical when investigating diffuse 
diseases of the peripheral lung such as RAO (McGorum et al. 1993e; Jean 1996). Volumes 
of saline used for the procedure have varied from 50 to 500 ml with a greater percentage of 
neutrophils  and  fewer  mast  cells  being  recovered  when  smaller  volumes  are  used, 
presumably representative of a bronchial lavage (Sweeney et al. 1992b). It was suggested 
that a volume in excess of 50ml should be used to ensure lavage of the alveoli (Sweeney 
and  Beech  1991).  Volumes  of  300ml  have  been  generally  adopted  although  some 
clinicians prefer to perform 3 sequential 100ml aliquots rather than a single 300 ml lavage. 
Whilst Mair et al. (1987) found no difference in these 2 methods, Sweeney et al. (1992) 
showed  that  sequential  lavages  increased  the  recovery  of  BALF  and  increased  the 
proportion of macrophages. Pickles et al. (2002a) found that when sequential aliquots of 
BALF  were  compared,  there  were  no  clinically  relevant  differences  indicating  that  all 
aliquots  may  be  considered  equal  and  even  small  volumes  of  recovered  fluid  are  of 
diagnostic  value  (Pickles  et  al.  2002a).  In  a  research  setting,  the  effects  of  BAL  on 
pulmonary  function  tests  needs  to  be  considered  (Leguillette  and  Lavoie  2006). 
Bronchoalveolar lavage induces a localised influx of neutrophils into the lavaged portion 
of the lung,  resulting in neutrophilia of subsequent  lavage fluids  for at  least  48 hours 
(Sweeney et al. 1994). 
 
Bronchoalveolar  lavage  is  not  considered  a  suitable  technique  for  the  investigation  of 
infectious lower airway disease. Bacterial pneumonia generally affects the cranioventral 
lung lobes which are not sampled if BAL tubes are passed blind. Transendoscopic methods 
may be used to sample the cranioventral lobes but these samples rarely yield representative 50 
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bacterial  cultures  (Sweeney  et  al.  1991).  Furthermore,  sample  contamination  with 
orophayngeal flora inevitably occurs as a result of the tube passing via the oropharynx 
unguarded. 
 
Discrepancies may be observed between the results of TA and BAL cytology in horses 
(Derksen et al. 1989; Traub -Dargatz et al. 1992; Hughes et al. 2003; Malikides et al. 
2003). However, other investigators have found close correlation between the results of TA 
and  BAL  cytology  (Dixon  et  al.  1995c).  The  reasons  for  these  discrepancies  are  not 
understood  but  may  indicate  that  1)  nucleated  cell  populations  vary  between  different 
segments of the airways and 2) in IAD, disease may be restricted to certain regions of the 
lower airways. Tracheal aspirates contain large quantities of mucin and large numbers of 
degenerate cells. It has been proposed therefore that BALF is a more reliable indicator of 
distal airway disease because cells are better preserved, there is less variability in normal 
cell populations and there is greater correlation with the pathological changes observed at 
histopathology (Larson and Busch 1985; Derksen et al. 1989; Dixon et al. 1995c).  As 
RAO is a disease of the distal airways it is accepted that BAL is the gold-standard for 
diagnosis (Robinson 2001). There is less agreement with respect to the diagnosis of IAD. 
The published consensus view is that BAL is required to confirm the diagnosis (Couëtil et 
al. 2007). This view is not universally accepted as there is a sub-set of horses, especially 
young racehorses, that show marked changes on TA cytology without alterations in BALF 
cytology (Derksen et al. 1989; Traub-Dargatz et al. 1992; Hughes et al. 2003; Malikides et 
al.  2003).  The  results  of  TA  are  used  widely  in  the  investigation  of  IAD  in  young 
racehorses (Burrell et al. 1996; Chapman et al. 2000; Christley et al. 2001). In older horses 
a high proportion of neutrophils may be present in TA samples in the absence of clinical 
evidence of disease (Robinson et al. 2006) and hence the relevance of TA cytology may 
decrease with  increased age. Malikides  et  al. (2003) proposed that both  TA and  BAL 
samples ought to be collected in order to best investigate lower airway disease. 
 
1.5.3.3 Sample Processing 
Delays  in  processing  of  up  to  8  hours  will  result  in  minimal  cellular  deterioration  if 
samples are kept at room temperature and this may be extended to 24 hours if samples are 
refrigerated  at  4°c  (Pickles  et  al.  2002c).  Samples  for  microbial  culture  should  be 
processed more quickly to prevent bacterial overgrowth. Airway washes can be made into 
smears but are of low cellularity and are therefore easier to examine if they are centrifuged 
to concentrate cells prior to being re-suspended, or are cytocentrifuged. Although both of 
these procedures, especially cytocentrifugation, are used routinely, both procedures may 51 
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cause alterations in cellular morphology. Centrifugation may cause a decrease in mast cell 
percentage  whilst  cytocentrifugation  may  cause  a  decrease  in  lymphocyte  percentage 
without affecting the total cell count (Lapointe et al. 1994).   Cytocentrifuged samples 
generally  contain  higher  macrophage  and  lower  lymphocyte  differential  counts  when 
compared to smear preparations, although in one study the differences were clinically non-
significant and cytological examination of the cytospun samples was easier to perform 
(Pickles et al. 2002b). A variety of stains are commonly employed including Diff Quik, 
Wright-Giemsa and May-Grünwald stains. Specific stains may also be used, for example, 
non-specific  esterase  to  differentiate  immature  macrophages  from  large  lymphocytes, 
Perl‟s  Prussian  blue  for  haemosiderin  and  Leishmann‟s  or  Toluidine  blue  for  the 
metachromatic granules of mast cells. Fast Romanowsky stains (for example Diff-Quik) 
are not suitable for identification of mast cells (Hughes et al. 2003). 
 
1.5.3.4 Evaluation of Tracheal Aspirates and Bronchoalveolar Lavage Fluid 
(BALF) 
Grossly, BALF samples may be assessed for turbidity, presence of flocculent debris, clot 
formation and colour. Normal samples are colourless and clear or only slightly turbid. 
Discolouration  may  indicate  increased  cellularity  (leukocytes  or  erythrocytes)  or 
contamination (Hodgson and Hodgson 2007). Turbidity is a feature of increased cellularity 
or increased protein concentration (Hodgson and Hodgson 2007). Increased mucus within 
tracheal aspirates is generally assumed to be a non-specific indicator of inflammation and 
subsequent cytological examination often reveals an increase in cellularity. Mucus may 
become inspissated and deeply basophilic staining or form airway casts (Curschmann‟s 
spirals) especially in  chronic or suppurative disease. The significance of mucus in  the 
absence  of  an  increase  in  cellularity  is  uncertain  (Hodgson  and  Hodgson  2007).  The 
presence of atypical bronchial epithelial cells has been described as an indicator of airway 
pathology. The presence of squamous epithelia from the upper respiratory tract indicates 
contamination.  Erythrocytes  and  haemosiderophages  are  an  indicator  of  pulmonary 
haemorrhage, most commonly as a result of EIPH or iatrogenic damage during sampling. 
The presence of haemosiderophages indicates that haemorrhage did not occur at the time 
of sample collection.  
 
Total nucleated cell counts (TNCC) may be increased in both infectious and non-infectious 
airway  diseases.  Total  nucleated  cell  counts  are  influenced  by  dilution  when  fluid  is 
infused and aspirated (in both  TA and BAL).  Efforts  have been made to  estimate the 
effects of dilution by correction according to the albumin or urea concentration (McGorum 52 
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et al. 1993f), however urea concentration may increase with pulmonary inflammation and 
confound  the  results.  Retrieval  of  a  set  percentage  of  the  infused  saline  has  been 
recommended  but  is  rarely  possible  (Hodgson  and  Hodgson  2007).  Cellular  clumping 
within mucus can result in a false decrease in TNCC; an effect that cannot be prevented by 
filtering  of  mucus  as  epithelial  cells,  macrophages  and  mast  cells  are  also  removed. 
Automated  counters  are  inaccurate  if  mucus  is  present  within  the  sample.    Though 
published  ranges  are  varied,  both  TA  and  BALF  from  normal  horses  contain  <1  x 
10
9cells/litre  with  few  to  no  erythrocytes  (Hodgson  and  Hodgson  2007).  Intracellular 
organisms and pollen may be visible. 
 
Differential  leukocyte  counts  are  widely  accepted  as  the  most  valuable  measures  of 
inflammation in non-infectious airway disease yet there is variation in reported cut-off 
values for different conditions. Macrophages and lymphocytes make up the majority of 
cells whilst other cell types are usually present in low numbers.  
  
Macrophages are the predominant cell type in both tracheal aspirates (TA) and BALF and 
increases are both difficult to detect and of uncertain significance (Hodgson and Hodgson 
2007). Haemosiderophages may be present as a result of haemorrhage distal to the larynx 
and  although  presence  in  BALF  correlates  well  with  exercise-induced  pulmonary 
haemorrhage (EIPH) they are also a normal finding in horses in training (McKane et al. 
1993).  Haemosiderophages  may  take  months  to  be  removed  from  the  lower  airways, 
making interpretation of their significance difficult and preventing any consensus on what 
constitutes a “normal” number (Hodgson and Hodgson 2007). 
 
The variation in percentage of lymphocytes within TAs and particularly BALF is large and 
although increased percentages have been associated with exercise intolerance and chronic 
coughing, the significance of large numbers is uncertain (McGorum and Dixon 1994). It 
has been suggested that the lymphocytic inflammation that commonly occurs in young 
horses  may  bear  some  similarity  to  the  acute  form  of  hypersensitivity  pneumonitis  or 
farmer‟s  lung  resulting  from  chronic  exposure  to  organic  antigens  (Viel  and  Hewson 
2001). 
 
Whilst RAO in horses is typified by airway neutrophilia, the condition of neutrophils may 
be the only means of differentiating infectious from purely inflammatory airway diseases; 
in RAO, IAD and EIPH neutrophils are typically mature with few degenerate or toxic 
changes.  In  contrast,  the  production  of  cytolysins  by  infectious  agents  often  causes 53 
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neutrophil  degeneration.  Recurrent  airway  obstruction  is  characterised  by  BALF 
neutrophilia  and  whilst  there  is  disagreement  over  cut  off  values  between  normal  and 
abnormal BALF, it is more appropriate to consider >25% neutrophils indicative of RAO 
and  <5%  consistent  with  absence  of  pulmonary  disease  (Robinson  2001).  Reported 
neutrophil percentages range from 0-28% in control horses (although in all but one study 
results were below 10%) and from 6-65% in horses with RAO (in all but one study results 
were  over  29%)  (Derksen  et  al.  1985b;  Costa  et  al.  2000b;  McGorum  et  al.  1993e; 
Tremblay et al. 1993). In horses with RAO it is not uncommon for neutrophil percentages 
to be as high as 98% (Lavoie 2007). However, neutrophil percentages in BALF do not 
necessarily  correlate  with  clinical  signs  (Grunig  et  al.  1989).  Some  horses  may  show 
marked respiratory difficulty and have only mild (10-20%) airway neutrophilia (Lavoie 
2007)  whilst  stabling  of  normal  horses,  both  young  and  old,  may  result  in  airway 
neutrophilia  (Tremblay  et  al.  1993;  Holcombe  et  al.  2001).  Outdoor  housing  and  hay 
feeding has similarly been shown to result in airway inflammation (Robinson et al. 2006). 
Horses with RAO that are in remission may not have any cytological changes; although 
airway  neutrophilia  can  be  induced  by  as  little  as  5  hours  of  exposure  to  allergens. 
Diagnosis therefore necessitates interpretation of cytology findings in light of other clinical 
findings and clinical history. 
 
Low numbers of eosinophils are a normal finding in equine airway secretions. Eosinophilia 
is typically considered a feature of parasitic and type I hypersensitivity diseases. Infection 
with  Dictyocaulus  arnfeldi  (although  rare)  may  cause  a  profound  airway  eosinophilia 
(MacKay  and  Urquhart  1979).  In  the  absence  of  parasitic  disease,  eosinophilia  (often 
accompanied  by  mastocytosis)  may  be  assumed  to  be  the  result  of  a  hypersensitivity 
response, however increases are often small and transient (<24h) and eosinophilia is rarely 
a feature of RAO  (Lavoie 2007). Airway  eosinophilia may be cytological  evidence of 
eosinophilic pulmonary disease. Eosinophilia in the BALF of young racehorses has been 
associated with airway hyperreactivity (Hare and Viel 1998). 
 
Mast cells are most often seen in BALF, however occasionally mast cells may be identified 
in tracheal aspirates (Mair 1987, Hughes et al. 2003). While large percentages of mast cells 
have been identified in normal horses (McGorum and Dixon 1994), increases have also 
correlated with increased hyperreactivity to histamine bronchoprovocation in horses with 
exercise  intolerance  (Hare  et  al.  1994;  Hoffman  et  al.  1998).  Some  studies  may  have 
underestimated  mast  cell  numbers  by  mistakenly  relying  on  fast  Romanowsky  stains 
(McKane et al. 1993; Lapointe et al. 1994). The use of fast Romanowsky stains will result 54 
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in a significantly lower mast cell percentage compared to the use of a metachromatic stain 
(e.g. Leishmann‟s stain) (Hughes et al. 2003). 
 
1.5.4 Diagnostic Imaging 
1.5.4.1 Radiography 
Thoracic radiography in adult horses is complicated by the size of the animal‟s chest and 
by the overlying structures of the forelimb. High exposures are often required to achieve 
sufficient x-ray beam penetration for acquisition of thoracic radiographs. Tissue contrast is 
increased  by  capturing  the  image  at  maximal  inspiration.  In  order  to  achieve  optimal 
timing  with  minimal  movement,  thoracic  radiography  is  generally  performed  under 
standing sedation. Dorsoventral images cannot be obtained in the adult horse; radiography 
may be performed from both sides of the chest to allow the site of unilateral lesions to be 
determined. The trachea, lungs, main-stem bronchi, cardiac silhouette, aorta, pulmonary 
vasculature, caudal vena cava, mediastinum, diaphragm, ribs, vertebrae and sternum are all 
visible  on  thoracic  radiographs.  The  major  indication  for  thoracic  radiographic 
examination  is  investigation  of  parenchymal  disorders  especially  where  disease  of  the 
deeper parenchyma is suspected. Radiographic investigation of the peripheral parenchyma 
may  be  valuable;  however  ultrasonographic  examination  is  frequently  more  useful 
(Barakzai and McAllister 2007). Radiographic investigation is insensitive for the detection 
of thickening of the bronchi which is a characteristic pathology of both RAO and IAD 
(Christley and Rush 2007; Lavoie 2007).  In cases of chronic RAO, a generalised increase 
in  opacity  may  be  evident  with  a  bronchointerstitial  pattern  (Barakzai  and  McAllister 
2007).  Some  authors  have  reported  flattening  of  the  diaphragm  indicative  of  alveolar 
hyperinflation (McPherson et al. 1978; Seahorn et al. 1996). Air trapping within the distal 
airways may also result in less radiographic difference between inspiratory and expiratory 
radiographs than would be seen in normal horses (Farrow 2002). The major indication for 
thoracic radiography during investigation of RAO, SPARAO or IAD is the elimination of 
other possible diagnoses. 
 
1.5.4.2 Ultrasonography 
Normally aerated lung is highly echogenic and the interface of the pleura and aerated lung 
produces a reverberation artefact which prevents examination of deeper structures. In both 
RAO and IAD, the peripheral parenchyma remains either normally or over-inflated and has 
the same ultrasonographic appearance as normal lung. As with radiography, the major 55 
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indication of ultrasonographic examination in the investigation of RAO and IAD is the 
elimination of other conditions.  
 
1.5.4.3 Nuclear Scintigraphy 
Nuclear scintigraphy enables examination of regional ventilation (V), regional perfusion 
(Q),  V:Q  relationship,  alveolar  epithelial  permeability,  inflammatory  cell  distribution, 
mucociliary clearance and aerosol deposition within the respiratory tract  (Votion et al. 
1997a; Votion et al. 1997b; Votion et al. 1998; Votion et al. 1999a; Votion and Lekeux 
1999; Votion and Lekeux 2003). Given alternate techniques are available for many of these 
analyses and the availability of nuclear scintigraphy is limited, it is a technique that is 
rarely utilised in the examination of the respiratory tract. 
 
1.5.5 Lung Biopsy  
In isolated cases of lower respiratory tract disease, diagnosis may require histopathologic 
examination  of  pulmonary  tissue.  Biopsy  is  generally  performed  for  investigation  of 
pulmonary  infiltrative  disease  and  is  rarely  required  for  diagnosis  of  lower  airway 
inflammation. The least invasive means of harvesting tissue is collection of pinch biopsies 
of  bronchial  tissue  under  endoscopic  guidance  (Lugo  and  Peroni  2007),  however  this 
technique has not been adequately validated by comparison with established diagnostic 
methods. In one study of horses with RAO, bronchial mucosal biopsies were less likely to 
detect airway inflammation than percutaneous biopsies (Wilson et al. 1993). Percutaneous 
needle  lung  biopsy  (Raphel  and  Gunson  1981)  has  become  the  standard  method  for 
collection  of  lung  tissue  as  it  is  reasonably  safe,  easy  to  perform,  inexpensive  and  is 
performed under standing sedation. Samples obtained may be small and may not be of 
diagnostic value (Lugo and Peroni 2007). However in one study, diagnosis was established 
in 54 of 66 horses with diffuse pulmonary disease via percutaneous biopsy (Pusterla et al. 
2007). Complications of the procedure may include epistaxis, pneumothorax, pulmonary 
haemorrhage,  tachypnoea  and  respiratory  distress  (Savage  et  al.  1998)  but  the  rate  of 
complications  may  be  reduced  by  the  use  of  spring-loaded  automated  biopsy  devices 
(Venner et al. 2006). In a study of 66 horses with respiratory tract disease, complications 
were observed in only 6 cases using an automated device (Pusterla et al. 2007). Larger 
samples of lung tissue may be obtained via thorascopically guided wedge resection (Lugo 
and Peroni 2007). Whilst this technique is reported to be safe (Lugo and Peroni 2007) and 
has the advantage that the biopsy site may be visualised in order to check for haemorrhage, 56 
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the procedure is expensive and there are associated risks of collapsing and re-inflating the 
lung during thoracoscopy (Vachon and Fischer 1998). 
 
1.5.6   Analysis of Markers in Blood  
The results of haematological and serum biochemical examinations in horses with RAO or 
SPARAO are generally unremarkable (Couetil and Hinchcliff 2004; Lavoie 2007) and the 
main indication for performance of these analyses is to exclude other possible diagnoses.  
Results  of haematological  and blood biochemical  analyses are normal  by definition in 
cases of IAD. Small increases in fibrinogen may be observed in the acute stages of RAO 
(Couetil and Hinchcliff 2004;  Borges et al. 2007). Horses with  acute exacerbations of 
airway inflammation and horses with inflamed airways that are undergoing exercise may 
experience hypoventilation and ventilation perfusion mis-matching, resulting in hypoxia 
and  less  commonly  hypercapnia  that  may  be  detected  by  collection  of  arterial  blood 
samples (Dixon et al. 1995c; Couetil and Denicola 1999). 
 
1.5.7   Allergy Testing 
Some studies have identified differences in response to intradermal injection of histamine 
and fungal antigens between normal horses and horses with RAO (McPherson et al. 1979a; 
Wong  et  al.  2005).  However,  other  studies  have  failed  to  demonstrate  any  difference 
following injection of allergens into the dermis or directly into the bronchi (McGorum and 
Dixon 1993; McGorum et al. 1993a;  Lorch et al. 2001; Tahon et al. 2009) and these 
methods are not used in the diagnosis of allergic respiratory disease. Evaluation of IgE 
concentration in serum has also proved unhelpful in the diagnosis of RAO (Tahon et al. 
2009). 
 
1.5.8 Pulmonary Function Tests 
The  diagnostic  tests  outlined  in  sections  1.5.1  –  1.5.6  allow  the  clinician  to  establish 
whether lower airway inflammation is present and may give an indication of the severity of 
disease.  However,  in  order  to  establish  the  functional  consequences  of  disease,  lung 
function testing is required. Pulmonary function testing (PFT) enables measurement of 
lung volume, mechanical function and the efficiency of gaseous exchange  (Marlin and 
Deaton 2007). Specialist equipment and expertise is required for PFT and these procedures 
are mostly used in research settings. Standard PFT techniques such as measurement of 57 
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oesophageal pressure and flow rates may not detect differences between normal horses, 
horses with RAO that are in remission or horses with IAD. More sensitive techniques such 
as forced oscillation, forced expiration, volumetric capnography and plethysmography can 
be  used  to  detect  lower  airway  dysfunction  in  horses  with  IAD  or  sub-clinical  RAO 
(Derksen et al. 1985a; Fairbairn et al. 1993a; Hoffman and Mazan 1999; Votion et al. 
1999b; Couetil et al. 2001; van Erck et al. 2003; Andrew et al. 2007; Nolen-Walston et al. 
2009).  
 
1.5.9 Detection of Markers of Inflammation and Oxidative Stress 
Pro-inflammatory oxidants are generated by metabolic enzymes, inflammatory cells and 
mitochondrial electron leakage. Endogenous and exogenous antioxidants counterbalance 
oxidative processes to maintain homeostasis. If homeostasis is not maintained, a state of 
oxidative stress  may ensue in  which cell damage may occur. Reactive oxygen species 
(ROS) or oxidants are oxygen-containing molecules that are more reactive than the oxygen 
molecule itself (Noguchi and Niki 1999). Reactive oxygen species may contain one or 
more unpaired electrons and are known as free radicals; for example, nitric oxide (NO
-), 
superoxide (O2
.-) and the hydroxyl radical (HO
-). Species that do not contain un-paired 
electrons are known as non-radical oxidants and include peroxynitrite (ONOO
-), hydrogen 
peroxide  H2O2  and  hypochlorous  acid  (HOCl).  Antioxidants  may  be  components  of 
systems that prevent ROS generation, inactivate ROS or limit the deleterious effects of 
oxidative injury (Cheeseman and Slater 1993).  
 
Measurement of free radicals is rarely possible due to the complexity of the laboratory 
processes  and  equipment  required.  Measurement  of  markers  of  oxidative  damage  and 
measurement  of  pro-oxidant  elements  and  anti-oxidants  is  more  commonly  performed 
(Kirschvink et  al. 2008). However, measurement  remains  largely  restricted to  research 
institutions.  Ascorbic  acid  is  the  principal  non-enzymatic  anti-oxidant  in  pulmonary 
epithelial lining fluid (PELF) accompanied by glutathione (GSH) and uric acid (Art et al. 
1999; Deaton et al. 2002; Deaton et al. 2005a). Nucleated cells present within PELF also 
contain superoxide dismutase, glutathione peroxidise and catalase (Deaton 2006). 
 
Increased concentrations of reduced glutathione (GSH), oxidised glutathione (GSSG), 8-
isoprostane,  myeloperoxidase  (MPO)  and  reduced  levels  of  ascorbic  acid  have  been 
identified  in  pulmonary  epithelial  lining  fluid  (PELF)  in  horses  with  RAO;  as  have 
increased levels of GSH and GSSG in erythrocytes RAO (Art et al. 1999; Kirschvink et al. 
2002b;  Deaton et  al. 2004a;  Art et  al. 2006). Nucleated cells  in  PELF collected from 58 
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horses  with  RAO  have  higher  activities  of  the  enzymatic  anti-oxidants  catalase  and 
glutathione  peroxidise  than  control  horses  (Kramaric  et  al.  2005).  Concentrations  of 
oxidative  markers  and  antioxidants  have  been  shown  to  correlate  with  neutrophil 
percentages in BALF, indicating that inflammatory burst may be the major contributor to 
ROS production (Kirschvink et al. 2002b; Deaton et al. 2004a; Deaton et al. 2004b; Art et 
al. 2006). Initial induction of neutrophilic airway inflammation is not generally associated 
with  detectable  pulmonary  oxidative  stress  and  a  sustained  inflammatory  response  is 
considered necessary to deplete antioxidant capacity (Deaton 2006). Oxidant markers also 
correlated with measurements of lung function in RAO-affected horses (Kirschvink et al. 
2002b),  however  the  mechanisms  by  which  oxidative  stress  may  induce  the 
pathophysiological  mechanisms  of  RAO  are  unknown  (Deaton  2006).  Pulmonary 
oxidative stress is also a factor in human respiratory diseases including asthma and COPD 
(Rahman et al. 2000; Rahman 2005).  
 
Horses with RAO have been supplemented with antioxidants including vitamin E, ascorbic 
acid,  selenium  and  natural  flavenoids  in  an  effort  to  reduce  oxidative  stress  in  these 
animals (Deaton et al. 2002; Kirschvink et al. 2002a). Deaton et al. (2002) demonstrated 
that trace element supplementation resulted in increased levels of these antioxidants in 
plasma and that PELF ascorbic acid concentrations were increased. However, in another 
study,  supplementation  of  anti-oxidants  failed  to  result  in  any  improvement  in  lung 
function variables (Kirschvink et al. 2002a). 
 
1.5.10 Exhaled Breath and Breath Condensate Analysis 
 
Collection of exhaled breath is a method described for diagnosis and monitoring of lower 
airway disease. The procedure is non-invasive and can be performed frequently without 
causing distress to the patient. Exhaled breath condensate (EBC) has been studied widely 
in the investigation of human respiratory diseases, most notably asthma (Jobsis et al. 1997; 
Ho et al. 1999; Hanazawa et al. 2000; Niimi et al. 2004; Brunetti et al. 2006). There are 
many constituents of exhaled breath condensate that may be influenced by lower airway 
inflammation including  hydrogen peroxide (H2O2), nitric oxide, adenosine, arachidonic 
acid metabolites, cytokines, 8-isoprostane and ammonia (Horvarth et al. 2005). Hydrogen 
peroxide is one of the most widely used analytes in man (Horvath et al. 2005) and is 
primarily produced by activated inflammatory cells in the airways as a result of oxidative 
stress (Babior 2000).  
 59 
  59 
Analysis of H2O2 concentration is complex as it is photo- and thermo-sensitive, reacts 
readily with a wide variety of chemicals and degrades rapidly (Duz et al. 2009). Despite 
these biological characteristics, concentration of H2O2 in EBC has been shown to correlate 
with presence and severity of asthma (Antczak et al. 2000; Loukides et al. 2002) and pH 
has been demonstrated to be a reliable indicator of inflammatory respiratory disease in man 
(Kostikas et al. 2002; Vaughan et al. 2003b; Borrill et al. 2005).  
 
There are few studies of the collection and analysis of EBC from horses. In one study, 
H2O2  concentration  in  EBC  was  correlated  with  ascorbic  acid  concentration  in  PELF 
(Deaton  et  al.  2004b).  However,  further  studies  which  compared  horses  with  airway 
inflammation  to  normal  controls  failed  to  find  significant  differences  in  exhaled  H2O2 
concentrations (Deaton et al. 2005a; Wyse et al. 2005). Prolonged exposure to airway 
inflammation may be required to deplete antioxidant capacity (Deaton 2006). 
 
Duz et al. (2009) reported a method of EBC collection that was well tolerated by horses. In 
that study, no significant differences in EBC hydrogen peroxide and pH between horses 
with mild lower airway inflammation and normal horses were found (Duz et al. 2009), 
however a trend for a decrease in EBC pH was detected. Using current methods, analysis 
of  EBC  is  not  reliable  in  the  detection  of  lower  airway  inflammation  and  further 
development and research is required (Wyse et al. 2004; Duz et al. 2009). 
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1.6  Study Aims 
 
The aim of the study was to investigate the expression of HO-1 and iNOS in the equine 
respiratory tract. The primary objective was to investigate whether HO-1 and iNOS were 
expressed within leukocytes from equine BALF and to quantify expression in different cell 
types.  
If it proved possible to characterise and quantify expression then additional aims were to 
investigate: 
1.  Associations between HO-1 and iNOS expression and clinical signs of respiratory 
disease 
2.  Possible relationships between induction of HO-1 and iNOS 
3.  Associations between HO-1 and iNOS expression and markers of oxidative stress 
in EBC 
 
1.7   Study Hypotheses 
It was hypothesised that:   
1.  HO-1 and iNOS would be expressed in leucocytes from equine BALF and would 
be expressed most strongly in neutropils and macrophages. 
2.  Expression of HO-1 and iNOS would correlate positively with recognised markers 
of lower airway inflammation. 
3.  Expression of HO-1 and expression of iNOS would be correlated positively with 
one another in leucocytes from equine BALF. 
4.  Expression of HO-1 and iNOS in leucocytes from BALF would be higher in horses 
with higher concentrations of H2O2 and lower pH in exhaled breath condensate. 
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CHAPTER TWO 
 
MATERIALS AND METHODS 
 
2.1  Animals 
 
All investigations were performed with the consent of The Ethics and Welfare Committee, 
University of Glasgow. All horses over 12 months of age presented to the Weipers‟ Centre 
for  Equine  Welfare  at  The  University  of  Glasgow  or  The  Liphook  Equine  Hospital, 
Hampshire  for  the  investigation  of  suspected  lower  respiratory  tract  disease  between 
September 2004 and September 2007 were included. All horses were examined by the 
author. Horses of less than 12 months of age were excluded from the study. 
 
2.2 Clinical Examination 
 
Clinical examination of each horse was performed and results were recorded on a standard 
examination form developed prior to the start of sample collection (Appendix 1).  
 
The age, breed, and gender of each horse included in the study were recorded. Prior to 
specific examination of the respiratory tract the animal‟s condition score was graded on a 
1-5 scale (Carroll and Huntington 1988). Mucous membrane colour was recorded as grey, 
pale pink, pink, dark pink, red or toxic and capillary refill time was assessed subjectively 
and recorded to the nearest second. Heart rates were recorded during auscultation of the 
heart. Rectal temperature was recorded in °C. 
 
The pattern and nature of breathing was assessed from a distance and scored according to a 
formula reported previously (Seahorn et al. 1997). The degree of medial and lateral nostril 
flare and the degree of abdominal lift was used to determine a single score calculated for 
each  horse  (Seahorn  et  al.  1997).  The  nares  were  examined  for  evidence  of  nasal 62 
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discharge. The quantity of any discharge was recorded as nil, scant, moderate or profuse. 
The  appearance  of  any  discharge  was  noted  as  serous,  mucopurulent,  purulent, 
brown/beige or blood-tinged. The owners of horses included in the study were questioned 
as to whether the horse had a history of nasal discharge or coughing. According to owner 
responses, the frequency of coughing was recorded as occasional, frequent single, frequent 
paroxysmal or at exercise only. Further, coughing was classified as productive or non-
productive  and  dry  or  moist.  Historical  data  was  recorded  but  was  not  included  in 
statistical analysis. 
 
Both  lung  fields  and  the  trachea  were  auscultated  and  the  presence  of  any  wheezes 
(indicative  of  bronchoconstriction)  and/or  crackles  (indicative  of  fluid  in  the  distal 
airways) were recorded. Auscultation was repeated using a re-breathing bag in order to 
increase the sensitivity of detection of abnormal breath sounds and findings were recorded.  
 
Endoscopy was performed in all horses. Horses examined at The University of Glasgow 
were examined using a 1.4m videoendoscope (Stortz, Slough, UK). Horses examined at 
The  Liphook  Equine  Hospital  were  examined  using  a  1.5m  videoendoscope  (EV 
Veterinary Products, Shropshire, UK). If the trachea was judged to be erythematous, this 
was noted, however data were not subjected to statistical analysis as more reliable and 
objective means of assessing lower airway inflammation were used (BALF cytology). The 
degree  of  tracheal  mucus  accumulation  was  graded  according  to  a  scale  reported 
previously (Gerber et al. 2004b). The presence of oedema around the carina was recorded; 
however, during the study period Koch et al. (2007) demonstrated this observation was not 
useful  for  assessment  of  lower  airway  inflammation  and  data  were  not  included  in 
statistical analysis.  
 
Tracheal aspirates were performed in the majority of horses included in the study using a 
standardised protocol. In brief, twenty millilitres of phosphate buffered saline (PBS) was 
instilled into the trachea trans-endoscopically and then aspirated from the tracheal sump 
via  the  same  catheter.  Detomidine  (0.01mg/kg,  intravenously)  and  butorphanol  (0.02 
mg/kg, intravenously) were used to facilitate endoscopy and subsequent bronchoalveolar 
lavage as required.  
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2.3  Bronchoalveolar Lavage 
 
Bronchoalveolar lavage was performed in all horses using a commercially available cuffed 
BAL tube from Cook Veterinary Products (Bloomington, Indiana, US) or Bivona (Gary, 
Indiana,  US).  The  diameters  of  both  tubes  were  identical.  In  all  horses,  BAL  was 
performed using the same protocol. The BAL tube was lubricated with a small quantity of 
sterile, water-soluble lubricant and passed via the ventral meatus into the trachea until it 
wedged in a bronchus. The cuff of the tube was then inflated with 5 ml air and 300ml of 
PBS in 6 x 50ml syringes was instilled as rapidly as possible into the distal airways. The 
saline was then withdrawn via the tube and the samples in each syringe pooled to give a 
single sample. Volumes of fluid collected were recorded. 
 
2.4  Fluid Processing 
 
The pooled sample of  BALF  was  mixed by repeated inversion  and 2ml aliquots were 
removed using a sterile syringe. Aliquots  from  all samples  were snap frozen in  liquid 
nitrogen within 5 minutes of collection and stored either in liquid nitrogen or in a freezer at 
-80°C for subsequent processing. For each BALF sample collected at the University of 
Glasgow, one aliquot was frozen and one aliquot was refrigerated and processed within 4 
hours of collection. In the majority of BALF samples, processing was performed within 
one  hour,  although  previous  studies  have  demonstrated  that  results  of  cytological 
examination are not affected if samples are processed within 4 hours (Pickles et al. 2002c). 
Frozen BALF was thawed at laboratory temperature (approximately 22
oC) prior to slides 
being prepared as they were for fresh BALF. Total cell counts were performed using an 
automated analyser. Samples were then cytospun at 1500 rpm for 5 minutes. Six slides 
were  produced  for  each  fresh  and  frozen  sample  to  provide  slides  for  cytological  and 
immunocytochemical examination from identical sample aliquots. Slides for cytological 
examination were stained using Leishmann‟s and Giemsa stains and leukocyte differential 
counts were calculated following examination of 200 cells. The remaining slides were air 
dried and stored for subsequent immunostaining. 
 
2.5  Immunocytochemistry 
 
Cytospins were prepared prior to immunocytochemical staining taking place and stored at 
4ºC until staining with either iNOS (Biomol International, Exeter, UK) or H0-1 (Biomol 64 
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International,  Exeter,  UK)  antibody.  Both  antibodies  used  were  rabbit  polyclonal  and 
staining  was  performed  using  Dako  EnVision  kit  K4011  (Dako,  Ely,  UK)  as  per 
manufacturer‟s instructions with all incubations at room temperature.  
 
The cytospins were placed initially in 10mM Tris buffer saline pH 7.5 with Tween (TbT; 
Dako, Ely, UK) for 5 minutes prior to application of EnVision Peroxidase block (Dako, 
Ely, UK) in order to quench endogenous peroxidases for 5 minutes. The sections were 
washed  twice  for  5  minutes  with  TbT  before  application  of  designated  antibody  at  a 
previously optimised dilution for 1 hour. Both optimal antibody dilutions were 1/50 with 
the antibodies diluted using Dako Real antibody diluents (Dako, Ely, UK). The sections 
were washed twice for 5 minutes with TbT before application of the labeled polymer-HRP 
anti-rabbit signal amplification step for 30 minutes. The sections were then washed twice 
for 5 minutes and 3,3‟ diaminobenzidine chromogen solution applied for 10 minutes in 
order  to  allow  visualisation  of  the  epitope-antibody  interaction.  This  reaction  was 
terminated  by  placing  the  sections  in  de-ionised  water.  The  sections  were  then 
counterstained by transferring into Gill‟s Haematoxylin (4 minutes), differentiated in 1% 
acid alcohol (3 dips) and then the nuclei blued in Scotts tap water substitute (1 minute). 
After washing in running tap water the sections were taken through graded alcohol (70%, 
100%  and  100%  ethanol)  then  xylene  (x3)  before  application  of  a  coverslip  and 
permanently  mounting  using  a  distyrene,  plasticizer,  and  xylene  (DPX)  mountant  for 
microscopy. 
 
2.6  Examination of Immunostained Slides 
 
Slides were examined under a light microscope at 40-100 x magnification. Representative 
regions of each slide were selected and images captured using a digital camera connected 
to the microscope. One hundred cells were examined for each slide. If insufficient cells 
were present in a single image capture then further captures were taken from the same slide 
and if necessary, from further slides made from the same aliquot until in excess of 100 
cells were present or all cells on the slides had been examined. All cells on a capture were 
counted to ensure that the count was objective and representative. Counts were facilitated 
by the use of automated counting software used in association with Adobe Photoshop (CS2 
Version 9; Adobe Systems Incorporated, USA).  
 
Cells in fresh samples were classified as neutrophils, macrophages or lymphocytes on the 
basis of morphology. Differentiation of immunostained eosinophils and mast cells was 65 
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found to be impossible. It was intended that cell morphology would be determined and 
staining graded for frozen samples in the same manner. However, cell morphology was 
disrupted markedly by the freezing and thawing of cells and distinction between cell types 
was  not  possible.  Assessment  of  frozen  samples  was  performed  by  considering  cells 
collectively without differentiation into specific cell types. 
 
The  results  of  pilot  studies  indicated  that  in  virtually  all  cells  uptake  was  diffuse 
throughout  the  cytoplasm  of  the  cell  and  distributed  equally  throughout  the  cell.  The 
degree of staining for each cell was graded on 0-4 scale: 
  Grade 0: No stain uptake 
  Grade 1: Stain visible but barely discernable 
  Grade 2: Pale brown staining 
  Grade 3: Dark brown staining 
 
On the rare occasion that stain uptake was not equal throughout the cytoplasm an average 
of the degree of staining across the cell was taken. 
 
2.7  Collection of Exhaled Breath Condensate 
 
Exhaled  breath  condensate  (EBC)  was  collected  according  to  a  method  described 
previously (Duz et al. 2009). Collection of EBC was performed before horses were sedated 
for  the  BAL  procedure.  A  face  mask  was  connected  via  tubing  to  a  polypropylene 
condensation  chamber  immersed  in  ethanol/liquid  nitrogen  slurry  to  maintain  a 
temperature below -80°C. The face mask was constructed from a muzzle modified with 
fibreglass  and  incorporated  two  one-way  non-rebreathing  valves.  A  rubber  diaphragm 
around the mask created an airtight seal with the horse‟s head. The non re-breathing valves 
were connected by a rubber flexible tube (Cranlea, UK) to the condensation chamber. 
Exhaled breath condensed on the internal surface of the polypropylene container. A one-
way  valve  on  the  outlet  of  the  condensation  chamber  prevented  contamination  of  the 
sample with environmental air. Breath condensate was collected over a 10 minute time 
period. Collected samples of EBC were maintained on ice during transit to the laboratory. 
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2.8  Analysis of Exhaled Breath Condensate 
 
Exhaled breath condensate was thawed and analysed immediately. Measurement of H2O2 
concentration was performed using a spectrophotometric assay based on the oxidation of 
3,3‟,5,5‟-tetramethylbenzidine  (TMB)  in  the  presence  of  horseradish  peroxidise  (HRP; 
Sigma-Aldrich,  UK)  modifying  a  published  method  (Gallati  and  Pracht  1985).  In 
summary, 15 µl of HRP (75IU/ml), 140 µl of TMB in 0.42M citrate buffer (pH 3.8) and 
140  µl  of  EBC  were  mixed  at  room  temperature.  The  reaction  was  stopped  after  10 
minutes  by  addition  of  15µl  of  9M  sulphuric  acid.  The  product  of  the  reaction  was 
analysed immediately with an automated microplate reader (FLUOstar OPTIMA, BMG 
labtech, Aylesbury, UK) using a wavelength for absorbance of 450 nm. Exhaled breath 
condensate  H2O2  concentration  was  calculated  from  a  standard  curve  of  known 
concentrations of H2O2 (from 0.1 to 10 µM) prepared fresh for each assay. The lower 
detection limit of the assay was 0.1 µM. Linearity of the standard curve was acceptable (r
2 
> 99%) between 0 and 10 µM. The measurement was repeated 4 times for each sample and 
the final H2O2 concentration was calculated as the mean of the 4 measurements.  
 
Measurement of pH of  EBC samples  was  performed using  a pH meter (pH21, Hanna 
Instruments Ltd) connected to a glass-body pH electrode with an accuracy of ± 0.02 pH 
(HI-2031B, Hanna Instruments Ltd). 
 
2.9  Case definitions 
 
In accordance with the guidelines published in the consensus statements pertaining to RAO 
and  IAD,  the  results  of  cytological  analysis  of  BALF  were  considered  central  to  the 
diagnosis of lower airway inflammation (Couëtil et al. 2007; Robinson 2001). Pulmonary 
function testing was not available. Cut-offs were based upon the findings of studies of 
BALF from normal horses (Table 2.9) and values published previously (Mair et al. 1987; 
Grunig et al. 1989; Vrins et al. 1991; Naylor et al. 1992; Lapointe et al. 1993; McGorum 
et al. 1993e; Jean 1996; Robinson 2001; Couëtil et al. 2007). Neutrophilia was used to 
quantify airway inflammation; horses with greater than 5% neutrophilia in BALF were 
considered  to  have  inflammation  of  the  distal  airways.  Horses  with  less  than  5% 
neutrophils in BALF were considered to be free of lower airway inflammation.  Relative 67 
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increases in eosinophil and mast cell counts were noted but were not used to define the 
presence of inflammation as they are an inconsistent finding in horses with lower airway 
inflammation (Derksen et al. 1985b; Derksen et al. 1989; Vrins et al. 1991; Winder et al. 
1991).  Following  demonstration  of  the  presence  of  airway  inflammation,  clinical  and 
historical data were used to determine whether horses were likely to be suffering from IAD 
or RAO.  For example, horses that demonstated clinical signs  at rest or in response to 
environmental  allergens  were  considered  to  be  suffering  from  RAO.  Horses  that  were 
investigated for performance, did not have marked neutrophilia in BALF and failed to 
exhibit signs at rest were considered more likely to be suffering from IAD. 
 
Table 2.9. Published values for differential cell counts in equine BALF (mean values). 
  McGorum 
et al. 1993 
Mair et al. 
1987 
Naylor et 
al. 1992 
Lapointe et 
al. 1994 
Vrins et 
al. 1991 
Neutrophil (%)  1.4  6.2  4.4  2.4  3.6 
Macrophage (%)  58.5  70.3  48.2  25.6  65.1 
Lymphocyte (%)  31.8  7.6  38.8  71.4  28.9 
Eosinophil (%)  0  1.0  1.3  0.0  0.1 
Mast Cell (%)  7.4  0.6  7.3  0.5  1.4 
   
   
2.10  Data Analysis 
 
Data were collated and processed using Microsoft Excel (Microsoft Office 2007, Microsoft 
Corporation, Richmond, USA). Statistical analysis was performed using Minitab (Minitab 
Ltd, Pennsylvania, USA). Grouped data were compared using Pearson‟s correlation when 
data were continuous. Categorical data sets were compared using the Mann-Whitney test. 
Significance  was  assumed  where  p<0.05.  Results  were  also  plotted  graphically  to  aid 
interpretation. 
Intra-observer agreement was investigated by calculation and graphical representation of 
the means and standard deviations for repeated analysis. 
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CHAPTER THREE 
 
CHARACTERISATION OF EXPRESSION OF HO-1 
AND iNOS WITHIN INFLAMMATORY CELLS OF 
FRESH AND FROZEN EQUINE BALF 
 
3.1   Introduction 
Haem oxygenase-1 is a heat shock protein responsible for the degradation of haem into 
bilirubin, carbon monoxide and iron (Tenhunen et al. 1969). The significance of HO-1 in 
respiratory disease is not known, however there is extensive evidence that the products of 
HO  are  protective  against  tissue  damage  which  may  be  induced  by  inflammation  and 
oxidative stress (Vogt et al. 1995; Otterbein et al. 1999b; Christou et al. 2000; Hashiba et 
al. 2001; Stocker 2004). Carbon monoxide in particular has been pursued as a possible 
therapeutic intervention for human lung injury (Otterbein et al. 2000; Otterbein 2002). 
Haem oxygenase-1 has been identified in equine lung tissue and its induction may have 
implications  for  respiratory  physiology  and  pathology  (Wyse  et  al.  2006).  Further 
characterisation of the expression of HO-1 would be a useful step to help elucidate the 
importance of this enzyme in equine respiratory health and disease. 
Nitric oxide, produced by nitric oxide synthase (NOS) has been implicated as a mediator of 
airway inflammation in human asthma and is produced in large quantities from bronchial 
epithelial and inflammatory cells of affected patients (Barnes and Liew 1995).  Potentially 
deleterious  effects  of  NO  and  RNS  include  vasodilation  and  plasma  extravasation, 
increased airway secretions, impaired ciliary motility, increased Th2-mediated eosinophilic 
inflammation, necrosis and apoptosis (Barnes and Liew 1995). In horses, expression of 
inducible  iNOS  was  found  to  be  greater  in  the  bronchial  epithelium  of  animals  with 
SPARAO than in unaffected animals (Costa et al. 2001). Nitric oxide produced by the 
activity  of  iNOS  may  therefore  be  an  important  mediator  in  equine  lower  airway 69 
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inflammation  and  further  characterisation  of  the  expression  of  iNOS  would  be  a  step 
forward in understanding its potential roles and significance. 
Following collection of fluid samples from the equine respiratory tract, laboratory facilities 
may not always be available to permit immediate immunocytochemical examination. The 
equipment and skills required for cytospin preparations and immunostaining are generally 
restricted to specialist laboratories. The effects of delays in the analysis of bronchoalveolar 
lavage  fluid  have  been  investigated  (Pickles  et  al.  2002a,  2002b,  2002c).  In  addition, 
immunostaining commonly results in variation in the appearance of cells between batches 
and these variations are exaggerated when equipment and personnel are not standardised 
(C.Nixon, personal communication). It would be advantageous if samples could be frozen 
and  stored  for  subsequent  processing  for  cytological  and  immunocytochemical 
examinations. This had particular relevance to our study as a cytospin was not always 
available to allow immediate preparation of slides from fresh BALF.   
 
3.2   Aims 
To  determine  whether  there  is  good  agreement  in  immunocytochemical  examination 
findings  of  both  HO-1  and  iNOS  expression  between  leukocytes  in  fresh  and  frozen 
aliquots  of  BALF  samples  obtained  from  horses.  This  would  allow  the  results  of 
immunostaining  from  frozen  samples  to  be  utilised  in  later  investigations.  It  was 
hypothesised  that  there  would  be  no  significant  difference  between  the  results  of 
immunostaining fresh and frozen BALF. 
 
3.3  Methods 
Samples  of BALF were collected and processed as  described in  Chapter 2.3.  In brief, 
following  sedation  with  detomidine  and  butorphanol,  BALF  was  collected  using  a 
commercially available BAL tube. Phosphate buffered saline in 6 x 50ml aliquots was 
instilled as rapidly as possible into the distal airways. The saline was then withdrawn via 
the tube and the samples in each syringe pooled to give a single sample. Aliquots of 2ml 
were obtained from the pooled sample and slides were prepared from one single aliquot 
within 4 hours of collection. A further aliquot was snap frozen in liquid nitrogen within 5 
minutes of collection and then transferred to a freezer within which the temperature was 
maintained  at  -80°c.    Frozen  samples  were  subsequently  thawed  at  room  temperature 
(around 22°C) and then processed in the same manner as fresh samples. The slides were 70 
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stained for iNOS and HO-1 using rabbit polyclonal antibodies utilizing a Dako EnVision 
kit K4011 (Dako, Ely, UK) as per manufacturer‟s instructions and all incubations were 
performed at room temperature as outlined in Chapter 2.  
 
Stained BALF from 12 horses was examined as described in Chapter 2. In short, during 
examination  of  each  slide,  the  degree  of  staining  was  determined  for  each  cell. 
Representative regions of each slide were selected and images captured using a digital 
camera connected to the microscope (Figure 3.3.1). One hundred cells were examined for 
each slide. If insufficient cells were present in a single image capture then further captures 
were taken from the same slide and if necessary, from further slides made from the same 
aliquot  until  in  excess  of  100  cells  were  present  or  all  cells  on  the  slides  had  been 
examined. All cells on a capture were counted to ensure that the count was objective and 
representative. For samples that were prepared before freezing, cells were classified as 
neutrophils, macrophages or lymphocytes. Pilot data had indicated that staining of mast 
cells and eosinophils was inconsistent and that these cell types were difficult to identify 
with  confidence  following  immunostaining.  They  were,  therefore,  not  included  in  the 
counts.  
 
Examination of slides made from samples that had been frozen revealed changes in cell 
morphology had occurred that prevented reliable identification of cell types (Figure 3.3.1). 
Comparison of the images in figure  3.3.1 illustrates the differences between fresh and 
frozen samples. For frozen samples, nucleated cells were not differentiated by cell type and 
were considered collectively. The quality of iNOS staining for four samples was very poor 
and these slides were excluded from analysis (Figure 3.3.2). In order to allow statistical 
comparisons to be performed the results of the counts for each cell type in fresh BALF 
were combined to give total numbers of cells staining each grade (i.e. the same as for the 
frozen samples). Percentage of cells positive for immunocytochemical staining for fresh 
and frozen aliquots of BALF samples were compared using Pearson‟s correlation. 
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Figure 3.3.1 Haem oxygenase-1 staining in a cytospin prepared from fresh (left) and frozen 
(right) BALF collected from Horse 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.2. Inducible nitric oxide synthase staining in a cytospin prepared from fresh 
(left) and frozen (right) BALF collected from horse 11. 
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3.4 Results 
The results of staining for fresh and frozen BALF are presented in Table 3.4.1 – 3.4.4 and 
the  results  of  statistical  analysis  of  the  data  are  presented  in  Table  3.4.5.  Only  one 
statistically significant correlation was identified; cells staining grade 3 for iNOS. The 
results for fresh and frozen samples were displayed graphically in figures 3.4.1 and 3.4.2. 
The random distribution of the data points illustrates the lack of correlation between the 
results for fresh and frozen samples.  
 
Table 3.4.1 Results of staining for HO-1 in frozen and thawed BALF from 12 horses. 
 
Horse  
Number of cells staining grades 0-3  
(percentage of the total number of cells in brackets) 
  0  0(%)  1  1(%)  2  2(%)  3  3(%) 
1  36  30  47  39  37  31  0  0 
2  10  9  28  25  72  65  0  0 
3  44  42  30  28  30  28  0  0 
4  3  3  17  17  21  21  59  59 
5  85  85  15  15  0  0  0  0 
6  13  12  56  50  42  38  0  0 
7  95  95  5  5  0  0  0  0 
8  25  25  36  35  42  41  0  0 
9  97  97  3  3  0  0  0  0 
10  55  55  45  45  0  0  0  0 
11  1  1  92  87  13  12  0  0 
12  2  2  64  53  55  45  0  0 
 
Table 3.4.2 Results of staining for HO-1 in fresh BALF from 12 horses. 
 
Horse 
Number of cells staining grades 0-3  
(percentage of the total number of cells in brackets) 
0 
0 
(%)  1  1 (%)  2 
2 
(%)  3  3 (%) 
1  2  2  50  38  79  59  2  2 
2  30  30  20  20  25  25  26  26 
3  23  19  16  13  18  15  65  53 
4  42  36  21  18  51  44  3  3 
5  17  23  37  51  19  26  0  0 
6  48  41  42  36  24  21  2  2 
7  15  12  0  0  47  39  59  49 
8  48  37  48  37  19  15  14  11 
9  35  38  40  43  10  11  7  8 
10  0  0  16  15  89  85  0  0 
11  71  53  31  23  29  21  4  3 
12  29  25  33  28  42  36  13  11 
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Table 3.4.3 Results of staining for iNOS in frozen and thawed BALF from 9 horses. 
 
 Horse 
Number of cells staining grades 0-3  
(percentage of the total number of cells in brackets) 
  0  0(%)  1  1(%)  2  2(%)  3  3(%) 
2  28  27  44  43  30  29  0  0 
3  28  28  34  34  19  19  20  20 
4  17  15  40  34  59  51  0  0 
5  100  100  0  0  0  0  0  0 
6  63  52  20  17  38  31  0  0 
8  43  35  56  45  25  20  0  0 
9  50  50  50  50  0  0  0  0 
10  50  50  50  50  0  0  0  0 
12  78  61  50  39  0  0  0  0 
 
 
Table 3.4.4 Results of staining for iNOS in fresh BALF from 9 horses. 
 
Horse 
Number of cells staining grades 0-3  
(percentage of the total number of cells in brackets) 
0  0 (%)  1  1 (%)  2  2 (%)  3  3 (%) 
2  57  54  15  14  29  28  4  4 
3  7  6  26  21  23  19  65  54 
4  7  6  14  12  92  81  0  0 
5  30  28  77  72  0  0  0  0 
6  35  32  45  41  24  22  5  5 
8  8  7  59  48  46  38  9  7 
9  41  21  50  25  108  54  0  0 
10  0  0  60  35  101  59  9  5 
12  7  5  63  44  69  48  4  3 
 
 
Table 3.4.5 Results of Pearson‟s Correlations comparing the results of staining (performed 
on percentage values) for fresh and frozen cells. Significant associations highlighted in 
bold. 
 
   HO-1  iNOS 
   r value  p value  r value  p value 
Cells staining 0  -0.370  0.237  0.113  0.772 
Cells staining 1  0.004  0.991  -0.602  0.086 
Cells staining 2  -0.240  0.452  0.250  0.516 
Cells staining 3  -0.189  0.557  0.988  0.000* 
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Figure 3.4.1 Scatter plot showing the results of staining fresh and frozen BALF cells from 
12 horses.  
 
Figure 3.4.2 Scatter plot showing the results of staining fresh and frozen BALF cells from 
12 horses.  
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3.5  Discussion 
A significant correlation was determined in only 1 or the 6 tests of correlation performed; 
cells staining grade 3 for iNOS. For this type and degree of staining the correlation was not 
only significant but was linear with the r value being 0.988. However,  this result was 
strongly influenced by the presence of a single strong positive result (case 3) and a large 
number of negative results. Overall, correlation was poor and as the preservation of the 
fresh samples was visibly superior it was assumed that error was introduced by freezing 
and thawing. When fresh and frozen cells were compared the frozen cells were smaller and 
irregular in  appearance. Cells were commonly aggregated and distinction of individual 
cells proved difficult. The subjective assessment of staining in individual frozen cells was 
therefore less precise. Background staining was also greater in the slides of frozen BALF. 
A  degree  of  background  staining  is  expected  with  the  immunocytochemical  methods 
utilised (C.Nixon, personal communication) as was observed in the slides of fresh BALF. 
However,  with  the  comparatively  large  amount  of  background  staining  of  the  frozen 
samples and the shrunken appearance of the frozen cells we suspected that constituents of 
the cytoplasm were contributing to the  background staining. The freezing and thawing 
processes are suspected to have damaged the phospholipid cell membrane.  
We  rejected  the  hypothesis  that  there  would  be  no  significant  difference  between  the 
results  of  immunostaining  fresh  and  frozen  BALF.  Frozen  BALF  would  appear  to  be 
unsuitable for immunocytochemistry and the results from cases in which only frozen data 
was available were omitted from further analysis within this collection of studies. These 
results are presented in Appendix 3. For immunocytochemical staining of cells in BALF, 
processing  of  samples  should  be  performed  shortly  after  collection  of  BALF  without 
freezing.  
 
Alternatively,  cryopreservation  techniques  could,  and  in  this  study  should,  have  been 
performed. Conventional cryoprotectants are glycols, such as ethylene glycol, propylene 
glycol and glycerol. In molecular biology, glycerol is the most commonly used glycol; 
dimethyl  sulfoxide  (DMSO)  is  even  more  widely  utilised  and  is  also  regarded  as  a 
conventional cryoprotectant.One method is the addition of DMSO to a final concentration 
of 10% followed by slow freezing (Pegg 2007). Cells may then be preserved frozen at -
80°C or stored in liquid nitrogen. A controlled rate cooling process is preferable to allow 
biological samples to equilibrate in the cryoprotectant gradually and particularly to permit 
sufficient  water to  leave the cell during progressive freezing of the extracellular fluid. 
Optimal rate of freezing varies between cells of differing size and water permeability: a 76 
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typical cooling rate of around 1°C per minute is appropriate for many mammalian cells 
after treatment with cryoprotectants such as dimethyl sulphoxide. Foetal bovine serum may 
also be added to 10% DMSO to enhance the survival of some cell lines. In our study cells 
might have been preserved successfully if BALF had been centrifuged and the cell pellet 
resuspened in a mixture of DMSO and foetal bovine serum. However, FBS carries the risk 
of infection by abnormal prion proteins and viruses serum-free cryopreservative solutions 
have been developed recently. A sericin cryopreservative solution consisting of phosphate-
buffered saline, 1% sericin, 0.5% maltose, 0.3% proline, 0.3% glutamine and 10% DMSO 
has recently been shown to be effective (Toyosawa et al. 2009). 
 
In a previous study cytospin slides were prepared and frozen for subsequent thawing and 
immunostaining (Horvath et al. 1998). The limiting factor in our investigations was the 
availability of a cytospin and hence this method of sample storage offered no advantage. 
The effects of a delay between slide preparation and immunostaining were not investigated 
in  this  study.  It  is  unknown  whether  it  is  possible  to  store  air-dried  slides  prior  to 
immunostaining. 
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CHAPTER FOUR 
 
INTRA –OBSERVER AGREEMENT OF THE 
ASSESSMENT OF IMMUNOSTAINING 
INFLAMMATORY CELLS FROM EQUINE BALF 
 
 
4.1  Introduction 
Immunostaining  has  been  used  previously  to  identify  the  presence  of  HO-1  in  equine 
tissues fixed in formalin and embedded in paraffin (Wyse et al. 2006). Expression was 
identified,  on  the  basis  of  cell  morphology,  within  alveolar  type  II  epithelial  cells, 
neutrophils and macrophages. Immunostaining has also been used to identify the presence 
of iNOS within paraffin embedded sections of lung and other equine tissues (Mirza et al. 
1999; Costa et al. 2001; Mirza et al. 2005). Immunostaining of cells contained within 
BALF for iNOS and HO-1 has not, to the author‟s knowledge, been performed previously. 
In all previously reported studies rabbit antibodies directed against the target protein (either 
HO-1 or iNOS), have been used to induce a colour change and in doing so, label cells 
containing  the  target  protein.    Identification  of  immunostaining  is  dependent  upon  the 
operator noting a subjective colour change. It is important that the subjective methods used 
to quantify the degree of staining within each sample give a true and repeatable indication 
of expression. If the methods used to quantify immunostaining proved to be repeatable 
then they would be used to further characterize HO-1 and iNOS expression within equine 
BALF. 
 
4.2   Aims 
To  determine  whether  the  methods  used  to  assess  the  degree  of  immunostaining  in 
leukocytes  collected  from  equine  BALF  were  repeatable.  We  hypothesised  that  there 
would be good agreement between the results of sequential examinations performed on the 
same slides. If the hypothesis was proven we could be confident that analysis of a single 
slide on a single occasion would generate results that were a reliable measure of HO-1 and 
iNOS immunostaining in each sample and could be used in subsequent statistical analysis. 78 
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4.3  Methods 
Samples  of BALF were collected and processed as  described in  Chapter 2.3.  In brief, 
following  sedation  with  detomidine  and  butorphanol,  BALF  was  collected  using  a 
commercially available BAL tube. Phosphate buffered saline in 6 x 50ml aliquots was 
instilled as rapidly as possible into the distal airways. The saline was then withdrawn via 
the tube and the samples in each syringe pooled to give a single sample. Aliquots of 2ml 
were obtained from the pooled sample and 6 slides were made from one single aliquot 
within  4  hours  of  collection.  For  the  purposes  of  this  study  only  samples  that  were 
processed  without  freezing  were  used.  The  results  of  Chapter  3  indicated  that  the 
cytological appearance and immunostaining of nucleated cells was very poor for BALF 
samples that had been frozen after collection. Immunostained frozen cells were not suitable 
for  use  in  further  investigations.  The  slides  made  from  fresh  samples  of  BALF  were 
stained for iNOS and HO-1 using rabbit polyclonal antibodies utilizing a Dako EnVision 
kit K4011 (Dako, Ely, UK) as per manufacturer‟s instructions and all incubations were 
performed at room temperature as outlined in Chapter 2. Stained BALF from 14 horses 
was examined as described in Chapter 2. The quality of staining in isolated samples was 
very poor  and these slides  were excluded  from analysis.  Intra-operator agreement was 
determined for the 12 sets of slides stained for iNOS and 13 sets of slides stained for HO-
1.  
 
Slides were examined by the author who was blinded to the identity of each slide. During 
examination of each slide, the degree of staining was determined for each cell as described 
in Chapter 2. Representative regions of each slide were selected and images captured using 
a digital camera connected to the microscope. One hundred cells were examined for each 
slide. If insufficient cells were present in a single image capture then further captures were 
taken from the same slide and if necessary, from additional slides made from the same 
aliquot  until  in  excess  of  100  cells  were  present  or  all  cells  on  the  slides  had  been 
examined. All cells on a capture image were counted to ensure that the count was objective 
and representative. Cells were classified as neutrophils, macrophages or lymphocytes. Pilot 
data had indicated that staining of mast cells and eosinophils was inconsistent and that 
these cell types were difficult to identify with confidence following immunostaining and 
these  cell  types  were  not  included  in  the  counts.  This  process  was  repeated  twice  on 
subsequent days, again with the operator blinded to the identity of each slide. Results were 
tabulated and displayed graphically. 
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For  each of macrophage, neutrophil  and lymphocyte cell types,  total  numbers  of  cells 
staining each grade were calculated as a percentage of the total number of each cell type.  
Results  (percentages)  were  initially  plotted  on  a  histogram  to  enable  comparison  of 
sequential examinations for each of the samples (appendices 4.1 and 4.2).  
 
4.4  Results  
Signalment and clinical findings for horses included are shown in Table 4.4.1. Samples 
were  collected  from  14  horses  and  ponies  and  a  number  of  different  breeds  were 
represented. Ten horses were geldings and four were mares. Mean (± standard deviation) 
age of the animals was 13.8 ± 5.4 years (range; 4 to 21 years). Eight of the animals were 
diagnosed with RAO, one with IAD and the remaining 5 were not considered to have 
respiratory disease. The results of immunocytochemical staining for HO-1 and iNOS are 
presented in Tables 4.4.2 and 4.4.3 respectively. From these results means and standard 
deviations were calculated for each cell type for each degree of staining from each horse 
(Tables  4.4.4  and  4.4.5).  Means  and  standard  deviations  are  displayed  graphically  in 
figures 4.4.1 and 4.4.2. The means could be compared to the error bars representing a 
single standard deviation.  
 
Further  consideration  was  given  to  more  objective  analysis  of  the  results.  It  was  not 
appropriate to calculate coefficients of variation (CV) as several of the means approach or 
are  zero.  In  these  cases  CV  becomes  an  unreliable  measure  of  repeatability  (Parkin, 
T.D.H., personal communication). There is also an obvious lack of independence between 
measures i.e. if the percentage of cells staining 1 was very high it is not possible for the 
percentage of cells staining 2 and 3 to also be high. ANOVA is not appropriate as data are 
not normally distributed, nor are the variances for each comparative group equal.  
 
Bland Altman plots were considered as a means of indicating how much agreement is 
present  and  it  is  possible  to  calculate  the  95%  confidence  intervals  for  the  repeated 
measures.  However,  it  is  then  open  to  clinical  judgment  as  to  whether  these  95% 
confidence intervals are so wide as to imply poor repeatability. As with any statistical 
analysis sample size calculations could be performed to provide an indication of the likely 
power of the analysis (Bland and Altman 1996a,b,c). The appropriate method as outlined 
by Bland and Altman (2010) indicates that in order to estimate the true repeatability to 
within  10%  either  side  of  the  estimate  we  would  have  required  either  16  repeated 80 
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measurements from the 13 horses or 128 horses each being measured 3 times. Neither 
scenario was feasible given the time and resource constraints of the study. 
 
 
Table 4.4.1 Signalment and clinical data for 14 horses from which BALF was collected 
and prepared slides underwent immunostaining. 
 
Horse  Age  Breed  Gender  Diagnosis 
         
1  18  Standardbred  Gelding  Clinically normal 
2  21  Thoroughbred  Mare  RAO 
3  11  Cross bred  Gelding  RAO 
4  4  Thoroughbred  Gelding  Orthopaedic dz 
5  6  Pony  Mare  Clinically normal 
6  18  ThoroughbredX  Mare  Clinically normal 
7  14  Welsh Se D  Mare  RAO 
8  13  Cob  Gelding  IAD 
9  9  We Se B  Mare  RAO 
10  9  We Se B  Mare  RAO 
11  15  Thoroughbred  Mare  Clinically normal 
12  21  Pony  Mare  RAO 
13  18  Thoroughbred  Mare  RAO 
14  16  Pony  Mare  RAO 
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Table 4.4.2 Haem oxygenase-1 staining for 13 samples of BALF repeated on 3 occasions. 
The number of cells with each grade of staining grade are calculated as percentages of the 
total number of each cell type. Ex = examination. 
 
  
 
Grade 0 Staining  Grade 1 Staining 
Grade 1 Staining 
 
Grade 2 Staining 
Grade 2 Staining 
 
Grade 3 Staining 
Horse 
number 
Ex 1  Ex 2  Ex 3  Ex 1  Ex 2  Ex 3  Ex 1  Ex 2  Ex 3  Ex 1  Ex 2  Ex 3 
                                      
   Macrophages (% of cells staining each grade at each examination) 
1  3  2  21  33  57  75  61  38  4  3  2  0 
2  0  5  0  22  5  17  53  76  50  24  14  33 
3  10  8  50  5  8  25  10  46  0  76  38  25 
4  14  13  21  14  5  35  71  74  38  2  8  6 
5  26  20  15  60  49  35  15  17  45  0  14  5 
6  0  21  10  55  37  40  40  37  35  4  5  15 
7  0  0  11  0  10  6  42  10  72  58  80  11 
8  0  23  7  33  28  37  37  21  50  30  28  7 
9  40  36  40  45  31  30  9  33  10  5  0  20 
10  0  13  0  0  35  54  100  41  46  0  11  0 
11  0  0  0  40  40  29  53  50  71  7  10  0 
12  0  17  0  11  33  41  60  30  28  29  20  31 
13  0  40  14  50  20  57  50  40  14  0  0  14 
                                      
   Neutrophils (% of cells staining each grade at each examination) 
1  0  8  3  42  45  34  58  32  56  0  16  6 
2  50  25  0  50  25  100  0  25  0  0  25  0 
3  0  0  0  0  25  0  25  63  100  75  13  0 
4  33  0  0  33  100  100  0  0  0  33  0  0 
5  0  0  0  38  14  0  63  36  100  0  50  0 
6  0  76  50  38  11  50  63  10  0  0  3  0 
7  0  7  0  0  7  0  67  33  100  33  53  0 
8  0  33  33  80  20  67  20  33  0  0  13  0 
9  0  16  20  0  32  40  50  28  20  50  24  20 
10  0  0  0  0  0  0  0  0  0  0  0  0 
11  0  0  0  100  0  50  0  100  50  0  0  0 
12  0  0  0  0  0  0  0  0  0  0  0  0 
13  4  3  9  50  35  27  46  53  45  0  9  18 
                                      
   Lymphocytes (% of cells staining each grade at each examination) 
1  0  9  0  40  45  40  60  27  60  0  18  0 
2  54  33  54  15  9  15  2  24  2  29  33  29 
3  25  24  25  18  13  18  17  50  17  39  12  39 
4  69  53  69  22  27  22  9  15  9  0  5  0 
5  28  4  28  33  96  33  39  0  39  0  0  0 
6  79  51  79  21  49  21  0  0  0  0  0  0 
7  100  20  100  0  80  0  0  0  0  0  0  0 
8  66  29  66  34  45  34  0  26  0  0  0  0 
9  45  8  45  55  33  55  0  42  0  0  17  0 
10  0  12  0  68  29  68  32  24  32  0  35  0 
11  93  42  93  7  33  7  0  25  0  0  0  0 
12  45  90  45  38  10  38  17  0  17  0  0  0 
13  0  0  0  0  0  0  0  0  0  0  0  0 
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Table 4.4.3 Inducible nitric oxide synthase staining for 12 samples of BALF repeated on 3 
occasions. The number of cells with each grade of staining grade are calculated as 
percentages of the total number of each cell type. 
 
  Grade 0 Staining  Grade 1 Staining 
Grade 1 Staining 
 
Grade 2 Staining 
Grade 2 Staining 
 
Grade 3 Staining 
Horse 
number 
Ex 1  Ex 2  Ex 3  Ex 1  Ex 2  Ex 3  Ex 1  Ex 2  Ex 3  Ex 1  Ex 2  Ex 3 
                         
  Macrophages (% of cells staining each grade at each examination) 
2  0  0  0  31  27  56  58  55  33  11  18  11 
3  0  7  0  3  3  4  8  23  4  89  67  92 
4  0  0  0  6  4  4  94  95  96  0  1  0 
5  32  44  40  68  56  55  0  0  5  0  0  0 
7  0  2  3  52  47  23  40  34  72  8  17  2 
8  0  0  3  12  18  34  72  77  53  16  5  10 
9  13  21  13  33  10  51  53  67  34  0  2  2 
10  0  0  8  23  22  40  69  73  33  8  5  19 
11  0  0  2  59  60  30  16  10  33  25  29  35 
12  0  4  0  60  73  56  31  22  27  9  0  16 
13  0  0  0  52  48  14  48  52  86  0  0  0 
14  0  0  0  56  68  25  44  32  75  0  0  0 
                         
  Neutrophils (% of cells staining each grade at each examination) 
2  0  0  0  100  64  47  0  27  51  0  9  2 
3  0  12  0  61  35  29  28  24  38  11  29  33 
4  0  20  0  100  20  0  0  60  0  0  0  0 
5  0  17  40  100  33  0  0  33  0  0  17  0 
7  0  0  3  100  43  36  0  57  64  0  0  0 
8  0  0  3  83  76  55  17  24  27  0  0  0 
9  7  2  13  25  24  26  68  74  67  0  0  0 
10  0  3  8  0  34  53  0  61  38  0  1  7 
11  57  63  2  43  25  45  0  13  27  0  0  18 
12  0  0  0  0  0  0  0  0  0  0  0  0 
13  53  48  0  21  24  60  26  28  20  0  0  0 
14  0  0  0  49  0  0  51  0  0  0  0  0 
                         
  Lymphocytes (% of cells staining each grade at each examination) 
2  88  75  52  0  25  26  12  0  22  0  0  0 
3  11  7  6  22  37  14  23  30  50  45  26  31 
4  54  50  48  46  50  40  0  0  13  0  0  0 
5  23  0  75  77  100  25  0  0  0  0  0  0 
7  81  91  33  19  9  54  0  0  13  0  0  0 
8  22  14  21  78  86  50  0  0  29  0  0  0 
9  100  60  71  0  10  18  0  30  12  0  0  0 
10  0  0  0  50  38  77  50  63  23  0  0  0 
11  82  93  85  18  7  5  0  0  5  0  0  5 
12  9  6  48  44  42  15  48  52  36  0  0  0 
13  0  97  83  0  1  8  0  2  8  0  0  0 
14  0  67  100  0  0  0  0  33  0  0  0  0 
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Table 4.4.4 Means and standard deviations data for repeated examination of slides 
immunostained for HO-1. 
 
   Grade 0  Grade 1  Grade 2  Grade 3 
Horse  mean  sd  mean  sd  mean  sd  mean  sd 
   Macrophages 
1  9  11  55  21  34  29  4  4 
2  2  3  15  9  60  14  25  25 
3  22  24  12  11  19  24  0  0 
4  16  4  18  15  61  20  11  19 
5  20  5  48  12  26  17  0  0 
6  10  11  44  10  37  3  42  39 
7  4  6  5  5  41  31  2  4 
8  10  12  33  4  36  15  22  19 
9  39  2  35  9  17  13  12  11 
10  4  7  30  27  62  33  0  0 
11  0  0  36  7  58  12  0  0 
12  6  10  29  16  39  18  0  0 
13  18  20  42  20  35  18  5  3 
   Neutrophils 
1  4  4  40  5  48  15  7  8 
2  25  25  58  38  8  14  8  14 
3  0  0  8  14  63  38  29  40 
4  11  19  78  38  0  0  11  19 
5  0  0  17  19  66  32  17  29 
6  42  39  33  20  24  34  1  2 
7  2  4  2  4  67  33  29  27 
8  22  19  56  32  18  17  4  8 
9  12  11  24  21  33  16  31  16 
10  0  0  0  0  0  0  0  0 
11  0  0  50  50  50  50  0  0 
12  0  0  0  0  0  0  0  0 
13  5  3  38  12  48  4  9  9 
   Lymphocytes 
1  3  5  42  3  49  19  6  10 
2  47  12  13  4  9  13  30  3 
3  25  0  17  3  28  19  30  16 
4  64  9  24  3  11  3  2  3 
5  20  14  54  36  26  22  0  0 
6  69  16  31  16  0  0  0  0 
7  73  46  27  46  0  0  0  0 
8  53  21  38  6  9  15  0  0 
9  33  21  47  12  14  24  6  10 
10  4  7  55  23  29  5  12  20 
11  76  30  15  15  8  14  0  0 
12  60  26  28  16  11  10  0  0 
13  0  0  0  0  0  0  0  0 
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Table 4.4.5 Means and standard deviations data for repeated examination of slides 
immunostained for iNOS. 
 
 
   Grade 0  Grade 1  Grade 2  Grade 3 
Horse  mean  sd  mean  sd  mean  sd  mean  sd 
   Macrophages 
1  0  0  38  15  49  13  13  4 
2  2  4  3  1  12  10  83  14 
3  0  0  5  1  95  1  0  1 
4  39  6  60  7  2  3  0  0 
5  2  2  40  15  49  20  9  8 
6  1  2  22  11  67  12  10  6 
7  16  5  31  21  51  16  2  1 
8  3  4  28  11  58  22  11  7 
9  1  1  50  17  20  12  30  5 
10  1  3  63  9  27  4  8  8 
11  0  0  38  21  62  21  0  0 
12  0  0  50  22  50  22  0  0 
  Neutrophils 
1  0  0  70  27  26  25  4  5 
2  4  7  42  17  30  7  25  12 
3  7  12  40  53  20  35  0  0 
4  19  20  44  51  11  19  6  10 
5  1  2  60  35  40  35  0  0 
6  1  2  71  15  23  5  0  0 
7  7  5  25  1  69  4  0  0 
8  4  4  29  27  33  31  3  4 
9  41  33  38  11  13  14  6  10 
10  0  0  0  0  0  0  0  0 
11  34  29  35  22  25  4  0  0 
12  0  0  16  29  17  29  0  0 
  Lymphocytes 
1  72  18  17  15  11  11  0  0 
2  8  3  24  12  34  14  34  10 
3  50  3  45  5  4  7  0  0 
4  33  38  67  38  0  0  0  0 
5  69  31  27  24  4  7  0  0 
6  19  4  71  19  10  16  0  0 
7  77  21  9  9  14  15  0  0 
8  0  0  55  20  45  20  0  0 
9  87  6  10  7  2  3  2  3 
10  21  24  34  16  45  8  0  0 
11  60  52  3  5  4  4  0  0 
12  56  51  0  0  11  19  0  0 
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Figure 4.4.1. Means and standard deviations for cells immunostained for HO-1. Each 
graph represents a different cell type and each bar a different horse. The grade of staining 
is indicated by the colour of the bar; grade 0 (clear) on the left through to grade 3 (dark 
orange) on the right. 
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Figure 4.4.2. Means and standard deviations for cells immunostained for iNOS. Each 
graph represents a different cell type and each bar a different horse. The grade of staining 
is indicated by the colour of the bar; grade 0 (clear) on the left through to grade 3 (dark 
orange) on the right.
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4.5  Discussion 
Given the limited number of horses and samples measured per horse it is difficult to reach 
a definitive conclusion on the repeatability of this method for assessing immunostaining of 
leukocytes in equine BALF. The results do show that we would require a large number of 
horses or sample measurements to reach a conclusion that had sufficient statistical power 
to indicate the likely true repeatability of this assessment. Nevertheless as only a single 
operator was used for all measurements (thus removing any inter-operator error) and taking 
account of time and resource restrictions, it was felt appropriate to continue to use this 
method of subjective analysis throughout the rest of the study.  The results obtained in 
subsequent  chapters  are  thus  limited  by  our  failure  to  demonstrate  definitively  that 
methods were repeatable. The conclusions drawn in subsequent chapters are done so with 
this caveat in mind and furthermore being cognicant of the fact that subsequent evaluations 
were based upon a single observation of staining for each sample. 
The standard deviation from the mean was greater overall for neutrophils than for other 
cell types. The reason why neutrophil counts were more variable is uncertain. There did 
not appear to be any differences in repeatability between staining for iNOS and HO-1. 
Further analysis could be performed to determine whether results are reproducible between 
observers. In subsequent chapters of the current study all the analyses were performed by a 
single observer but should more observers be required then inter-observer repeatability 
ought to be assessed. A further limitation of this study was the failure to establish whether 
the methods used to prepare the slides are repeatable. The same slides were used in this 
study  with  no  investigation  of  potential  differences  that  might  occur  between  slides. 
Different slides prepared from the same sample were compared during the initial analysis 
and although an impression was gained that the slides were similar this was not tested 
objectively. Case numbers were limited and the majority of cases were affected by one 
disease condition, namely RAO. Ideally, a greater number of samples would have been 
analysed in this study and the samples would have been collected from normal animals as 
well as from animals with a range of respiratory diseases. It is possible that the degree of 
repeatability may be influenced by degrees and/or patterns of staining. 
 
 
 
   88 
  88 
 
CHAPTER FIVE 
 
 
EXPRESSION OF H0-1 WITHIN THE 
INFLAMMATORY CELLS OF EQUINE BALF 
 
 
5.1  Introduction 
Evidence for a role of HO-1 activity has been identified in the pathogenesis of numerous 
pulmonary  diseases  in  man  including  acute  respiratory  distress  syndrome  (ARDS), 
interstitial  pulmonary  fibrosis,  COPD  and  asthma.  Asthma  is  a  chronic  inflammatory 
airway disease associated with increased ROS and inflammatory mediators, all of which 
have been demonstrated to induce expression of HO-1 (Barnes 1990).  The pathogenesis of 
RAO has some parallels with the pathogenesis of asthma and oxidative stress has been 
identified in affected animals during exacerbation of disease (Art et al. 1999; Deaton et al. 
2004a; Deaton et al. 2004b; Deaton et al. 2006). Haem oxygenase-1 is induced in airways 
during asthma (Carter et al. 2004) and it is possible that it will be similarly induced in the 
airways of horses with lower airway inflammation (Wyse et al. 2006). 
In human airways, the distribution of HO-1 has been investigated using immunostaining 
and  western  blot  techniques.  Immunostaining  has  identified  HO-1  to  be  distributed 
throughout the submucosa of the distal airways, particularly the airway epithelium and 
submucosal macrophages (Lim et al. 2000; Maestrelli et al. 2001). Further evidence for 
macrophages being the predominant source of HO-1 was provided in a mouse model of 
asthma with immunofluoresecence occurring mostly in the cytoplasm and particularly in 
the perinuclear region (Maestrelli et al. 2001). In a model of inflammation in the pleural 
cavity, western blot analysis revealed an increase in HO-I protein in macrophages but not 
in  neutrophils  (Minamino  et  al.  2001).  Haem  oxygenase-1  expression  has  been 
demonstrated in alveolar macrophages, neutrophils and type II epithelial cells from normal 
equine lungs (Wyse et al. 2006).  
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5.2  Aims 
The aims of this study where to determine whether there are relationships between HO-1 
staining  in  leukocytes  from  equine  BALF  and  other  markers  of  respiratory  tract 
inflammation. It was hypothesised that there would be positive correlation between the 
degree of HO-1 staining in leukocytes from BALF and recognised markers of lower airway 
inflammation. 
 
5.3  Methods 
Horses presented for the investigation of respiratory disease or poor performance were 
examined and clinical findings recorded as outlined in Chapter 2.2. Samples of BALF were 
collected and processed as described in Chapter 2.3. In brief, following sedation, BALF 
was collected using a commercially available BAL tube. Phosphate buffered saline was 
instilled into the distal airways and then aspirated via the tube. The retrieved fluid was 
pooled  to  give  a  single  sample.  Slides  were  prepared  from  each  BALF  sample  for 
immunostaining  within  4  hours  of  collection.  The  slides  were  stained  for  HO-1  using 
rabbit polyclonal antibodies utilizing a Dako EnVision kit K4011 (Dako, Ely, UK) as per 
manufacturer‟s instructions and all incubations were performed at room temperature as 
outlined in Chapter 2. Stained slides prepared from BALF from 13 horses were examined 
and the degree of staining determined for a representative sample of cells as described in 
Chapter  2.6.  The  results  of  cytological  examinations  for  one  horse  were  lost  and 
comparisons of immunostaining and cytological analysis were therefore performed for 12, 
rather than 13, horses. Staining was graded on a 0-3 scale for each cell. 
From the results of examination of immunocytochemical staining of cells, the following 
calculations were made:  
i)  the percentage of cells with any stain uptake (i.e. grades 1-3) 
ii)  the percentage of cells staining greater than 1 (i.e. grades 2 and 3)  
 iii)       the percentage of cells staining greater than 2 (i.e. grade 3).   
Pearson‟s correlation was used to compare the continuous immunocytochemical staining 
data with continuous clinical and cytological data. Mann-Whitney tests were performed to 
compare the categorical immunocytochemical staining data with categorical clinical data. 90 
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For  the  cough,  mucus  and  clinical  score  categories,  horses  with  no  abnormalities  (no 
cough, no mucus and a clinical score of 0) were compared to horses with abnormal results. 
Possible associations between HO-1 immunostaining of leukocytes in BALF and lower 
airway inflammation was investigated further by comparing staining in horses considered 
to have neutrophilic airway inflammation with those considered to have normal airways. 
Horses were divided into 2 groups: horses with a neutrophil relative percentage of > 5% in 
BALF  were  considered  to  have  lower  airway  inflammation  and  horses  with  <  5% 
neutrophils were classified as free of lower airway inflammation. This single indicator of 
airway  inflammation  was  chosen  as  it  is  the  most  reliable  indicator  of  lower  airway 
inflammation (Robinson 2001). The degree of HO-1 immunostaining of inflammatory cells 
in BALF in the diseased and control groups was compared using a Mann-Whitney test. 
5.4  Results 
There were nine horses with neutrophilic lower airway disease and three horses that were 
considered to have no cytological evidence of lower airway inflammation. The result of 
cytological  analysis of  BALF  for one horse  (horse 4)  was  lost. The results  of clinical 
examinations, cytological examinations and immunostaining are presented in table 5.4.1. 
Eight horses had a history of coughing and were compared to 5 that did not and seven 
horses in which mucus had been identified were compared with 6 in which it was not. For 
both clinical score and neutrophilic inflammation, 10 horses classified as having abnormal 
results were compared to 3 that were considered normal.  Neutrophils were more likely to 
stain for HO-1 than other cell types. Results of statistical analysis are presented in Table 
5.4.2.  Statistically  significant  associations  were  identified  between  the  percentage  of 
macrophages  staining  >1  and  mast  cell  percentages;  between  the  percentage  of 
macrophages staining >2 and both respiratory rate and neutrophil percentage. In addition 
the percentage of neutrophils staining greater than 1 or 2 was associated with respiratory 
rate and clinical score. The percentage of lymphocytes staining greater than 1 or 2 was 
associated with eosinophil percentage.  91 
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Figure 5.4.1. Leukocytes from equine BALF stained for HO-192 
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Table 5.4.1 Clinical and cytology findings and HO-1 immunostaining results for 13 cases 
of suspected respiratory disease or poor performance. Respiratory rate (Resp), neutrophil 
(Neut), macrophage (Macro), lymphocyte (Lymp), eosinophil (Eos) and mast cell (Mast). 
 
  
Cough 
Resp 
(breaths 
per 
minute) 
Mucus 
grade 
Clinical 
score 
BALF cytology  HO-1 staining 
Neut 
(%) 
Macro 
(%) 
Lymph 
(%) 
Eos 
(%) 
Mast  
(%) 
Macrophages  Neutrophils  Lymphocytes 
%>0  %>1  %>2  %>0  %>1  %>2  %>0  %>1  %>2 
1  Yes  8  1  0  3  49  39  2  7  97.1  63.8  2.9  100.0  57.6  0.0  100.0  60.0  0.0 
2  Yes  16  0  0  11  33  45  0  11  100.0  77.8  24.4  50.0  0.0  0.0  46.2  30.8  28.8 
3  Yes  32  3  2  29  26  36  3  6  90.5  85.7  76.2  100.0  100.0  75.0  75.0  56.6  39.5 
4  No  12  0  0                 86.4  72.7  1.5  66.7  33.3  33.3  31.1  8.9  0.0 
5  Yes  16  1  0  0  100  0  0  0  74.5  14.9  0.0  100.0  62.5  0.0  72.2  38.9  0.0 
6  Yes  16  0  0  4  35  56  0  5  100.0  44.7  4.3  100.0  62.5  0.0  21.3  0.0  0.0 
7  Yes  36  2  4  72  15  11  0  2  100.0  100.0  57.7  100.0  100.0  33.3  0.0  0.0  0.0 
8  No  16  0  0  27  69  3  0  1  100.0  67.4  30.4  100.0  20.0  0.0  34.2  0.0  0.0 
9  No  28  2  4  23  64  11  0  2  60.0  14.7  5.3  100.0  100.0  50.0  54.5  0.0  0.0 
10  No  16  1  0  22  62  6  0  10  100.0  100.0  0.0  100.0  0.0  0.0  100.0  31.6  0.0 
11  Yes  16  0  0  15  30  50  0  5  100.0  60.0  7.3  100.0  0.0  0.0  6.6  0.0  0.0 
12  Yes  16  0  0  13  41  35  0  11  100.0  88.9  28.9  100.0  50.0  0.0  54.7  17.2  0.0 
13  No  16  0  0  18  23  55  0  5  100.0  50.0  0.0  95.8  45.8  0.0  100.0  33.3  0.0 
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Table 5.4.2. Results of Pearson‟s correlations used to investigate possible assocations 
between the degree of staining for HO-1 and respiratory rate (Resp), neutrophil (Neut) %, 
macrophage (Macro) %, lymphocyte (Lymp) %, eosinophil (Eos) % and mast cell (Mast) 
%. Significant results (p<0.05) are highlighted in bold. 
 
 
 
Table 5.4.3. Results of Mann-Whitney tests used to investigate possible associations 
between the degree of staining for HO-1 and coughing, mucus score, clinical score and 
neutrophilic inflammation. Significant results (p<0.05) are highlighted in bold. 
 
      Cough  Mucus 
Clinical 
Score 
Neutrophilic 
Inflammation 
% macrophages 
staining  >0 for HO-1 
w value  42.000  34.000  16.000  71.500 
p value  0.626  0.871  0.579  0.159 
% macrophages 
staining >1 for HO-1 
w value  32.500  47.000  67.500  72.000 
p value  0.770  0.830  0.735  0.190 
% macrophages 
staining >2 for HO-1 
w value  26.000  50.000  59.000  74.000 
p value  0.211  0.943  0.074  0.103 
% neutrophils 
staining >0 for HO-1 
w value  30.500  42.000  22.000  63.500 
p value  0.428  0.257  0.918  1.000 
% neutrophils 
staining >1 for HO-1 
w value  29.000  35.500  36.000  32.000 
p value  0.415  0.060  0.014  0.585 
% neutrophils 
staining >2 for HO-1 
w value  37.500  40.500  55.500  65.500 
p value  0.720  0.162  0.004  0.706 
% lymphocytes  
staining >0 for HO-1 
w value  40.000  40.000  73.000  28.000 
p value  0.508  0.222  0.671  1.000 
%lymphocytes  
staining >1 for HO-1 
w value  31.000  40.000  64.500  33.000 
p value  0.608  0.212  0.391  0.475 
% lymphocytes  
staining >2 for HO-1 
w value  33.000  48.000  66.000  63.500 
p value  0.767  0.943  0.347  1.000 
 
 
 
 
      Resp   Neut %  Macro %  Lymp %  Eos %  Mast % 
% macrophages 
staining >0 for H0-1 
r value  -0.248  0.124  -0.563  0.448  -0.013  0.489 
p value  0.414  0.701  0.057  0.144  0.967  0.107 
% macrophages 
staining >1 for HO-1 
r value  0.155  0.504  -0.533  0.044  0.203  0.580 
p value  0.614  0.094  0.075  0.893  0.527  0.048 
% macrophages 
staining >2 for HO-1 
r value  0.736  0.651  -0.453  -0.087  0.493  -0.008 
p value  0.004  0.022  0.139  0.787  0.103  0.981 
% neutrophils 
staining >0 for HO-1 
r value  0.244  0.148  0.188  -0.271  0.143  -0.462 
p value  0.422  0.645  0.558  0.394  0.657  0.131 
% neutrophils 
staining >1 for HO-1 
r value  0.684  0.376  -0.101  -0.158  0.393  -0.452 
p value  0.010  0.228  0.756  0.623  0.206  0.141 
% neutrophils 
staining >2 for HO-1 
r value  0.744  0.489  -0.230  -0.161  0.569  -0.226 
p value  0.004  0.107  0.472  0.617  0.053  0.480 
%lymphocytes  
staining >0 for HO-1 
r value  -0.298  -0.416  0.300  -0.037  0.382  0.298 
p value  0.322  0.178  0.344  0.909  0.221  0.346 
% lymphocytes  
staining >1 for HO-1 
r value  -0.177  -0.343  0.085  0.118  0.716  0.333 
p value  0.562  0.275  0.794  0.715  0.009  0.290 
% lymphocytes  
staining >2 for HO-1 
r value  0.351  0.040  -0.315  0.236  0.609  0.326 
p value  0.239  0.902  0.318  0.461  0.036  0.300 94 
  94 
5.5  Discussion 
In the current study the percentage of neutrophils staining greater than 1 and greater than 2 
for HO-1 correlated with both respiratory rate and clinical score. However, there was no 
correlation between the total number of neutrophils staining for HO-1 and either of these 
clinical parameters. When assessing equine respiratory disease the number of neutrophils 
as a percentage of the total number of leukocytes in BALF is considered a reliable means 
of assessing the severity and correlates with histopathological changes in RAO (Larson 
and Busch 1985). It was therefore surprising that whilst HO-1 expression appeared to be 
related to clinical indicators of respiratory disease there was no relationship with relative 
neutrophilia. The significant associations that were identified between the percentage of 
neutrophils staining greater than 1 and 2 and clinical score are of questionable clinical 
relevance as only 3 horses actually had an abnormal clinical score and hence analysis was 
based upon very small numbers. Further investigations with more horses demonstrating 
more  marked  evidence  of  respiratory  dysfunction  at  rest  ought  to  be  performed.  No 
statistically  significant  associations  were  identified  between  HO-1  expression  and  the 
presence of a cough or tracheal mucus. 
Other  associations  between  immunostaining  of  specific  leukocyte  types  in  BALF  and 
clinical findings of respiratory disease were found also. The percentage of macrophages 
staining greater than 1 for HO-1 correlated with the percentage of mast cells in BALF 
however  this  result  was  barely  significant  (p=0.048).  The  percentage  of  macrophages 
staining greater than 2 for HO-1 correlated with neutrophil percentage in BALF and with 
respiratory rate. The percentage of lymphocytes staining greater than 1 and greater than 2 
for HO-1 correlated with the percentage of eosinophils in BALF. Correlations with BALF 
eosinophil ratio are of  questionable relevance  as  eosinophils  were  only  identified in  2 
horses and results are therefore based upon very limited data. Similarly lymphocytes only 
stained grade 3 in 2 horses making associations with this variable equally equivocal.   
Although  statistically  significant  associations  between  degrees  of  HO-1  staining  in 
leukocytes in BALF and indicators of respiratory disease were sporadic, it is plausible that 
there  is  an  association  between  HO-1  expression  in  neutrophils  and  macrophages  and 
equine  lower  airway  disease.  Similar  associations  have  been  identified  in  human 
respiratory disease. Haem oxygenase-1 is induced in airways during asthma (Carter et al. 
2004)  and  levels  of  HO-1  expression  in  macrophages  from  sputum  have  been 
demonstrated to be increased in asthmatic patients compared to healthy controls (Horvath 
et  al.  1998).  In  another  study  comparing  smoking  and  non-smoking  human  subjects, 95 
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immunostaining was identified predominantly in alveolar macrophages (a median of 36% 
staining positive in smokers and 13% in nonsmoking subjects) (Maestrelli et al. 2001).  
Inflammation, infection, sepsis and endotoxaemia all result in ROS production and in these 
conditions  HO-1  induction  may  be  protective  via  the  biological  roles  of  its  products 
(section 1.3.4) (Rizzardini et al. 1993; Rizzardini et al. 1994). Numerous cytoprotective 
functions for HO-1 and its products have been identified. There is evidence that HO-1 is 
cytoprotective in the face of oxidative stress, lung apoptosis and inflammation (Keyse and 
Tyrell 1987, 1989; Otterbein et al. 1999a; Christou et al. 2000; Minamino et al. 2001). 
Haem oxygenase-1 activity decreases inflammatory cell rolling, adhesion and migration 
from the vascular compartment (Wagener et al. 2001).  Bilirubin has anti-oxidant activity, 
inhibits leukocyte rolling, stabilises mast cell membranes and decreases TGF-β expression 
(Hayashi et al 1999; Wang et al 2002). Carbon monoxide protects against inflammatory 
hyperoxic  lung  injury  by  down-regulation  of  the  expression  of  pro-inflammatory 
cytokines.  In a model of hyperoxia-induced lung injury the presence of CO prolonged 
survival, likely as a result of its anti-inflammatory actions (Ryter et al. 2002). Carbon 
monoxide  inhibited  the  appearance  of  markers  of  lung  injury  (haemorrhage,  fibrin 
deposition,  oedema,  protein  accumulation  in  the  airway)  and  oxidative  damage  (lipid 
peroxidation) (Ryter et al. 2002). Carbon monoxide also inhibited the influx of neutrophils 
in  BALF  (Ryter  et  al.  2002).  Carbon  monoxide  production  correlated  with  inhibited 
expression of the pro-inflammatory cytokines IL-1β, TNFα and IL-6 (Ryter et al. 2002). 
The  stage  in  the  disease  process  at  which  BALF  samples  were  collected  may  have 
influenced the degree of HO-1 expression. In the face of acute inflammation, HO activity 
initially decreases with the highest levels of expression being recorded as inflammation is 
resolving  (Willis  et  al.  1996).  Willis  et  al.  (1996)  speculated  that  during  tissue 
inflammation there may be sequential induction of enzymes with pro-inflammatory effects, 
for example COX-2 and iNOS, followed by increased expression of enzymes with anti-
inflammatory  effects,  including  HO-1,  which  are  responsible  for  the  resolution  of 
inflammatory lesions and aimed at preventing a chronic inflammatory response.  
The effects of timing on HO-1 expression in horses could be investigated further; however 
challenge studies in horses known to suffer from RAO would probably be required to 
ensure sample collection early in the course of the inflammatory response. Although Willis 
et al. 2006 found higher levels of HO-1 expression as inflammation is resolving, it is also 
possible that cells may become activated and express HO-1 before they reach the airways 
and are sampled in BALF.  96 
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A limitation of the current study is the assumption that expression is likely to correlate 
with activity. It was also our intention to investigate the activity of HO-1 in sections of 
pulmonary tissue from horses with respiratory disease and control animals in addition to 
investigating expression in BALF in order to follow-on from the work of Wyse et al. 
(2006). Wyse et al. (2006) found detectable HO-1 activity in both the cranioventral and 
caudodorsal lung lobes; with activity being comparable between the 2 regions. The activity 
of HO-1 has been measured in human lung tissue (Tenhunen et al. 1968; Carraway et al. 
1998). The methods are relatively straightforward and were used in preliminary work in 
the current study (data not shown). This method was used successfully for measurement of 
HO-1 activity in the lungs of horses subjected to euthanasia at the University of Glasgow 
for reasons other than respiratory disease and the results were consistent with those of 
Wyse et al. (2006). It was expected that through the study period a small number of cases 
with respiratory tract inflammation would be subjected to euthanasia even if respiratory 
tract disease was not the primary reason for euthanasia. Unfortunately, insufficient horses 
with respiratory disease were recruited to the study. Further studies of the expression and 
activity of HO-1 within the respiratory tract  during health and disease  are  required to 
clarify  whether  there  is  an  association  between  HO-1  activity  and  respiratory  disease. 
These studies ought to use alternative methods of objective assessment of HO-1 staining 
given the failure in this study to clearly demonstrate that methods of assessment were 
repeatable.  
 
Considering the number of correlations performed in this study the apparently statistically 
significant results may have arisen purely by chance. Further investigations ought to be 
performed  with  greater  numbers  of  horses  in  order  to  substantiate  our  findings.  A 
limitation of the current study was the lack of samples from horses considered to be free 
from lower airway disease. Ethical constraints prohibited sampling from normal horses and 
few of the horses sampled turned out to be free from respiratory disease. The majority of 
cases  included in  the current  study were suffering from RAO. Ethical  constraints  also 
prevented collection of pulmonary or bronchial biopsies from horses in the current study as 
they are rarely justified clinically. Comparison of patterns of immunostaining in samples of 
tissue and BALF collected simultaneously would have added useful data.    97 
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CHAPTER SIX 
 
 
EXPRESSION OF iNOS WITHIN INFLAMMATORY 
CELLS OF EQUINE BALF 
 
 
6.1  Introduction 
Nitric oxide, produced by NOS has been implicated as a mediator of airway inflammation 
in  human  asthma  and  is  produced  in  large  quantities  from  bronchial  epithelial  and 
inflammatory cells of affected patients (Barnes and Liew 1995). In humans iNOS was first 
identified in macrophages (Pechkovsky et al. 2002), however it has since been identified 
within the cytosol of a diverse range of cell types (Fischer et al. 2002) including alveolar 
type  II  epithelial  cells  (Warner  et  al.  1995),  lung  fibroblasts  (Romanska  et  al.  2002), 
airway and vascular smooth muscle cells (Thomae et al. 1993; Xue et al. 1994; Griffiths et 
al. 1995), bronchial epithelial cells (Adcock et al. 1994; Robbins et al. 1994; Watkins et 
al.  1997;  Pechkovsky  et  al.  2002),  mast  cells  (Gilchrist  et  al.  2002),  endothelial  cells 
(Ermert et al. 2002), neutrophils (Boucher et al. 1999) and chondrocytes (Kobzik et al. 
1993; Ricciardolo et al. 2006).  
 
In rodent models of allergic airway inflammation, iNOS inhibitors have been shown to 
decrease eosinophil infiltration and cytokine release. Some authors have suggested that 
iNOS inhibitors may have a therapeutic benefit in cases of allergic airway disease that are 
refractory  to  corticosteroid  treatment  (Hansel  et  al.  2003).  Little  research  has  been 
performed  into  the  expression  of  NOS  and  synthesis  of  NO  in  the  horse.  Increased 
expression of iNOS has been identified in leukocytes within the mucosa and submucosa of 
the intestine and vasculature of horses with ischaemic intestinal injury (Mirza et al. 1999; 
Mirza  et  al.  2005).  Investigation  of  NOS  expression  and  NO  production  in  equine 
respiratory disease is limited to the findings of a single study in which 7 horses with SPA-
RAO and 6 horses not affected by the disease were compared (Costa et al. 2001). Nitric 
oxide  concentrations  in  plasma,  BALF  and  ELF  were  determined  using  a 
chemiluminescence  method  whilst  iNOS,  nitrotyrosine  and  nicotinamide  (NT)  adenine 98 
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dinucleotide  phosphate  diaphorase  (NADPHd)  were  localised  in  formalin-fixed  lung 
specimens using immunohistochemical and histochemical staining.  
Nitric oxide produced by the activity of iNOS may be an important mediator in equine 
lower airway inflammation. Further characterization of the expression of iNOS may assist 
in the understanding of the potential roles and importance of NO in health and disease of 
the lower respiratory tract of horses. 
6.2  Aims 
The aims of this study were to determine whether there is a relationship between iNOS 
staining  in  leukocytes  from  equine  BALF  and  other  markers  of  respiratory  tract 
inflammation. It was hypothesised that there would be positive correlation between the 
degree  of  iNOS  staining  in  leukocytes  from  BALF  and  markers  of  lower  airway 
inflammation. 
 
6.3  Methods 
Horses presented for the investigation of respiratory disease or poor performance were 
examined and clinical findings recorded as outlined in Chapter 2.2. Samples of BALF were 
collected and processed as described in Chapter 2.3. In brief, following sedation, BALF 
was collected using a commercially available BAL tube. Phosphate buffered saline was 
instilled into the distal airways, aspirated via the tube and fluid recovered was pooled to 
give  a  single  sample.  Slides  were  prepared  for  immunostaining  within  4  hours  of 
collection. The slides were stained for HO-1 using rabbit polyclonal antibodies utilizing a 
Dako EnVision kit K4011 (Dako, Ely, UK) as per manufacturer‟s instructions with all 
incubations at room temperature as outlined in Chapter 2. Stained BALF from 12 horses 
were examined and the degree of staining determined for a representative sample of cells 
as described in Chapter 2.6. The results of cytological examinations for one horse were lost 
and comparisons of immunostaining and cytological analysis were therefore performed for 
11, rather than 12, horses. Immunocytochemical staining was graded on a 0-3 scale for 
each cell. From these results the following calculations were made:  
i)  the percentage of cells with any stain uptake (i.e. grades 1-3) 
ii)  the percentage of cells staining greater than 1 (i.e. grades 2 and 3)  
 iii)       the percentage of cells staining greater than 2 (i.e. grade 3).   99 
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Pearson‟s  correlations  were  used  to  compare  immunocytochemical  staining  categorical 
data with continuous clinical data. Mann-Whitney tests were performed for comparison of 
immunocytochemical staining data and categorical clinical data. For the cough, mucus and 
clinical score categories horses with no abnormalities (no cough, no mucus and a clinical 
score of 0) were compared to horses with abnormal results. 
The relationship between NO immunostaining of leukocytes in BALF and lower airway 
inflammation was investigated further by comparing staining in horses with the degree of 
neutrophilia in BALF. Horses were divided into 2 groups: horses with a neutrophil relative 
percentage of > 5% in BALF were considered to have lower airway inflammation and 
horses with < 5% neutrophils were classified as free of lower airway inflammation. This 
single indicator of airway inflammation was chosen as it is the most reliable indicator of 
lower  airway  inflammation  (Robinson  2001).  The  degree  of  NO  immunostaining  of 
inflammatory cells in BALF in the diseased and control groups was compared using a 
Mann-Whitney test. 
6.4  Results 
There were nine horses with neutrophilic lower airway disease and three horses that were 
considered to have no cytological evidence of lower airway inflammation. The results of 
cytological analysis of BALF for one horse (horse 4) were lost. Seven horses had a history 
of coughing and were compared to 5 that did not and seven horses in which mucus had 
been identified were compared with 5 in which it was not. For clinical score 10 horses 
were classified as having abnormal results compared to 2 that were considered normal.  
For  neutrophilic  inflammation,  nine  horses  were  classified  as  having  abnormal  results 
compared  to  3  that  were  considered  normal.    Significant  associations  were  identified 
between  the  number  of  macrophages  staining  >  0  for  iNOS  and  the  number  of 
macrophages  present  in  BALF  as  well  as  the  presence  of  a  cough.  The  number  of 
macrophages and lymphocytes staining greater than 2 were significantly associated with 
respiratory  rate.  The  number  of  lymphocytes  staining  >1  was  associated  with  the 
percentages of eosinophils and mast cells in BALF. Staining for iNOS of >2 in all cell 
types was associated with eosinophil percentages. 
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Figure 6.4.1. Leukocytes from equine BALF stained for iNOS 
 
 
Figure 6.4.2. Neutrophils from equine BALF staining for iNOS 101 
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Table 6.4.1 Clinical and cytology findings and iNOS immunostaining results for 12 cases 
of suspected respiratory disease or poor performance. 
 
 
 
 
 
 
 
 
   Cough  Respiratory 
rate 
(breaths 
per minute) 
Mucus 
grade 
Clinical 
score 
BALF cytology  iNOS Staining 
Neut 
(%) 
Macro 
(%) 
Lymph 
(%) 
Eos 
(%) 
Mast  
(%) 
Macrophages  Neutrophils  Lymphocytes 
%>0  %>1  %>2  %>0  %>1  %>2  %>0  %>1  %>2 
2  Yes  16  0  0  11  33  45  0  11  100.0  69.4  11.1  100.0  0.0  0.0  12.3  12.3  0.0 
3  Yes  32  3  2  29  26  36  3  6  100.0  97.4  89.5  100.0  38.9  11.1  89.2  67.7  44.6 
4  No  12  0  0  0              100.0  93.9  0.0  100.0  0.0  0.0  46.2  0.0  0.0 
5  Yes  16  1  0  0  100  0  0  0  67.7  0.0  0.0  100.0  0.0  0.0  77.3  0.0  0.0 
6  Yes  16  0  0  4  35  56  0  5  100.0  48.3  8.3  100.0  0.0  0.0  18.6  0.0  0.0 
8  No  16  0  0  27  69  3  0  1  100.0  87.7  15.8  100.0  17.2  0.0  77.8  0.0  0.0 
9  No  28  2  4  23  64  11  0  2  86.7  53.3  0.0  93.0  68.0  0.0  0.0  0.0  0.0 
10  No  16  1  0  22  62  6  0  10  100.0  77.4  8.1  100.0  61.8  5.9  100.0  50.0  0.0 
11  Yes  16  0  0  15  30  50  0  5  100.0  41.0  24.6  42.9  0.0  0.0  17.9  0.0  0.0 
12  Yes  16  0  0  13  41  35  0  11  100.0  40.0  8.9  100.0  100.0  0.0  91.5  47.6  0.0 
13  No  16  0  0  18  23  55  0  5  100.0  48.0  0.0  47.4  26.3  0.0  13.6  7.4  3.7 
14  Yes  24  1  0  89  5  3  0  3  100.0  44.4  0.0  100.0  50.6  0.0  0.0   0.0   0.0  102 
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Table 6.4.2. Results of Pearson‟s correlations comparing the degree of staining for iNOS 
with respiratory rate (Resp rate), neutrophil (Neut) %, macrophage (Macro) %, lymphocyte 
(Lymph) %, eosinophil (Eos) % and mast cell (Mast) %. Significant results (p<0.05) are 
highlighted in bold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.4.3. Results of Mann-Whitney tests used to investigate differences between the 
degree of staining for iNOS and categorical clinical and cytological findings. Significant 
results (p<0.05) are highlighted in bold. w= Mann-Whitney statistic. 
 
      Cough  Mucus 
Clinical 
score 
Neutrophilic 
Inflammation 
% macrophages 
staining >0 for iNOS 
w value  46.000  51.000  68.500  16.000 
p value  <0.001  0.287  0.322  0.579 
% macrophages 
staining >1 for iNOS 
w value  36.000  33.000  59.000  18.000 
p value  0.144  1.000  0.237  0.853 
% macrophages 
staining >2 for iNOS 
w value  25.000  27.000  63.000  65.000 
p value  0.256  0.400  0.738  0.250 
% neutrophils  
staining >0 for iNOS 
w value  49.000  35.000  67.000  21.000 
p value  0.523  0.6699  0.672  0.826 
% neutrophils 
staining >1 for iNOS 
w value  41.000  41.000  59.000  10.000 
p value  0.501  0.178  0.221  0.090 
% neutrophils 
staining >2 for iNOS 
w value  45.000  40.000  60.500  20.000 
p value  1.000  0.287  0.186  1.000 
% lymphocytes 
staining >0 for iNOS 
w value  44.500  33.000  66.500  0.120 
p value  0.935  1.000  0.830  96.800 
%lymphocytes  
staining >1 for iNOS 
w value  31.000  35.000  62.000  54.000 
p value  0.856  0.717  0.549  0.239 
% lymphocytes 
staining >2 for iNOS 
w value  45.000  34.000  60.500  18.000 
p value  1.000  0.803  0.186  1.000 
 
 
 
 
     
Resp 
rate 
Neut 
% 
Macro 
% 
Lymph 
%  Eos % 
Mast 
% 
% macrophages 
staining >0 for iNOS 
r value  -0.060  0.256  -0.757  0.474  0.135  0.553 
p value  0.853  0.422  0.007  0.141  0.691  0.077 
% macrophages 
staining >1 for iNOS 
r value  0.168  0.051  -0.271  0.052  0.520  0.307 
p value  0.603  0.874  0.420  0.880  0.101  0.358 
% macrophages 
staining >2 for iNOS 
r value  0.599  0.056  -0.245  0.219  0.954  0.126 
p value  0.040  0.864  0.467  0.518  <0.001  0.712 
% neutrophils  
staining >0 for iNOS 
r value  0.163  0.087  0.307  -0.527  0.160  0.074 
p value  0.613  0.789  0.359  0.096  0.638  0.828 
% neutrophils 
staining >1 for iNOS 
r value  0.394  0.366  -0.083  -0.287  0.058  0.335 
p value  0.205  0.241  0.808  0.392  0.866  0.314 
% neutrophils 
staining >2 for iNOS 
r value  0.576  0.106  -0.103  -0.034  0.874  0.244 
p value  0.050  0.742  0.763  0.921  <0.001  0.470 
% lymphocytes 
staining >0 for iNOS 
r value  0.024  -0.255  -0.121  -0.332  0.356  0.210 
p value  0.944  0.423  0.724  0.319  0.283  0.536 
% lymphocytes  
staining >1 for iNOS 
r value  0.444  0.013  -0.121  0.055  0.665  0.619 
p value  0.171  0.969  0.724  0.872  0.026  0.042 
% lymphocytes 
staining >2 for iNOS 
r value  0.754  0.105  -0.251  0.161  0.997  0.052 
p value  0.007  0.745  0.457  0.636  <0.001  0.879 103 
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6.5  Discussion 
Correlation  was  observed  between  high  percentages  of  neutrophils,  macrophages  and 
lymphocytes  staining  for  iNOS  and  the  percentage  of  eosinophils  identified  in  BALF. 
However,  in  all  but  1  case  eosinophils  were  not  identified  and  in  that  single  case 
eosinophils only accounted for 3% of cells. This statistically significant finding is based 
upon very limited data therefore.  In other species a number of associations between iNOS 
and  eosinophil  activity  have  been  identified  previously.  Peroxynitrite  increases  airway 
hyper-responsiveness,  respiratory  epithelial  damage and eosinophil activation in  guinea 
pigs (Sadeghi-Hashjin et al. 1996). In models of allergic airway disease, iNOS knockout 
mice  show  reduced  eosinophil  tracking,  plasma  extravasation  and  airway  obstruction 
(Xiong et al. 1999). Nitric oxide promotes production of chemokines for eosinophils in 
mice  indicating  the  possibility  of  a  positive-feedback  loop  with  inflammatory  cells 
producing  NO  that  promotes  further  leukocyte  recruitment  (Ricciardolo  et  al.  2004). 
Immunohistochemistry  has  been  used  to  identify  3-nitrotyrosine  residues  within  tissue 
samples (Saleh et al. 1998) and biological fluids (Ohshima et al. 1999). 3-Nitrotyrosine is 
formed  readily  from  hydrogen  peroxide  and  nitrite  in  a  process  mediated  by 
myeloperoxidase and eosinophil peroxidise (Kettle et al. 1997; Eiserich et al. 1998; Wu et 
al. 1999). 3-Nitrotyrosine contributes to cellular dysfunction and is a specific biomarker of 
nitrosative stress.  
Other significant correlations were seen between iNOS staining in particular cell types and 
indicators of respiratory disease. Although plausible explanations for these relationships 
could be proposed there was no apparent pattern to their occurrence and they may have 
resulted  by  chance  due  to  the  large  number  of  statistical  tests  being  performed. 
Furthermore group sizes were frequently uneven and hence tests were often being made 
with only 2 or 3 horses in one category. For example, only 2 horses had normal neutrophil 
percentages in BALF and only 2 had positive (>0) clinical scores. 
Inducible NOS has been identified in a diverse range of cell types and is induced by a 
range of pro-inflammatory mediators (Fischer et al. 2002) that would be present in the 
lower airway during RAO and IAD. In other species increases in iNOS expression results 
in  attenuated  airway  hyperresponsiveness  and  reduced  bronchoconstriction  and  a 
detectable increase in NO metabolites in BALF (Liu et al. 1993; Schuiling et al. 1998; 
Toward and Broadley 2000; Samb et al. 2001; Hjoberg et al. 2004). Furthermore NO 
signalling  mediates  airway  secretion  in  response  to  inflammatory  mediators  such  as 
histamine, TNF-α, methacholine and bradykinin (Adler et al. 1995). Production of NO is 104 
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increased  in  response  to  inflammatory  cytokine  production.  In  laboratory  animals, 
macrophages have been shown to produce nitrite in a dose- and time- dependent manner 
following  activation  with  lipopolysaccharide  and  IFN-γ,  a  process  that  is  blocked  by 
glucocorticoids (Jorens et al. 1991). Other cytokines, including TGF-β, IL-4 and IL-10 
inhibit the expression of iNOS (Nijkamp and Folkerts 1994). In addition, NO reduces the 
production  the  inflammatory  cytokines  TNF,  IL-1,  MIP-1a  from  human  macrophages 
during inflammatory conditions, suggesting a modulatory role in disease (Thomassen et al. 
1997). Nitric oxide also suppresses antigen-induced degranulation, mediator release and 
cytokine expression by mast cells. In vivo, NO inhibits mast cell-dependent histamine-
induced vasodilation, vasopermeation and leukocyte-endothelial cell attachment (Coleman 
2002). 
 
In a previous report of iNOS expression in horses, those animals with SPARAO had a 
higher percentage of bronchial epithelial cells staining for iNOS than non-affected horses 
(Costa et al. 2001). Interestingly, staining of peribronchiolar leukocytes for iNOS was no 
greater for horses with SPARAO than for control horses. This is consistent with the results 
above in which no clear association could be determined between the degree of iNOS 
staining in leukocytes and clinical signs of disease. In the study by Costa et al. (2000), 
nitric oxide concentrations in plasma, BALF and ELF were also determined whilst iNOS, 
nitrotyrosine  and  nicotinamide  adenine  dinucleotide  phosphate  diaphorase  (NADPHd) 
were  localised  in  formalin-fixed  lung  specimens  using  immunohistochemical  and 
histochemical  staining.  Plasma  concentration  of  NO  in  affected  horses  was  non-
significantly increased over non-affected controls. Nitric oxide concentrations in BALF 
and ELF were not different between groups. Immunoreactivity of iNOS was increased in 
bronchial epithelial cells in 3 of 5 lung lobes. Staining for NT and NADPHd did not differ 
between the two groups (Costa et al. 2000b).  
 
The absence of a detectable increase in NO production in the lower respiratory tract in the 
study by Costa et al. (2000) was unexpected given an increase in exhaled NO has been 
reported in multiple studies of human patients suffering from asthma (Alving et al. 1993; 
Kharitonov et al. 1994; Massaro et al. 1995; Kharitonov et al. 1996a).  
Further  investigation  into  the  relationships  between  clinical  respiratory  disease,  iNOS 
expression and activity and the products of iNOS expression are required. The findings of 
the current study are limited by the number of horses included and by the lack of samples 
from horses considered to be free from lower airway disease. Ethical constraints prohibited 
sampling from normal horses and few of the horses sampled turned out to be free from 105 
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respiratory disease. The majority of cases included in the current study were suffering from 
RAO. Ethical  constraints  also  prevented  collection  of pulmonary or bronchial biopsies 
from horses in the current study as they are rarely justified clinically. Future studies ought 
to  use  more  objective  methods  that  can  be  demonstrated  to  be  repeatable  given  the 
concerns over the repeatability of the methods used in this study. Furthermore, methods of 
assessing  activity  and  expression,  or  at  least  greater  than  one  means  of  assessing 
expression, should be incorporated. Following on from the work by Costa et al. (2000) it 
would have been useful to have compared immunostaining in samples of tissue and BALF 
collected simultaneously. Attempts were made to collect tissue samples from horses with 
RAO and horses  with  no evidence of respiratory  disease however insufficient samples 
were collected.  
The effects of timing on sample collection and immunostaining are unknown. As with HO-
1 the effects of iNOS expression in different stages of respiratory inflammation could be 
investigated further however challenge studies in horses known to suffer from RAO would 
probably be required to ensure sample collection early in the course of the inflammatory 
response. 
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CHAPTER SEVEN 
 
INTERRACTIONS BETWEEN iNOS AND HO-1 
EXPRESSION IN THE INFLAMMATORY CELLS OF 
EQUINE BALF 
 
7.1  Introduction 
Haem oxygenase-1 and iNOS are up-regulated in similar disease states and often by the 
same trigger factors. It is has been suggested therefore that there are complex  interactions 
between the 2 enzyme systems (Ryter and Otterbein 2004). Induction of HO-1 may inhibit 
production of NO primarily by reducing the concentration of available haem which is a 
constituent of iNOS (Maines 1997). There may also be competition between the 2 systems 
for NADPH and electrons (Maines 1997).  
 
By contrast, NO and peroxynitrite have been demonstrated to up-regulate HO-1 expression 
(Foresti  and  Motterlini  1999;  Foresti  et  al.  1999;  Liang  et  al.  2000)  and  it  has  been 
suggested that CO may induce iNOS and assume many of the roles of NO under oxidative 
conditions (Foresti and Motterlini 1999; Zuckerbraun et al. 2003).  In turn, iNOS induces 
HO-1 thus resulting in a positive feedback system (Zuckerbraun et al. 2003). The effects of 
CO may be tissue specific as CO has been associated with inhibition of NOS in other 
models of tissue injury (Nakao et al. 2003).  
 
Nitric oxide has been shown both to inhibit (Willis 1995) and activate (Motterlini et al. 
1996) HO activity. Nitric oxide has even been suggested to be the strongest inducer of HO-
1 (Motterlini et al. 1996) and it is therefore possible that many of the effects of NO may be 
modulated via HO-1 (Ryter and Otterbein 2004). Inhibitory activity of NO on HO-1 has 
also been reported and is likely due to NO orchestrated oxidative damage to the proteins of 
haem-oxygenase and its substrate haem. Nitric oxide has a higher affinity for haem than 
oxygen has for haem and the presence of NO therefore prevents oxidation. Conversely, the 
presence of free radicals may induce HO-1 activity in other conditions.  
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Interactions between HO-1 and iNOS are therefore complex and at times contradictory. 
Relative levels of synergy and competition may be tissue specific and be influenced by the 
nature of the inflammatory response. 
 
 
7.2  Aims 
 
The aims of this study were to investigate whether a relationship exists between HO-1 and 
iNOS expression in leukocytes from equine BALF. It was hypothesised that a positive 
linear relationship would exist between the expression of HO-1 and iNOS.  
 
7.3  Methods 
 
Cases  presented  for  the  investigation  of  respiratory  disease  or  poor  performance  were 
examined and clinical findings recorded as outlined in Chapter 2.2. Samples of BALF were 
collected and processed as described in Chapter 2.3. In brief, following sedation BALF 
was collected using a commercially available BAL tube. Phosphate buffered saline was 
instilled into the distal airways, aspirated via the tube and the retrieved fluid was pooled to 
give  a  single  sample.  Slides  were  prepared  for  immunostaining  within  4  hours  of 
collection. The slides were stained for HO-1 and iNOS using rabbit polyclonal antibodies 
utilizing a Dako EnVision kit K4011 (Dako, Ely, UK) as per manufacturer‟s instructions 
with all incubations at room temperature as outlined in Chapter 2. Stained BALF slides 
from 14 horses was examined and the degree of staining determined for a representative 
sample of cells as described in Chapter 2.6. Staining was graded on a 0-3 scale for each 
cell. In 3 horses results were not obtained because staining was not of sufficient quality for 
one of the stains and statistical analysis was therefore performed on the results from 11 
horses. 
Results  of  immunostaining  for  HO-1  and  iNOS  were  compared  using  Pearson‟s 
correlation.  
7.4  Results 
 
The  results  of  immunostaining  for  HO-1  and  iNOS  were  tabulated  (Table  7.4.1)  and 
displayed graphically (Figures 7.4.1, 7.4.2 and 7.4.3). The results of Pearson‟s correlations 
for  each  cell  type  at  each  grade  of  staining  are  displayed  in  Table  7.4.2.  Statistically 108 
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significant correlations were identified for all grades of staining in macrophages with r 
values of 0.633, 0.724 and 0.892 indicating a strong correlation. Statistically significant 
correlations were also identified in neutrophils staining >2 and lymphocytes staining >1 
and >2. These correlations were also strong with r being above 0.6.   109 
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Table 7.4.1. The relationship between HO-1 and iNOS expression in leukocytes from 
equine BALF. 
 
   Macrophages  Neutrophils  Lymphoctes 
   %>0  %>1  %>2  %>0  %>1  %>2  %>0  %>1  %>2 
Case   HO-1  iNOS  HO-1  iNOS  HO-1  iNOS  HO-1  iNOS  HO-1  iNOS  HO-1  iNOS  HO-1  iNOS  HO-1  iNOS  HO-1  iNOS 
2  100.0  100.0  77.8  69.4  24.4  11.1  50.0  100.0  0.0  0.0  0.0  0.0  46.2  12.3  30.8  12.3  28.8  0.0 
3  90.5  100.0  85.7  97.4  76.2  89.5  100.0  100.0  100.0  38.9  75.0  11.1  75.0  89.2  56.6  67.7  39.5  45.0 
4  86.4  100.0  72.7  93.9  1.5  0.0  66.7  100.0  33.3  0.0  33.3  0.0  31.1  46.2  8.9  0.0  0.0  0.0 
5  60.0  67.7  14.9  0.0  0.0  0.0  100.0  100.0  62.5  0.0  0.0  0.0  72.2  77.3  38.9  0.0  0.0  0.0 
6  100.0  100.0  44.7  48.3  4.3  8.3  100.0  100.0  62.5  0.0  0.0  0.0  21.3  18.6  0.0  0.0  0.0  0.0 
8  100.0  100.0  67.4  87.7  30.4  15.8  100.0  100.0  20.0  17.2  0.0  0.0  34.2  77.8  0.0  0.0  0.0  0.0 
9  74.5  86.7  14.7  53.3  5.3  0.0  100.0  93.0  100.0  68.0  50.0  0.0  54.5  0.0  0.0  0.0  0.0  0.0 
10  100.0  100.0  100.0  77.4  0.0  8.1  100.0  100.0  0.0  61.8  0.0  5.9  100.0  100.0  31.6  50.0  0.0  0.0 
11  100.0  100.0  60.0  41.0  7.3  24.6  100.0  42.9  0.0  0.0  0.0  0.0  6.6  17.9  0.0  0.0  0.0  0.0 
12  100.0  100.0  88.9  40.0  28.9  8.9  100.0  100.0  50.0  100.0  0.0  0.0  54.7  91.5  17.2  47.6  0.0  0.0 
13  100.0  100.0  50.0  48.0  0.0  0.0  95.8  47.4  45.8  26.3  0.0  0.0  100.0  13.6  33.3  7.4  0.0  4.0 
 
 
Table 7.4.2. The results of Pearson‟s correlations used to investigate relationships between 
the degree of staining for HO-1 and iNOS in leukocytes from equine BALF. Significant 
results are highlighted in bold. 
 
   Macrophages  Neutrophils  Lymphocytes 
   r value  p value  r value  p value  r value  p value 
% staining > 0  0.724  0.012  -0.188  0.579  0.373  0.259 
% staining > 1  0.633  0.036  0.296  0.376  0.642  0.033 
% staining > 2  0.892  <0.001  0.615  0.044  0.778  0.005 
 110 
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Figure 7.4.1 The relationship between HO-1 and iNOS staining in macrophages from 
equine BALF. Each scatter plot represents the degree of staining above a certain grade. 
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Figure 7.4.2. The relationship between HO-1 and iNOS staining in neutrophils from equine 
BALF. Each scatter plot represents the degree of staining above a certain grade. 
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Figure 7.4.3. The relationship between HO-1 and iNOS staining in lymphocytes from 
equine BALF. Each scatter plot represents the degree of staining above a certain grade. 
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7.5  Discussion 
In the current study there were statistically significant correlations between the degree of 
HO-1 and iNOS staining for 6 out of the 9 categories investigated. A positive correlation 
was identified for all degrees of macrophage staining and the 3 r values were between 0.6 
and 0.9 indicating a high level of correlation. Significant correlations were also identified 
for  the  percentage  of  neutrophils  staining  >  2  and  for  the  percentage  of  lymphocytes 
staining >1 and >2. The r values were greater than 0.6 indicating a strong correlation. It 
was a concern however that the data set was small and the presence of one or two outlying 
results may have had a large influence on the results of statistical analysis in some of the 
categories. Further work with greater case numbers should be performed.  
To  the  author‟s  knowledge,  associations  between  expression  of  HO-1  and  iNOS  in 
leukocytes in equine BALF have not been reported previously. Correlation between the 
two systems was not unexpected as significant and complex interactions between the two 
systems are known to exist in other species (Ryter and Otterbein 2004). The findings of the 
current study may indicate that expression of HO-1 and iNOS in the lower airways of 
horses are induced by the same or similar initiating factors. This was expected as many of 
the initiating factors that have been identified are common to both enzyme systems and 
would  be  present  as  a  consequence  of  inflammatory  disease  of  the  lower  airways.  
Inducible NOS may be induced by endogenous factors including  the pro-inflammatory 
cytokines TNFα, IFN-γ and interleukin1-β (IL-1 β) or exogenous factors such as bacteria, 
bacterial  toxins  (especially  lipopolysaccharide),  viruses,  allergens  and  environmental 
pollutants (Morris and Billiar 1994; Yan et al. 1995; Yeadon and Price 1995; Goldman et 
al. 1996). In addition, hypoxia, oxidative injury and tumour  cells may stimulate iNOS 
expression  (Yan  et  al.  1995;  Yeadon  and  Price  1995;  Goldman  et  al.  1996).  Haem 
oxygenase-1  gene  expression  is  induced  via  a  diverse  range  of  signalling  pathways 
(Maines 1997) and notably is induced strongly by agents and conditions associated with 
oxidative stress. In addition, a number of important redox-independent pathways are also 
involved in up-regulating HO-1 gene expression.  
Inflammation, infection, sepsis and lipopolysaccharide all result in ROS production.  In 
vitro,  the  pro-inflammatory  cytokines  IL-1,  IL-6  and  TNF-α  induce  HO-1  expression 
(Rizzardini  et  al.  1993;  Terry  et  al.  1999).  In  addition,  growth  factors  (including 
transforming growth factor-β and platelet derived growth factor) induce HO-1 expression 
in association with the generation of ROS (Kutty et al. 1994; Durante et al. 1999). In 
addition to cytokine and growth factor influences on HO-1 expression, hypoxia alters the 114 
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iron and intracellular redox equilibrium activating HO-1 gene expression (Motterlini et al. 
2000).  Conversely,  hyperoxia  is  associated  with  increased  production  of  mitochondrial 
ROS  and oxidative lung injury (Freeman and Crapo 1981). 
 
Alternatively  induction  of  one  of  the  proteins  may  induce  the  other.  Nitric  oxide,  the 
product  of  iNOS  has  been  demonstrated  to  up-regulate  HO-1  expression  (Foresti  and 
Motterlini 1999; Foresti et al. 1999; Liang et al. 2000) and it has been suggested that CO 
may assume many of the roles of NO under oxidative conditions (Foresti and Motterlini 
1999).  Motterlini et al. (1996) suggested that NO might be the strongest inducer of HO-1 
and other authors have proposed that many of the effects of NO may be modulated via HO-
1 (Ryter and Otterbein 2004). In addition, CO, one of the principal products of HO-1, has 
been shown to induce iNOS in hepatocytes which in turn induces HO-1 (Zuckerbraun et al. 
2003). However, changes in NO expression did not appear to modulate HO-1 expression in 
one human study (Brunetti et al. 2006). 
 
A stronger association between iNOS and HO-1 expression in macrophages than other cell 
types  was  found.  Macrophages  are  the  most  consistent  source  of  HO-1  and  iNOS  in 
previous  studies  of  human  and  laboratory  animal  respiratory  physiology  and  disease 
(Kitada  et  al.  2001;  Pechkovsky  et  al.  2002;  Brunetti  et  al.  2006).  Absence  of  an 
association in some cases and in other cell types might be due to the effects of sample 
timing relative to the stage of the disease process. Willis  et al. (1996) speculated that 
during tissue inflammation there may be sequential  induction  of  enzyme systems  with 
induction  of  iNOS  being  followed  by  increased  expression  of  enzymes  with  anti-
inflammatory  effects,  including  HO-1.  Furthermore  whilst  HO-1  may  be  identified  in 
healthy  tissue  from  equine  lungs  (Wyse  et  al.  2006)  under  healthy  conditions  iNOS 
expression may not be detected (Buttery et al. 1994). 
 
Previous  studies  in  other  species  provide  evidence  of  mutual  inhibition  as  well  as 
stimulation  (Willis  1995;  Wang  et  al.  2003).  Further  investigations  of  the  interactions 
between  the  two  enzyme  systems  are  indicated  in  order  to  investigate  relationships  in 
different  disease  states  and  at  different  stages  of  disease.  Future  studies  ought  to  use 
methods with a more established means of objectively assessing expression, and preferably 
activity, given the concerns over the repeatability of the methods used in this study. A 
greater number of horses should be used than were used in the current study with a more 
comprehensive and representative sample of animals suffering from different disease states 
and those considered free of respiratory disease. Future studies also ought to investigate 115 
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levels  of  activity  for  both  enzyme  systems  rather  than  merely  looking  at  expression. 
Expression may not provide a reliable indication of enzyme activity.    116 
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CHAPTER  EIGHT 
 
CORRELATION BETWEEN MARKERS OF 
OXIDATIVE STRESS ASSESSED BY 
IMMUNOSTAINING AND EXHALED BREATH 
CONDENSATE ANALYSIS 
8.1  Introduction 
Biomarkers in exhaled breath condensate (EBC) have been investigated widely in studies 
of human respiratory physiology and diseases, most notably asthma (Jobsis et al. 1997; Ho 
et al. 1999; Hanazawa et al. 2000; Niimi et al. 2004 Brunetti et al. 2006). There are many 
constituents  of  exhaled  breath  condensate  that  may  be  influenced  by  lower  airway 
inflammation  including  H2O2,  NO,  adenosine,  arachidonic  acid  metabolites,  cytokines, 
leukotrienes, 8-isoprostane, pH and ammonia (Horvath 2005). Hydrogen peroxide and pH 
are the most commonly measured in humans (Horvath et al. 2005). Hydrogen peroxide is 
produced primarily by activated inflammatory cells in the airways as a result of oxidative 
stress  (Babior  2000).  Hydrogen  peroxide  concentration  in  EBC  has  been  shown  to 
correlate with presence and severity of asthma (Antczak et al. 2000; Loukides et al. 2002) 
and  pH  has  been  demonstrated  to  be  a  reliable  indicator  of  inflammatory  respiratory 
disease in man (Kostikas et al. 2002; Vaughan et al. 2003b; Borrill et al. 2005).  
 
In one study performed in horses, H2O2 concentration in EBC was correlated with ascorbic 
acid  concentration  in  PELF  (Deaton  et  al.  2004b).  However,  further  studies  which 
compared horses with airway inflammation to normal controls failed to find significant 
differences in exhaled hydrogen peroxide concentrations (Deaton et al. 2005a; Wyse et al. 
2005, Duz et al. 2009). Prolonged exposure to inflammatory stimuli may be required to 
deplete antioxidant capacity (Deaton 2006). 
 
Haem oxygenase-1 is the major stress protein induced by H2O2, (Keyse and Tyrrell 1989). 
In  addition,  any  agents  that  directly  or  indirectly  generate  ROS  or  alter  the  redox 
equilibrium will induce HO-1 expression; HO-1 is therefore a general marker of oxidative 117 
  117 
stress (Applegate et al. 1991). Hypoxia, oxidative injury and tumour cells may stimulate 
iNOS expression (Goldman et al. 1996; Yan et al. 1995; Yeadon and Price 1995). 
8.2  Aims 
To investigate the relationship between HO-1 and iNOS staining in leukocytes from equine 
BALF and markers of oxidative stress in exhaled breath condensate. It was hypothesised 
that expression of HO-1 and iNOS would be higher in horses which had greater 
concentrations of H2O2 and lower pH in EBC ie a positive correlation would be observed 
with H2O2 and a negative correlation with pH. 
8.3  Methods 
Horses presented for the investigation of respiratory disease or poor performance were 
examined and clinical findings recorded as outlined in Chapter 2.2. Samples of BALF were 
collected and processed as described in Chapter 2.3. In brief, following sedation BALF 
was collected using a commercially available BAL tube. Phosphate buffered saline was 
instilled into the distal airways, withdrawn via the tube and the fluid obtained pooled to 
give  a  single  sample.  Slides  were  prepared  for  immunostaining  within  4  hours  of 
collection. The slides were stained for HO-1 using rabbit polyclonal antibodies utilizing a 
Dako EnVision kit K4011 (Dako, Ely, UK) as per manufacturer‟s instructions with all 
incubations at room temperature as outlined in Chapter 2. Stained BALF was examined 
and the degree of staining determined for a representative sample of cells as described in 
Chapter 2.6. Staining was  graded on a 0-3 scale for each  cell.  From these results  the 
following calculations were made:  
i)  the percentage of cells with any stain uptake (i.e. grades 1-3), 
ii)  the percentage of cells staining greater than 1 (i.e. grades 2 and 3),  
 iii)       the percentage of cells staining greater than 2 (i.e. grade 3).   
Exhaled breath condensate was collected according to a method that has been published 
previously (Duz et al. 2009). Collection was performed before horses were sedated for the 
BAL procedure. Eight of the horses used for the analysis of BALF were available  for 
collection of EBC. For one of the 8, iNOS staining was unsatisfactory and comparisons 
between EBC and iNOS expression were therefore performed for 7 cases and comparisons 
between EBC and HO-1 performed for 8 cases. A face mask was connected via tubing to a 
polypropylene  condensation  chamber  immersed  in  ethanol/liquid  nitrogen  slurry  to 118 
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maintain  a  temperature  below  -80°C.  The  face  mask  was  constructed  from  a  muzzle 
modified with fibreglass and incorporating two one-way non-rebreathing valves. A rubber 
diaphragm around the mask created an airtight seal with the horse‟s head. The non re-
breathing  valves  were  connected  by  a  rubber  flexible  tube  (Cranlea,  UK)  to  the 
condensation  chamber.  Exhaled  breath  condensed  on  the  internal  surface  of  the 
polypropylene  container.  A  one-way  valve  on  the  outlet  of  the  condensation  chamber 
prevented contamination of the sample with  environmental  air.  Breath  condensate was 
collected over a 10 minute time period. Collected samples of EBC were maintained on ice 
during transit to the laboratory. 
 
Exhaled breath condensate was thawed and analysed immediately. Measurement of H2O2 
concentration was performed using a spectrophotometric assay based on the oxidation of 
3,3‟,5,5‟-tetramethylbenzidine  (TMB)  in  the  presence  of  horseradish  peroxidise  (HRP; 
Sigma-Aldrich,  UK)  modifying  a  published  method  (Gallati  and  Pracht  1985).  In 
summary, 15 µl of HRP (75IU/ml), 140 µl of TMB in 0.42M citrate buffer (pH 3.8) and 
140  µl  of  EBC  were  mixed  at  room  temperature.  The  reaction  was  stopped  after  10 
minutes  by  addition  of  15µl  of  9M  sulphuric  acid.  The  product  of  the  reaction  was 
analysed immediately with an automated microplate reader (FLUOstar OPTIMA, BMG 
labtech, Aylesbury, UK) using a wavelength for absorbance of 450 nm. Exhaled breath 
condensate  H2O2  concentration  was  calculated  from  a  standard  curve  of  known 
concentrations of H2O2 (from 0.1 to 10 µM) prepared fresh for each assay. The lower 
detection limit of the assay was 0.1 µM. Linearity of the standard curve was acceptable (r
2 
> 99%) between 0 and 10 µM. The measurement was repeated 4 times for each sample and 
the final H2O2 concentration was calculated as the mean of the 4 measurements.  
 
Measurement of pH of  EBC samples  was  performed using  a pH meter (pH21, Hanna 
Instruments Ltd) connected to a glass-body pH electrode with an accuracy of ± 0.02 pH 
(HI-2031B, Hanna Instruments Ltd). 
 
The  relationship  between  degrees  of  staining  and  the  results  of  EBC  analysis  were 
investigated using Pearson‟s correlation. 
 
8.4  Results 
Collection of EBC and BALF was performed in 8 horses; 4 thoroughbreds and 4 other 
breeds. Ages ranged from 11 to 21 years, there were 5 mares and 3 geldings. Six of the 8 119 
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were diagnosed with chronic RAO and the remaining two horses were considered to be 
free  from  respiratory  disease  (horses  6  and  11).  None  of  the  8  horses  had  received 
treatment  prior to  sampling.  The results  obtained  are presented in  Table 8.4.1 and the 
results of statistical analyses for HO-1 and iNOS staining are presented in tables 8.4.2 and 
8.4.3 respectively. 
 
 
Table 8.4.1 Results of HO-1 immunostaining in leukocytes from BALF and concentration 
of H2O2 and pH of EBC. 
 
   EBC  HO-1 Staining 
Case  H202 
(mMol) 
pH  Macrophages  Neutrophils  Lymphocytes 
%>0  %>1  %>2  %>0  %>1  %>2  %>0  %>1  %>2 
2  9.7  5.83  100.0  77.8  24.4  50.0  0.0  0.0  46.2  30.8  28.8 
3  6.3  4.85  90.5  85.7  76.2  100.0  100.0  75.0  75.0  56.6  39.5 
6  3.3  6.1  100.0  44.7  4.3  100.0  62.5  0.0  21.3  0.0  0.0 
7  2.4  4.84  100.0  100.0  57.7  100.0  100.0  33.3  0.0  0.0  0.0 
9  2.6  4.41  60.0  14.7  5.3  100.0  100.0  50.0  54.5  0.0  0.0 
11  5.0  7.74  100.0  60.0  7.3  100.0  0.0  0.0  6.6  0.0  0.0 
12  2.4  5.64  100.0  88.9  28.9  100.0  50.0  0.0  54.7  17.2  0.0 
13  0.9  5.53  100.0  50.0  0.0  95.8  45.8  0.0  100.0  33.3  0.0 
 
Table 8.4.2 Results of iNOS immunostaining in leukocytes from BALF and concentration 
of H2O2 and pH of EBC. 
 
   EBC  HO-1 Staining 
Case  H202 
(mMol) 
pH  Macrophages  Neutrophils  Lymphocytes 
%>0  %>1  %>2  %>0  %>1  %>2  %>0  %>1  %>2 
2  9.7  5.83  100.0  69.4  11.1  100.0  0.0  0.0  12.3  12.3  0.0 
3  6.3  4.85  100.0  97.4  89.5  100.0  38.9  11.0  89.2  67.7  44.6 
6  3.3  6.1  100.0  48.3  8.3  100.0  0.0  0.0  18.6  0.0  0.0 
9  2.6  4.41  86.7  53.3  0.0  93.0  68.0  0.0  0.0  0.0  0.0 
11  5.0  7.74  100.0  41.0  24.6  42.9  0.0  0.0  17.9  0.0  0.0 
12  2.4  5.64  100.0  40.0  8.9  100.0  100.0  0.0  91.5  47.6  0.0 
13  0.9  5.53  100.0  48.0  0.0  47.4  26.3  0.0  13.6  7.4  3.7 
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Table 8.4.3. The results of Pearson‟s correlations used to investigate relationships between 
HO-1 immunostaining in leukocytes from BALF and markers of oxidative stress in 
exhaled breath condensate. Statistically significant results are highlighted in bold.  
 
      H2O2  pH 
     r value  p value  r value  p value 
Macrophages 
% staining > 0  0.135  0.750  0.448  0.265 
% staining > 1  0.273  0.513  0.009  0.984 
% staining > 2  0.287  0.491  -0.429  0.289 
Neutrophils 
% staining > 0  -0.775  0.024  -0.081  0.849 
% staining > 1  -0.444  0.270  -0.821  0.012 
% staining > 2  0.066  0.877  -0.675  0.066 
Lymphocytes 
% staining > 0  -0.106  0.803  -0.393  0.335 
% staining > 1  0.392  0.337  -0.256  0.540 
% staining > 2  0.789  0.020  -0.208  0.620 
 
Table 8.4.4. The results of Pearson‟s correlations used to investigate relationships between 
iNOS immunostaining in leukocytes from BALF and markers of oxidative stress in 
exhaled breath condensate.  
 
      H2O2  pH 
      r value  p value  r value  p value 
Macrophages 
% staining > 0  0.254  0.582  0.548  0.203 
% staining > 1  0.594  0.160  -0.473  0.283 
% staining > 2  0.407  0.364  -0.128  0.785 
Neutrophils 
% staining > 0  0.331  0.468  -0.570  0.181 
% staining > 1  -0.462  0.297  -0.557  0.194 
% staining > 2  0.297  0.518  -0.365  0.421 
Lymphocytes 
% staining > 0  0.024  0.960  -0.184  0.693 
% staining > 1  0.176  0.705  -0.369  0.416 
% staining > 2  0.547  0.160  -0.376  0.406 
 
 
 
8.5  Discussion 
Three  statistically  significant  results  were  identified  between  expression  of  HO-1  in 
leukocytes from BALF and markers of inflammation in EBC. No significant correlations 
were identifieded between iNOS expression and EBC markers. A negative correlation was 
identified  between  neutrophils  staining  greater  than  0  and  H2O2  concentration  in  EBC 
whilst a positive correlation was identified for lymphocytes staining greater than 2 for HO-
1  and  H2O2  concentration  in  EBC.  A  negative  correlation  was  identified  between 
neutrophils staining greater than 1 and EBC pH. The positive correlation with H2O2 and 
negative correlation with pH were expected, however the negative correlation with H2O2 
was unexpected and contradicted the other significant result for H2O2. Considering only 3 
of the 36 correlations investigated were significant and the results were contradictory it is 121 
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unlikely that these results indicate a genuine association between HO-1 expression and 
markers in EBC. 
There may  be a number of explanations for these findings. First, the methods used to 
collect and analyse EBC may not be reliable. Second, the methods used to investigate 
expression of HO-1 and iNOS may not be reliable and third there may be no correlation 
between the expression of HO-1/iNOS and the constituents of EBC. It is likely that there 
are numerous biological processes that affect the composition of EBC.  The methods under 
investigation in this study may be of minor importance. 
In the present study the concentrations of H2O2 were much higher (by a factor of 10) than 
in previous studies (Deaton et al. 2004b; Wyse et al. 2005). This led to concern that the 
results may not be reliable. However, the methods used were different between studies and 
the methodology used in the current study was considered accurate when testing known 
concentrations  of  test  substance  and  the  inter-assay  coefficient  of  variation  was  <0.05 
consistent with good repeatability (Duz et al. 2009). Although comparison with previous 
studies was complicated by the disparity of the results we were confident that our results 
were accurate and repeatable. Inter- and intra-day variability in H2O2 concentration was 
high in horses with lower airway inflammation (data not shown) which may have been 
related to varied inflammatory responses to environmental challenges. The inter- and intra-
day variability of HO-1 and iNOS expression could not be investigated for practical and 
ethical issues of repeated collection of BALF from horses  and this may have led to  a 
disparity of the results. As this is the first study to investigate HO-1 and iNOS expression 
in  samples  from  the  equine  respiratory  tract  the  variation  in  expression  over  time  is 
unknown. Exhaled breath condensate was collected within two hours of BALF collection 
to minimize these potential effects.  
The importance of analysis of EBC as a tool in the investigation of equine respiratory 
disease remains to be determined. The analysis of EBC has not been used widely for the 
investigation of respiratory physiology or inflammatory diseases of the lower respiratory 
tract in horses.  In the current study and previous investigations, significant differences 
between animals with clinical disease and controls have not been evident (Deaton et al. 
2005b; Wyse et al. 2005; Duz et al. 2009).  However, Duz et al. (2009) did find a trend for 
decreased pH of EBC in horses with lower airway inflammation. It is yet to be determined 
whether analysis of EBC is a reliable means of assessing respiratory tract inflammation 
and perhaps correlation with other markers of inflammation and oxidative injury such as 
HO-1 and iNOS expression should not be expected.  Previous human studies have failed to 122 
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demonstrate associations between levels of HO-1 and levels of its exhaled products such as 
CO (Brunetti et al. 2006). 
Although H2O2, HO-1  and iNOS  are  all associated with  conditions  of  oxidative stress 
numerous other substances and processes may induce HO-1 and iNOS expression (Babior 
2000; Otterbein and Choi 2000; Horvath et al. 2001). It is possible that in the inflamed 
equine  lower  airway,  oxidative  processes  are  of  relatively  minor  importance  in  the 
induction of HO-1 and iNOS and hence there is a disparity between these different markers 
of oxidative injury. It is notable that in EBC there was no significant association between 
H2O2 and pH both of which ought to be markers of oxidative stress (Duz et al. 2009). 
Numerous compounds are present within EBC such as nitric oxide, adenosine, arachidonic 
acid metabolites, cytokines, 8-isoprostane and ammonia (Horvath et al. 2005). Although 
H2O2 is the compound most frequently measured in human studies of EBC (Loukides et al. 
2002; Horvath et al. 2005) it may be too simplistic to investigate this single marker of 
oxidative stress within a “soup” of other potential markers. In human airways, H2O2 is 
produced by epithelial cells of the conducting airways (Schleiss et al. 2000) in addition to 
inflammatory cells which may be influential as iNOS and HO-1 expression were only 
determined in cells collected from the distal airways. 
A limitation of the current study was the absence of repeated sampling from the same 
horse.  The  stage  in  the  disease  process  at  which  samples  were  collected  may  have 
influenced the results. It is possible that if analyses were performed at different stages in 
the disease process or even summated over a time period associations with constituents of 
EBC  might  have  been  identified.  A  further  limitation  of  the  current  study  was  the 
assumption that expression of HO-1 or iNOS was a reliable means of assessing activity. 
The concerns previously expressed over the repeatability of the methods used for analysis 
also extend to the results in this chapter. Future studies ought to investigate activity in 
addition  to  expression  and  be  performed  with  greater  numbers  of  horses  in  order  to 
substantiate our findings. The majority of horses in the current study were suffering from 
RAO. Future studies ought to contain more horses with other respiratory diseases and also 
a larger number of horses considered free of respiratory disease. 
The effects of treatment for respiratory disease on HO-1 and iNOS expression should also 
be considered. None of the horses in the current study were treated with corticosteroids 
prior to sampling. Future studies could investigate the effects of corticosteroids on iNOS, 
HO-1 and EBC constituents. A glucocorticoid response element is present in the HO-1 
promoter, and gene expression of HO-1 is inhibited by corticosteroids in vitro (Cantoni et 123 
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al. 1991; Lavrovsky et al. 1996). The reduction in iNOS expression known to result from 
corticosteroid therapy (Saleh et al. 1998) would be expected to result in reduced expression 
of HO-1.   
In conclusion, neither the pH nor the H2O2 concentration of EBC appeared to be influenced 
by the degree of expression of HO-1 or iNOS in leukocytes from BALF. This may have 
been  due  to  the  sampling  and  analytical  methods  used  and  future  studies  using  more 
precise methods should be performed. 
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CHAPTER NINE 
GENERAL DISCUSSION, CONCLUSIONS AND 
SUGGESTIONS FOR FURTHER INVESTIGATION 
 
9.1  Characterisation of HO-1 and iNOS in the Equine Respiratory 
Tract in Health and Disease 
 
The results of the current study indicate that HO-1 and iNOS are expressed in leukocytes 
present  in  equine  BALF.  Further,  methods  that  have  not  been  used  previously  in  the 
examination of equine BALF have been documented.  
The first of investigation aimed to determine whether frozen BALF could be used for 
immunostaining.  A  significant  correlation  was  determined  in  only  1  or  the  6  tests  of 
correlation performed; cells staining grade 3 for iNOS. For this type and degree of staining 
the  correlation  was  not  only  significant  but  was  linear  with  the  r  value  being  0.988. 
However, this result was strongly influenced by the presence of a single strong positive 
result (case 3) and a large number of negative results. Overall, correlation was poor and as 
the preservation of the fresh samples was visibly superior it was assumed that error was 
introduced by freezing and thawing. When fresh and frozen cells were compared the frozen 
cells  were  smaller  and  irregular  in  appearance.  Cells  were  commonly  aggregated  and 
distinction of individual cells proved difficult. The subjective assessment of staining in 
individual frozen cells was therefore less precise and background staining was also greater 
in  the  slides  of  frozen  BALF.  We  suspected  that  constituents  of  the  cytoplasm  were 
contributing  to  the  background  staining  and  the  freezing  and  thawing  processes  are 
suspected to have damaged the phospholipid cell membrane. Frozen BALF would appear 
to be unsuitable for immunocytochemistry and the results from cases in which only frozen 
data was available were omitted from further analysis For immunocytochemical staining of 
cells  in  BALF,  processing  of  samples  should  be  performed  shortly  after  collection  of 
BALF without freezing.  
In  order  to  ensure  the  results  of  subsequent  investigations  would  be  accurate  the 
repeatability  of  our  methods  was  investigated  and  intra-observer  variability  analysed. 125 
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Unfortunately, definitive conclusions over the repeatability of these methods could not be 
reached and this may have influenced the validity of conclusions drawn in later chapters. 
Furthermore, our failure to investigate activity of HO-1 and iNOS, concusions were based 
upon a single assessment of expression in each sample. The standard deviation from the 
mean  was  greater  overall  for  neutrophils  than  for  other  cell  types.  The  reason  why 
neutrophil  counts  were  more  variable  is  uncertain.  There  did  not  appear  to  be  any 
differences in repeatability between staining for iNOS and HO-1. We could be confident 
therefore that any variation noted in subsequent chapters was likely to be a true finding and 
not due to errors introduced during sample processing and analysis.  
The  degree  of  HO-1  staining  in  different  types  of  leukocytes  from  BALF  was  then 
compared  to  known  markers  of  airway  inflammation.    The  percentage  of  neutrophils 
staining greater than 1 and greater than 2 for HO-1 correlated with both respiratory rate 
and  clinical  score  but  not  with  other  markers  of  inflammation  such  as  neutrophil 
percentage.  When  assessing  equine  respiratory  disease  the  number  of  neutrophils  as  a 
percentage of the total number of leukocytes in BALF is considered a reliable means of 
assessing the severity and correlates with histopathological changes in RAO (Larson and 
Busch  1985).  It  was  therefore  surprising  that  whilst  HO-1  expression  appeared  to  be 
related to clinical indicators of respiratory disease there was no relationship with relative 
neutrophilia. The significant associations that were identified between the percentage of 
neutrophils staining greater than 1 and 2 and clinical score are of questionable clinical 
relevance as only 3 horses actually had an abnormal clinical score and hence analysis was 
based upon very small numbers. Further investigations with more horses demonstrating 
more  marked  evidence  of  respiratory  dysfunction  at  rest  ought  to  be  performed.  No 
statistically  significant  associations  were  identified  between  HO-1  expression  and  the 
presence of a cough or tracheal mucus. Other associations between immunostaining of 
specific leukocyte types in BALF and clinical findings of respiratory disease were found 
also however they were of questionable relevance as eosinophils were only identified in 2 
horses and results were therefore based upon very limited data.  
Correlation  was  observed  between  high  percentages  of  neutrophils,  macrophages  and 
lymphocytes staining for iNOS and the percentage of eosinophils identified in BALF. In 
other species a number of associations between iNOS and eosinophil activity have been 
identified previously; however, in our study this statistically significant result was based 
uponthe presence of eosinophils in only one horse. Other significant correlations were seen 
between  iNOS  staining  in  particular  cell  types  and  indicators  of  respiratory  disease. 
Although plausible explanations for these relationships could be proposed there was no 126 
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apparent pattern to their occurrence and they may have resulted by chance due to the large 
number  of  statistical  tests  being  performed.  Furthermore  group  sizes  were  frequently 
uneven and hence tests were often being made with only 2 or 3 horses in one category. For 
example,  only  2  horses  had  normal  neutrophil  percentages  in  BALF  and  only  2  had 
positive (>0) clinical scores. 
In the current study there were statistically significant correlations between the degree of 
HO-1 and iNOS staining for 6 out of the 9 categories investigated. A positive correlation 
was identified for all degrees of macrophage staining and the 3 r values were between 0.6 
and 0.9 indicating a high level of correlation. Significant correlations were also identified 
for  the  percentage  of  neutrophils  staining  >  2  and  for  the  percentage  of  lymphocytes 
staining >1 and >2. The r values were greater than 0.6 indicating a strong correlation. It 
was a concern however that the data set was small and the presence of one or two outlying 
results may have had a large influence on the results of statistical analysis in some of the 
categories. Further work with greater case numbers should be performed. To the author‟s 
knowledge, associations between expression of HO-1 and iNOS in leukocytes in equine 
BALF have not been reported previously. Correlation between the two systems was not 
unexpected as significant and complex interactions between the two systems are known to 
exist in other species (Ryter and Otterbein 2004).  
Expression of HO-1 and iNOS in leukocytes from BALF was compared to markers of 
oxidative  stress  in  EBC.  Three  statistically  significant  results  were  identified  between 
expression of HO-1 but no significant results were identifieded between iNOS expression 
and  EBC  markers.  A  negative  correlation  was  identified  between  neutrophils  staining 
greater than 0 and H2O2 concentration in EBC whilst a positive correlation was identified 
for  lymphocytes  staining  greater  than  2  for  HO-1  and  H2O2  concentration  in  EBC.  A 
negative correlation was identified between neutrophils staining greater than 1 and EBC 
pH. The positive correlation with H2O2 and negative correlation with pH were expected, 
however the negative correlation with H2O2 was unexpected and contradicted the other 
significant result for H2O2. Considering only 3 of the 36 correlations investigated were 
significant and the results were contradictory it is unlikely that these results indicate a 
genuine association between HO-1 expression and markers in EBC. 
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The evidence of expression of HO-1 in leukocytes from the lower airways complements 
the findings of Wyse et al. (2006) who identified expression of HO-1 in type II alveolar 
cells,  macrophages  and  neutrophils  in  sections  of  lung  harvested  from  healthy  horses. 
Several  studies  have  investigated  the  expression  of  HO-1  in  the  lungs  of  humans.  In 
bronchial biopsies from human subjects there was no difference in expression of HO-1 
between  normal  and  asthmatic  patients  and  between  asthmatic  patients  treated  with 
corticosteroids and those that were untreated (Brunetti et al. 2006). By contrast, levels of 
HO-1 expression in macrophages from sputum have been demonstrated to be increased in 
asthmatic patients compared to healthy controls (Horvath et al. 1998). Furthermore, in a 
study  comparing  smoking  and  non-smoking  human  subjects,  immunostaining  was 
identified predominantly in alveolar macrophages (a median of 36% staining positive in 
smokers  and  13%  in  non-smoking  subjects)  (Maestrelli  et  al.  2001).  The  majority  of 
positive cells were present within the alveolar spaces rather than the bronchial epithelium; 
positive cells being mostly macrophages (Maestrelli et al. 2001).   
In human airways HO-1 is distributed widely in the airway sub-mucosa, particularly within 
macrophages (Brunetti et al. 2006). Immunoreactivity of positive cells in that study was 
intense and non-granular yet no particular association with the cell membrane or specific 
organelle was observed (Brunetti et al. 2006). In another study, HO-1 expression was not 
identified  in  subepithelial  T  lymphocytes  (Horvath  et  al.  1998).  In  mice,  HO-1 
immunostaining of macrophages, eosinophils, neutrophils, CD4+ and CD8+ T cells was 
determined by double immunostaining and confocal fluorescence (Kitada et al. 2001). The 
majority of HO-1 positive cells in tissue sections and BALF were macrophages (Kitada et 
al. 2001). Staining was diffuse but centered on the Golgi apparatus and perinuclear region.  
Expression of iNOS has been investigated in both equine health and disease. Horses with 
SPARAO had a higher  percentage of bronchial epithelial  cells  staining for iNOS  than 
disease-free  horses  in  one  study  (Costa  et  al.  2001).  In  that  study,  staining  of 
peribronchiolar leukocytes for iNOS was no greater for horses with SPARAO than for 
control  horses.  This  is  consistent  with  the  findings  of  our  study  in  which  no  clear 
association  could  be  determined  between  the  degree  of  iNOS  (or  HO-1)  staining  in 
leukocytes and clinical signs of disease. These findings may indicate that leukocytes are 
not the predominant source of iNOS and HO-1 in the equine respiratory tract. In asthmatic 
humans  and  animal  models  of  airway  hyperresponsiveness,  iNOS  is  believed  to  be 
synthesized principally by bronchial epithelial cells and macrophages (Barnes and Liew 
1995). In the present study, macrophages stained more frequently for iNOS than did other 128 
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leukocytes which suggests that macrophages may be a significant source of iNOS in horses 
as they are in man.  
9.2  Study Limitations and Suggestions for Further Investigations 
 
9.2.1 Use of Frozen Samples 
The number of horses recruited to the current study was limited by the discovery that slides 
prepared from frozen samples of BALF were unsuitable for immunocytochemistry. It was 
unfortunate  that  this  was  not  determined  prior  to  sample  collection,  however,  where 
possible  samples  fresh  samples  were  collected  from  the  outset.  Frozen  samples  were 
collected for logistical reasons because cytospin preparations could only be produced at the 
University of Glasgow. Samples collected at The Liphook Equine Hospital and samples 
collected at the University of Glasgow when the author was not available to process them 
were snap frozen in liquid nitrogen and maintained at -80°C for subsequent processing. It 
was assumed that cell preservation would have been adequate for immunocytochemistry as 
in  a  previous  study,  cytospun  BALF  slides  were  frozen  and  later  thawed  for 
immunostaining (Horvath et al. 1998). The fixing of cells during cytospin preparation may 
mitigate  the  deleterious  effects  of  freezing  resulting  in  an  acceptable  quality  of 
immunostaining in the study by Horvath et al. (1998) and not in the current study. 
The frozen cells were smaller and irregular in appearance when compared to fresh samples 
and cells were commonly aggregated making identification of individual cells difficult. 
Staining of background material was also greater in the slides of frozen BALF and it was 
presumed that constituents of the cytoplasm of damaged cells were contributing to the 
background staining. The freezing and thawing processes were presumed to have resulted 
in damage to the cell membrane and loss of cytoplasm into BALF. It is possible that when 
freezing is performed on cells that are already fixed in a cytospin preparation, loss of 
cytoplasmic contents is reduced or prevented and cytoplasmic granules containing HO-1 
and iNOS remain within the limits of the cell despite damage to its membranes. 
If further work is performed in this area cryopreservation techniques should be utilised. 
Foetal bovine serum may be added to 10% DMSO to enhance the survival of some cell 
lines and ought to be effective in preserving equine leukocytes. BALF could be centrifuged 
and  the  cell  pellet  resuspened  in  a  mixture  of  DMSO  and  foetal  bovine  serum. 
Alternatively a sericin cryopreservative solution consisting of phosphate-buffered saline, 
1% sericin, 0.5% maltose, 0.3% proline, 0.3% glutamine and 10% DMSO has recently 129 
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been  developed  and  may  be  better  than  solutions  containing  serum  that  can  become 
infected (Toyosawa et al. 2009). 
 
9.2.2 Staining Methods 
Differentiation of cell type was difficult in both the fresh and frozen samples. This was 
highlighted  by  the  fact  that  neither  eosinophils  nor  mast  cells  were  identified  in  the 
analysis  of  immunostained  slides  despite  their  presence  being  demonstrated  by 
conventional  staining  methods  for  cytological  examination.  Reasons  for  this  failure  in 
staining of eosinophils and mast cells are unclear. The staining process or the stain itself 
may have disrupted the characteristic appearance of these cell types making it difficult to 
distinguish these cells from other leukocytes. Previous studies have used morphological 
characteristics to identify immunostained cells (Wyse et al. 2006) and we expected that 
this  method  would  be  adequate  in  the  current  study.  In  experiments  performed  using 
respiratory  secretions  or  tissue  samples  from  human  and  laboratory  animals,  double 
immunostaining  techniques  were  commonly  utilized  to  identify  macrophages,  T 
lymphocytes, eosinophils and neutrophils (Kitada et al. 2001; Lim et al. 2000; Maestrelli et 
al. 2001). Confocal fluorescence was utilized in these experiments. We attempted to use 
double  immunostaining  without  confocal  fluorescence  but  this  did  not  facilitate 
identification.  In previous studies of respiratory samples, immunocytochemical staining of 
mast cells was not investigated.  
Expression  of  iNOS  within  mast  cells  has  been  demonstrated  both  by 
immunohistochemistry and by demonstrating the presence of mRNA by PCR (Gilchrist et 
al.  2002).  Mast  cells  obtained  from  peritoneal  fluid  exhibited  negligible  expression  of 
iNOS  compared  to  peritoneal  macrophages  (Gilchrist  et  al.  2002).    Further  study  of 
sections from the respiratory tract of horses diagnosed with respiratory disease would be 
valuable. 
 
9.2.3 Expression of iNOS and HO-1 in the Equine Respiratory 
Tract 
During  planning  of  the  current  study  it  was  our  intention  to  document  staining  in 
histological sections from different levels of the respiratory tract in horses with IAD, RAO 
and in control horses. Samples were collected during the study period; however they were 130 
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inadvertently destroyed prior to analysis. A previous study of HO-1 immunostaining in 
airways of healthy horses identified expression of the enzyme in type II alveolar cells, 
macrophages and neutrophils (Wyse et al. 2006). In human airways, HO-1 is distributed 
widely  in  the  airway  submucosa,  particularly  the  airway  epithelium  and  submucosal 
macrophages (Brunetti et al. 2006). In mice, the cytoplasm (particularly in the perinuclear 
region) of macrophages are the predominant source of HO-1 (Kitada et al. 2001). 
 
Expression of iNOS might be expected to be strongest in macrophages (Pechkovsky et al. 
2002) but may also be seen within the cytosol of a diverse range of cell types. In man, 
expression of iNOS has been reported in alveolar type II epithelial cells (Warner et al. 
1995), lung fibroblasts (Romanska et al. 2002), airway and vascular smooth muscle cells 
(Thomae et al. 1993; Xue et al. 1994; Griffiths et al. 1995), bronchial epithelial cells 
(Adcock et al. 1994; Robbins et al. 1994; Watkins et al. 1997; Pechkovsky et al. 2002), 
mast  cells  (Gilchrist  et  al.  2002),  endothelial  cells  (Ermert  et  al.  2002),  neutrophils 
(Boucher et al. 1999) and chondrocytes  (Kobzik et al. 1993; Ricciardolo et al. 2006). 
Under healthy conditions iNOS expression may not be detected (Buttery et al. 1994). 
 
Bronchial brushings have been collected in anaesthetised children to further investigate the 
expression of iNOS in respiratory tract epithelium (Lane et al. 2004). The brushings were 
used to extract RNA and cytospin preparations were prepared for immunostaining. All of 
the  epithelial  cells  stained  positive  for  iNOS  whilst  there  was  little  expression  within 
macrophages. Bronchial brushing would be a technique that could be adapted for use in 
horses  and  might  provide  a  means  for  further  investigation  of  epithelial  expression  of 
iNOS and HO-1. 
 
A chemiluminescent method has been described for measuring NO in equine body fluids 
(Mirza et al. 1999; Hubert et al. 2003; Mirza et al. 2005) which potentially provides a 
means of measuring NO in the lower respiratory tract without contamination from the 
upper respiratory tract. This method also has an advantage over the methods in the current 
study as it has been shown to be valid on samples exposed to frozen storage for up to a 
year (Hubert et al. 2003). In brief, aliquots are added to a purge chamber of vanadium 
chloride in 1N HCl under a nitrogen atmosphere. Nitric oxide is liberated into the gaseous 
headspace and conducted into an NO analyser where it is reacted with ozone to produce a 
chemiluminescent signal in the 650 to 800nm range. The amount of light is proportional to 
NO  concentration  which  is  calculated  from  a  standard  curve  of  known  concentrations 
(Hubert  et  al.  2003).  This  method  has  been  used  successfully  to  measure  NO 131 
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concentrations in equine plasma, abdominal fluid, urine and BALF (Mirza et al. 1999; 
Costa et  al. 2000a;  Hubert et al. 2003;  Mirza et  al. 2005).  In a study  of horses  with 
SPARAO, significant differences in NO concentration were observed in plasma but not in 
BALF (Costa et al. 2000b). Although this finding is contrary to findings in humans with 
asthma,  exhaled  NO  was  measured  in  the  human  studies  and  measurements  were 
potentially contaminated with NO of upper respiratory tract origin (Alving et al. 1993; 
Persson et al. 1994; Massaro et al. 1995; Kharitonov et al. 1996a). 
   
The  stage  in  the  disease  process  at  which  BALF  samples  were  collected  may  have 
influenced  the  degree  of  expression  of  both  HO-1  and  iNOS.  In  the  face  of  acute 
inflammation, iNOS activity is expected to increase whilst HO activity initially decreases 
with the highest levels of expression being recorded as inflammation is resolving (Willis et 
al. 1996). Willis et al. (1996) speculated that during tissue inflammation there may be 
sequential induction of enzymes with pro-inflammatory effects, for example COX-2 and 
iNOS,  followed  by  increased  expression  of  enzymes  with  anti-inflammatory  effects, 
including  HO-1,  which  are  responsible  for  the  resolution  of  inflammatory  lesions  and 
aimed at preventing a chronic inflammatory response.  
The effects of timing on HO-1 expression in horses could be investigated further; however 
challenge studies in horses known to suffer from RAO would probably be required  to 
ensure sample collection early in the course of the inflammatory response and to ensure 
that the stage of the disease process was determined accurately.  
 
9.2.4 Activity of HO-1 in The Equine Respiratory Tract 
It was also our intention to investigate the activity of HO-1 in sections of pulmonary tissue 
from horses with respiratory disease and control animals with neither historical nor clinical 
evidence of respiratory disease. The activity of HO-1 has been measured in human lung 
tissue  (Tenhunen  et  al.  1968;  Carraway  et  al.  1998)  and  these  methods  have  been 
employed to determine HO-1 expression in equine lung tissue (Wyse et al. 2006). The 
methods are relatively straightforward and in preliminary work were used in the current 
study  (data  not  shown).  Tissue  samples  were  collected  immediately  after  death  from 
different regions of the lung; cranioventral lobes, caudodorsal lobes and a central location 
equally spaced between the two other sample sites. The samples were flushed via the larger 
arteries and bronchioles with 0.9% sodium chloride solution and immediately snap frozen 
in liquid nitrogen. They were then stored at -80°C for subsequent analysis. Liver was also 132 
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harvested as a source of biliverdin reductase and the spleen sampled as a positive control 
for HO-1 (Carraway et al. 1998).   
 
Tissue was homogenized in a buffer of 50mM Tris-HCl, 2mM magnesium chloride and 
250mM sucrose (pH7.4) containing the protease inhibitors pepstatin (8.4µM), leupeptin 
(5.8  µM)  and  pefabloc  (0.2mM)  (Sigma).  The  homogenates  were  sonicated  and  then 
centrifuged  for  20  minutes  at  18,000  g  to  separate  the  cytosolic  fraction.  The  protein 
content of each cellular fraction was determined by the bicinchoninic acid colorimetric 
method.  Haem  oxygenase  activity  was  measured  in  lung  and  spleen  supernatant  by 
incubation with NADPH, haemin and liver cytosol. Samples were incubated in darkness at 
60°C for 1 hour. Bilirubin  was  extracted in  500µl  of chlorophorm  and measured as  a 
change in the optical density at 464nm and 530nm using a molar extinction coefficient of 
51,819.  
This  method  was  used  successfully  for  measurement  of  HO-1  activity  in  the  lungs  of 
horses  subjected  to  euthanasia  at  the  University  of  Glasgow  for  reasons  other  than 
respiratory disease and the results were consistent with those of Wyse et al. (2006). It was 
expected  that  through  the  study  period  a  small  number  of  cases  with  respiratory  tract 
inflammation would be subjected to euthanasia even if respiratory tract disease was not the 
primary reason for euthanasia. Unfortunately, insufficient horses with respiratory disease 
were recruited to the study of tissue expression of iNOS and HO-1 to generate worthwhile 
data. Whilst respiratory disease is a common cause of impaired athletic performance in 
horses and may severely affect a minority of animals at rest it is rarely severe enough to 
warrant  euthanasia.  Respiratory  disease  is  commonly  encountered  by  veterinarians  in 
clinical  practice  and  cases  are  seldom  referred  for  further  investigation.    Further 
investigation would be valuable in the future if respiratory tract tissue samples from horses 
known to be suffering from respiratory disease could be snap frozen in liquid nitrogen 
immediately following euthanasia.  
9.2.5 Measurement of Exhaled Gases 
Carbon monoxide and NO may be clinically useful indicators of the activity of HO-1 and 
iNOS respectively. Measurement of these exhaled gases in addition to measurement of 
H2O2 concentration and pH in breath condensate would have been a logical addition to the 
present study. Concentrations of exhaled CO have been identified to be associated with the 
clinical severity of asthma (Zayasu et al. 1997; Horvath et al. 1998; Yamaya et al. 2001) 
and are reduced in patients receiving corticosteroid therapy (Horvath et al. 1998). In a 133 
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previous study exhaled CO was measured in 6 horses using a portable electrochemical 
monitor (Microlyser; Bedfont Scientific) (Wyse et al. 2005). Although the monitor was 
sensitive to 1ppm within a range of 1-500ppm the monitor frequently failed to detect any 
expired  CO  (Wyse  et  al.  2005).  An  increase  in  expired  CO  was  identified  following 
exposure to hay and straw, however results in both management systems ranged from 0-
2ppm (out of 500) indicating the relative imprecision of the instrument (Wyse et al. 2005). 
In human studies similar methods of analysis are used but concentrations of 4-15 ppm are 
reported (Zayasu et al. 1997).  
 
It was our intention to use the same monitor as used by Wyse et al. 2005 in order to 
investigate the relationship between expired CO and HO-1 expression. During initial pilot 
studies concentrations of CO failed to measure above 1ppm (and in the majority of cases 
measured  0)  in  horses  diagnosed  with  clinical  respiratory  disease.  As  the  methods  of 
measurement available were so imprecise at the required range, expired concentrations of 
CO were not monitored in the current study as it was considered that the results were likely 
to  have  been  misleading.  If  more  sensitive  and  affordable  analysers  were  to  become 
available then they would provide a valuable tool with which to investigate the relationship 
between  expired  CO,  HO-1  activity  and  equine  respiratory  disease.  In  addition  to  the 
imprecision of currently available methods of measurement there are practical difficulties 
in the assessment of exhaled CO concentrations in animals. Human patients are required to 
breath-hold for 20 seconds creating an accumulation of CO in the exhaled breath (Zayasu 
et al. 1997). Although this is not possible in horses, a form of re-breathing system with 
subsequent analysis of collected gas might be a means by which CO could be measured in 
future.  In  humans,  exercise  resulted  in  a  3-fold  increase  in  expired  CO  and  remained 
increased for 10 minutes (Horvath et al. 2005). Although exercise would not be possible in 
equine  patients  with  severe  respiratory  disease,  post-exercise  testing  in  athletic  horses 
might provide another means by which exhaled CO monitoring could be improved.  
 
Exhaled CO provides a useful monitor of disease severity in humans and concentrations 
decrease  following  treatment  with  corticosteroids  (Horvath  et  al.  2005).  If  practical 
methods  of  monitoring  could  be  employed  then  this  might  provide  a  useful  and  non-
invasive means of assessing respiratory health in horses. Non-invasive monitoring may 
even  be  useful  in  performance  horses  (in  which  sedation  and  airway  washes  are  not 
possible)  and  in  monitoring  the  efficacy  of  inhaled  or  systemic  treatment  with 
corticosteroids. In human medicine, exhaled breath analysis may be used to detect mild 
inflammation that is not detectable by pulmonary function tests (Choi et al. 2006). 134 
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Practical considerations prevented the measurement of NO in the current study. A number 
of  different  analysers  are  available,  however  they  all  measure  NO  concentration  by 
chemiluminescence and are extremely expensive (Hanazawa et al. 2000). Nitric oxide is 
one of the earliest and most sensitive indicators of airway inflammation in human asthma 
and is also produced in other inflammatory diseases such as bronchial hyperreactivity, 
COPD  and  interstitial  lung  disease  (Clini  et  al.  1998;  de  Jongste  and  Alving  2000). 
Exhaled NO is a very sensitive indicator of subclinical or early clinical disease and is also 
sensitive in monitoring responses to inhaled corticosteroids  (Choi et al. 2006). As NO 
concentrations  are  only  affected  by  inflammation  and  are  not  influenced  by 
bronchoconstriction, measurement may allow differential assessment of responses to anti-
inflammatory medications compared to bronchodilators such as beta2-agonists (Hanazawa 
et  al.  2000).  Measurement  of  NO  concentration  might  therefore  provide  valuable 
information as to the severity of respiratory disease and responses to treatment in horses in 
a non-invasive manner.  
 
In addition to being produced in the lower respiratory tract, NO is also derived from the 
nasal passages, especially in species with paranasal sinuses, and by microbes in saliva 
(Lundberg et al. 1994). Within the lower airways, the conducting airways produce more 
than  the  alveolar  region  (Hanazawa  et  al.  2000).  In  human  medicine,  NO  has  to  be 
collected during mouth breathing. In addition, direct methods of analysis are preferred to 
offline methods in which exhaled breath is stored (Hanazawa et al. 2000). This presents 
practical difficulties in analysis of breath from horses which cannot be instructed on how to 
breathe into an analyser. Flow rate has a large influence on the concentration of expired 
NO  and  therefore  must  remain  constant  (Silkoff  et  al.  1997).  In  human  patients, 
contribution from the upper airways is controlled by closing the soft palate using balloon 
catheters,  ensuring  exhalation  against  resistance  or  using  a  nose-clip  (Hanazawa  et  al. 
2000). Collection of exhaled breath for measurement of NO is difficult in children less 
than 7 years of age and not performed in children less than 4. It is therefore likely to prove 
difficult, if not impossible, to achieve accurate measurements in horses (Choi et al. 2006).  
 
The concentration of exhaled NO in exercising horses has been measured  (Mills et al. 
1996a). The authors suggested that the production of NO by the nasal mucosa may not be 
as significant as previously thought. They found no difference in exhaled NO at high and 
low flow rates and found no differences when an endotracheal tube was placed during 
anaesthesia (Mills et al. 1996b). The importance of nasal sources may therefore be less 135 
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important than the human literature would suggest and may decrease during exercise (Mills 
et  al.  1996a).  Further  investigation  into  associations  between  exhaled  NO  and  equine 
respiratory function are warranted. 
 
9.2.6 Measurement of Exhaled Breath Condensate 
Exhaled breath condensate, thought to be vapourised epithelial lining fluid of the lower 
airways (Chapman et al. 2000) has been investigated extensively in human medicine and is 
practical for use in horses (Deaton et al. 2004b; Wyse et al. 2005; Duz et al. 2009). There 
is potential for further exploration of the use of analysis of exhaled breath and breath 
condensate. Although results in equine studies have been disappointing to date (Deaton et 
al. 2004b; Wyse et al. 2005; Duz et al. 2009) investigation in veterinary medicine lags 
behind  investigation  of  human  respiratory  disease,  most  notably  asthma  and  there  are 
numerous avenues that remain to be explored. In human breath condensate over 300 gases 
have been identified and several have been associated with respiratory disease (Phillips et 
al. 1999). Pentane, ethane, carbon monoxide and nitric oxide have all been investigated as 
markers of inflammation and oxidative stress in humans (Kharitonov et al. 1994; Horvath 
et al. 1998) and have been identified in horses (Wyse et al. 2005). Hydrogen peroxide is 
the  most  extensively  studied  but  numerous  other  products  of  oxidative  stress  and 
inflammation are amenable to measurement by relatively inexpensive ELISA techniques 
(Wyse et al. 2004). 
 
9.3 Wider Significance of These Findings with Respect to Equine 
Respiratory Disease 
The expression of iNOS and HO-1 will be influenced by all inflammatory disease states 
and may have relevance to respiratory tract diseases that are of importance in horses. Most 
notably, expression of HO-1 is likely to be integral to the pathogenesis of exercise-induced 
pulmonary  haemorrhage  (EIPH);  a  disease  that  is  of  great  importance  to  the  equine 
industry. The importance of HO-1 and its products have not yet been investigated in this 
disease. 
 
During high-velocity exercise the pressure differential between the capillaries and alveolar 
lumen  increases  resulting  in  rupture  of  the  alveolar  capillaries  (Hinchcliff  2007). 
Haemorrhage into the interstitial space and alveoli results in rostral movement of blood in 
the  airways  and  the  presence  of  blood  in  the  bronchi  and  trachea  (Hinchcliff  2007). 136 
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Inflammation of the small airways such as occurs in IAD and RAO is one of a number of 
potential factors that may increase susceptibility to EIPH (Hinchcliff 2007). Haem released 
during haemorrhage into the airways may further contribute to the degree of inflammation 
resulting  in  a  positive  feedback  loop  and  a  progressive  increase  in  the  degree  of 
inflammation within the airways. Haem catalyses the formation of ROS thereby inducing 
oxidative  stress  and  cell  damage  (Jeney  et  al.  2002).  Haem  is  highly  lipophilic  and 
intercalates readily with the lipid membranes of cells and intracellular organelles, thereby 
rendering them unstable (Balla et al. 1991). 
 
The presence of haem  in  the airways  as  a result of haemorrhage is  likely to  result in 
induction of HO-1. The significance of haem as a pro-inflammatory mediator is implied by 
the  number  of  endogenous  mechanisms  that  have  been  identified  to  reduce  free  haem 
(Wagener et al. 2003). In man and laboratory species intracellular proteins such as haem 
binding  protein  23,  HO-2  and  HO-3  and  extracellular  proteins  such  as  albumin, 
haemopexin  and  HO-1  scavenge  free  haem  (Muller-Eberhard  and  Fraig  1993;  Maines 
1997). 
 
Haem oxygenase enzymes perform a vital physiological role in the metabolism of haem 
during  the  breakdown  of  senescent  erythrocytes  in  reticuloendothelial  cells  and  in  the 
turnover of intracellular haemoproteins and cytochromes, thereby ensuring redistribution 
of  haem  and  iron  to  the  tissues  (Maines  1988;  Poss  and  Tonegawa  1997).  Haem 
oxygenase-1 induction by haemoglobin infusion was demonstrated to be protective in a rat 
model of lipopolysaccharide-induced inflammatory lung injury (Otterbein et al. 1995). In 
vitro  studies  in  which  HO-1  was  produced  in  excess  of  physiological  requirements 
provided  evidence  of  conferred  protection  against  haem  and  haemoglobin-mediated 
toxicity (Abraham et al. 2006). Further investigation of the expression of HO-1 within the 
lungs of horses with EIPH might therefore be worthwhile and induction of HO-1 might 
have protective affects in horses affected by the disease.  
 
A therapeutic intervention for EIPH would be of huge potential significance. Almost all 
thoroughbred racehorses in training have haemosiderophages in BALF indicating a degree 
of  EIPH  (McKane  et  al.  1993).  Estimates  of  prevalence  based  upon  endoscopic 
examination range from 43 to 80% in racing Thoroughbreds (Pascoe et al. 1981; Raphel 
and Soma 1982; Sweeney et al. 1990). Whilst prevalence is generally lower in horses 
performing other athletic disciplines EIPH is also performance-limiting in Quarter horses, 
polo  ponies  and  eventers  (Hinchcliff  2007).  The  disease  is  performance-limiting, 137 
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recurrence  rate  is  high  and  the  costs  to  the  equine,  particularly  racing,  industry  are 
immense. 
 
As the roles of HO-1 and iNOS become elucidated there may be merit in investigating the 
effects  of  corticosteroids  on  their  expression.  Corticosteroids  are  used  commonly  as  a 
treatment for inflammatory diseases of the lower airways in horses.  In asthma, exhaled 
NO  concentrations  are  reduced  by  corticosteroid  therapy  (Hanazawa  et  al.  2000). 
Numerous murine models have demonstrated the inhibitory effects of steroids on iNOS 
(Donnelly and Barnes 2002). However, iNOS expression in human airway epithelial cells 
is  steroid  insensitive  (Nyman  et  al.  1991)  and  hence  inhibition  may  be  indirect  via 
suppression of IL-1β or TNF-α. A glucocorticoid response element is present in the HO-1 
promoter  and  gene  expression  of  HO-1  may  be  inhibited  by  corticosteroids  in  vitro 
(Brunetti et al. 2006).  
It is likely that the interactions between corticosteroids, HO-1, iNOS and the potentially 
therapeutic products of these proteins CO and NO will be exceedingly complex. However, 
as our understanding improves we may identify novel therapeutic targets that will allow 
improved management of equine respiratory disease. 
9.4  Conclusions 
Haem oxygenase-1 and iNOS are expressed in equine leukocytes collected from BALF. 
Convincing evidence that the expression of either HO-1 or iNOS in leukocytes from BALF 
was increased in horses with evidence of lower respiratory tract inflammation  was not 
obtained, however there was limited evidence of an association between expression of the 
2  proteins.  There  was  no  evidence  of  an  association  between  either  HO-1  or  iNOS 
expression and markers of oxidative stress measured in EBC. Further investigations into 
the expression and activity of HO-1 and iNOS ought to be performed with larger numbers 
of horses at different stages of different respiratory diseases.  
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Appendix 1 
 
 
Clinical Examination Form 
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Owner:     Horse:        Case Number:    
               
Age:     Breed:        Sex:       
               
        Date of Examination:       
               
Nasal Discharge 
(volume/nature)          Medial Nostril Flare (0-4)
 Ө    
                   
           Lateral Nostril Flare (0-4)    
                 
Cough (frequency/nature)          Abdominal Compression (0-4)    
                   
           Clinical Score    
               
           Bronchoalveolar Lavage:    
Condition Score
#          Fluid Retrieved (ml)      
                   
mucous membs (colour/CRT)          Total white cell count (x10
9/l)    
                   
Heart Rate          Neutrophils (%)      
                   
Respiratory Rate          Macrophages (%)      
                   
Rectal Temperature(
oc)          Lymphocytes (%)      
                    
        Eosinophils (%)      
Tracheal Auscultation                   
          Mast Cells (%)      
                      
               
Thoracic Auscultation                      
                 
                       
Auscultation (Rebreathing 
bag)                      
                 
                       
Tracheo/ Bronchoscopic findings:                   
                 
            Tracheal mucus score
*    
 
   
  Equine Respiratory Disease Examination Form        
  (Explanatory Notes Overleaf)        
         
  
The Liphook 
Equine Hospital  187 
  187 
*Tracheal mucus score:  
Grade 0 - None 
Grade 1-  little, multiple small blobs 
Grade 2 – moderate larger blobs 
Grade 3 – marked, confluent to stream forming 
Grade 4 – Large pool forming 
Grade 5 – Extreme, profuse amounts 
 
#Condition Score: 
(Carroll and Huntingdon, 1988) 
 
ӨClinical Score: (Seahorn, 1997) 
 
Medial Flare + Lateral Flare  + Abdominal Lift  = CS 
                         2    
Nostril flare: 
0= little or no movement on inspiration 
1= slight flare during inspiration, returning to normal as inspiration ends 
2= slight flare during inspiration, returning to near normal as inspiration ends 
3= greater flare during inspiration and flare does not approach normal position                                                         
during exhalation 
4= nostril remains maximally flared throughout respiratory cycle 
Abdominal Lift: 
0= no or little movement in the ventral region of the flank 
1= slight abdominal flattening with “heave line” beginning to form in the cranial portion of 
the ventral aspect of the flank 
2= obvious abdominal flattening and “heave line” extending to halfway between tuber 
coxae and the cubital joint 
3= obvious abdominal flattening and “heave line” extending beyond halfway between 
tuber coxae and the cubital joint, but not to the joint 
4= obvious flattening and “heave line” extending to the cubital joint 
 
Discharge:   nil, scant, moderate, profuse 
serous, mucopurulent, purulent, brown/beige, blood tinged 
 
Cough:  occasional, frequent single, frequent paroxysmal, at exercise 
    Productive or non-productive. Dry or wet sounding. 188 
  188 
Appendix 2 
 
 
 
 
Lung Tissue Collection189 
  189 
Characterising HO-1 and iNOS Expression in the Equine Respiratory 
Tract 
 
 
 
 Horses with Recurrent Airway Obstruction euthanased by firearm: 
 
 
One sample to be taken from each site (A-D) then 
1.  placed in PBS immediately 
2.  flushed with PBS using a pipette 
3.  placed in formalin  
4.  submitted to Colin for histopathology, HO staining and iNOS staining 
                                
 
 
 
Collection from either right or left lung 
A-Cranioventral Lung Lobe  
B- Cranial end of Caudal Lobe 
C- Caudodorsal Lung Lobe 
D- Bronchus (of a size that fits comfortably on a microscope slide) 
 
 
Thank you  
Any problems or questions please contact Dave Rendle on 07766080295 or speak to 
Sandy Love 
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Frozen Data 
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Appendix 4 
 
Appendix 4.1. Histograms for each horse showing sequential results of 3 examinations of 
the same samples stained for HO-1. Results from the 3 sequential examinations are shown 
consecutively with macrophages grades 0-3 (1-12 on x axis) followed by neutrophils 
grades 0-3 (13-24 on x axis) then mononuclear cells 0-3 (25-36 on x axis).  
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Appendix 4.2. Histograms for each horse showing sequential results of 3 examinations of 
the same samples stained for iNOS. Results from the 3 sequential examinations are shown 
consecutively with macrophages grades 0-3 (1-12 on x axis) followed by neutrophils 
grades 0-3 (13-24 on x axis) then mononuclear cells 0-3 (25-36 on x axis).  
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Appendix 5 
List of Manufacturers 
Adobe Systems Incorporated, 345 Park Avenue, San Jose, CA 95110-2704, USA 
 
Biomol International, Palatine House, Matford Court, Exeter, EX2 8NL, UK 
 
Bivona Inc, 5700 West 23
rd Avenue, Gary, Indiana, 46406USA 
 
BMG Labtech Ltd, PO Box 73, Aylesbury, HP20 2QJ, United Kingdom 
 
Cook Veterinary Products, Cook Medical Inc., PO Box 4195, Bloomington, Indiana 
47402-4195, USA 
 
Cranlea and Company, The Sandpits, Acacia Road, Bournville, Birmingham, B30 2AH, 
UK  
 
Hanna Instruments Ltd., Eden Way, Pages Industrial Park, Leighton Buzzard, 
Bedfordshire, LU7 4AD, UK  
 
Dako UK Ltd, Cambridge House, St Thomas Place, Ely, Cambridgeshire, CB7 4EX, UK 
 
EV Veterinary Products, The Barn, Wrestlers Farm, Brockhurst Road, Brockhurst, 
Shropshire, TF11 8NE, UK 
 
Karl Storz, Mittelstrasse 8, Postfach 230, 78503, Tuttlingen, Germany 
 
Microsoft Corporation, One Microsoft Way, Richmond, WA 98052- USA  
 
Minitab Inc, Minitab Headquarters , 3801 Enterprise Drive, State College, PA 16801, USA  
 
Sigma-Aldrich Company Ltd., The Old Brickyard, New Road, Gillingham, Dorset, SP8 
4XT, UK  
 
 
 
 